Bacterial Cell To Cell Communication
Bacterial Cell To Cell Communication
Bacterial Cell To Cell Communication
-
k
e
t
o
-
d
e
c
a
n
o
i
c
a
c
i
d
(
C
H
2
)
6
(
C
H
2
)
6
C C
H
2
O
S C
H
3
(
C
H
2
)
6
P
q
s
B
,
P
q
s
C
,
o
r
P
q
s
D
P
q
s
A
?
N H O
N H O
?
P
q
s
H
P
Q
S
C
O
2
p
q
s
H
N
H
2
C
O
O
H
a
n
t
h
r
a
n
i
l
a
t
e
N
H
2
C
C
o
A
O
S
P
q
s
A
?
O
H
C
O
F
i
g
u
r
e
2
.
2
.
P
r
o
p
o
s
e
d
s
y
n
t
h
e
s
i
s
s
c
h
e
m
e
f
o
r
P
Q
S
.
E
n
z
y
m
a
t
i
c
a
c
t
i
v
i
t
i
e
s
f
o
r
p
r
o
t
e
i
n
s
e
n
c
o
d
e
d
b
y
t
h
e
P
Q
S
s
y
n
t
h
e
t
i
c
r
e
g
i
o
n
h
a
v
e
n
o
t
b
e
e
n
p
r
o
v
e
n
,
b
u
t
a
p
o
s
s
i
b
l
e
s
y
n
t
h
e
s
i
s
s
c
h
e
m
e
c
a
n
b
e
p
r
o
p
o
s
e
d
b
a
s
e
d
o
n
h
o
m
o
l
o
g
i
e
s
t
o
k
n
o
w
n
e
n
z
y
m
e
s
.
I
n
t
h
i
s
m
o
d
e
l
,
t
h
e
p
u
t
a
t
i
v
e
c
o
e
n
z
y
m
e
A
(
C
o
A
)
l
i
g
a
s
e
,
P
q
s
A
,
l
i
n
k
s
C
o
A
t
o
e
i
t
h
e
r
a
t
e
n
-
c
a
r
b
o
n
a
c
y
l
c
h
a
i
n
o
r
a
n
t
h
r
a
n
i
l
a
t
e
.
T
h
e
q
u
e
s
t
i
o
n
m
a
r
k
s
b
y
P
q
s
A
i
n
d
i
c
a
t
e
t
h
e
p
o
s
s
i
b
i
l
i
t
y
o
f
t
h
e
e
n
z
y
m
e
s
a
c
t
i
n
g
i
n
o
n
e
r
e
a
c
t
i
o
n
o
r
t
h
e
o
t
h
e
r
.
T
h
e
a
c
y
l
c
h
a
i
n
i
s
t
h
e
n
t
r
a
n
s
f
e
r
r
e
d
t
o
a
n
a
c
y
l
c
a
r
r
i
e
r
p
r
o
t
e
i
n
(
A
C
P
)
t
h
r
o
u
g
h
t
h
e
a
c
t
i
o
n
o
f
o
n
e
o
f
t
h
e
t
h
r
e
e
p
u
t
a
t
i
v
e
a
c
y
l
c
a
r
r
i
e
r
p
r
o
t
e
i
n
s
y
n
t
h
a
s
e
s
e
n
c
o
d
e
d
b
y
p
q
s
B
,
p
q
s
C
,
a
n
d
p
q
s
D
.
T
h
e
s
e
d
i
f
f
e
r
e
n
t
p
u
t
a
t
i
v
e
A
C
P
s
y
n
t
h
a
s
e
s
c
o
u
l
d
b
e
r
e
s
p
o
n
s
i
b
l
e
f
o
r
t
h
e
g
r
e
a
t
v
a
r
i
a
b
i
l
i
t
y
s
e
e
n
i
n
2
-
a
l
k
y
l
-
4
-
q
u
i
n
o
l
o
n
e
s
.
W
h
i
l
e
t
h
i
s
i
s
h
a
p
p
e
n
i
n
g
,
c
h
o
r
i
s
m
a
t
e
i
s
c
o
n
v
e
r
t
e
d
t
o
a
n
t
h
r
a
n
i
l
a
t
e
t
h
r
o
u
g
h
t
h
e
a
c
t
i
o
n
o
f
t
h
e
p
u
t
a
t
i
v
e
a
n
t
h
r
a
n
i
l
a
t
e
s
y
n
t
h
a
s
e
P
h
n
A
B
.
A
n
t
h
r
a
n
i
l
a
t
e
i
s
t
h
e
n
c
h
a
r
g
e
d
w
i
t
h
C
o
A
,
p
o
s
s
i
b
l
y
b
y
P
q
s
A
a
s
m
e
n
t
i
o
n
e
d
a
b
o
v
e
.
A
n
t
h
r
a
n
i
l
a
t
e
-
C
o
A
w
o
u
l
d
t
h
e
n
b
e
c
o
n
d
e
n
s
e
d
w
i
t
h
t
h
e
b
-
k
e
t
o
-
d
e
c
a
n
o
i
c
a
c
i
d
a
t
t
a
c
h
e
d
t
o
t
h
e
A
C
P
a
n
d
t
h
e
d
i
r
e
c
t
P
Q
S
p
r
e
c
u
r
s
o
r
w
o
u
l
d
r
e
s
u
l
t
.
T
h
e
q
u
e
s
t
i
o
n
m
a
r
k
b
y
t
h
i
s
r
e
a
c
t
i
o
n
i
n
d
i
c
a
t
e
s
t
h
a
t
t
h
e
c
o
n
d
e
n
s
a
t
i
o
n
o
c
c
u
r
s
v
i
a
t
h
e
a
c
t
i
o
n
o
f
a
n
u
n
i
d
e
n
t
i
f
i
e
d
e
n
z
y
m
e
.
T
h
e
p
u
t
a
t
i
v
e
m
o
n
o
o
x
y
g
e
n
a
s
e
e
n
c
o
d
e
d
b
y
p
q
s
H
w
o
u
l
d
t
h
e
n
a
d
d
t
h
e
h
y
d
r
o
x
y
g
r
o
u
p
t
o
t
h
e
t
h
i
r
d
c
a
r
b
o
n
o
f
t
h
e
p
r
e
c
u
r
s
o
r
t
o
p
r
o
d
u
c
e
P
Q
S
.
separate lines of research. First, it was determined through an agar plate
cross-feeding assay that a pqsHmutant can feed a pqsC or pqsDmutant with a
compound that allows the production of PQS (13). Because these strains are
most likely affected at an early step of PQS production, the pqsH mutant
must be able to make a compound that is close to, or the direct precursor
of, PQS. Second, radiolabeled 2-heptyl-4-quinolone is converted to PQS by
a wild-type strain (9). This result suggested that this compound is the
immediate precursor of PQS and implied that a monooxygenase should be
responsible for the conversion of the precursor into PQS.
The main PQS biosynthetic gene cluster was then discovered because
of the involvement of anthranilate in PQS synthesis. The basic synthetic
pathway for quinolone compounds has been elucidated (6). This pathway
suggested that anthranilate would be a precursor for PQS synthesis and
this was shown to be the case when radiolabeled anthranilate was converted
into PQS (3). P. aeruginosa encodes at least four anthranilate synthases, one
of which is PhnAB. The phnA and phnB genes putatively encode the large
and small subunit, respectively, of anthranilate synthase (11). PhnAB was
initially believed to be directly involved in the synthesis of the blue phena-
zine compound pyocyanin (11). This role was made less likely with the
discovery that P. aeruginosa encodes two separate, duplicate phenazine
synthetic gene clusters, each with its own anthranilate synthase homolog (23).
A survey of mutants that contained insertions in and around the phnAB region
showed that this location was required for PQS synthesis (13). These mutants
were originally pooled because they did not produce pyocyanin, indicating
that PQS controls pyocyanin production (13). This also implies that
the regulation of pyocyanin by phnAB happens indirectly through PQS.
The genes of this region that were identified as being required for
PQS production were: PA0998 and PA0999, both of which are b-keto-
acylacyl carrier protein synthase homologs; PA1001 (phnA); and PA1003,
which is homologous to members of the LysR-type regulator family (13).
This genetic region is summarized in Figure 2.2. This study also showed
that the monooxygenase homolog encoded by pqsH (gene PA2587)
was required for PQS synthesis (13). At the same time, a parallel study led
to the identification of this region as being important for the autolytic
phenotype exhibited by older, plate-grown cultures of P. aeruginosa (7). It
was shown that the phenotype of a mutant that produced colonies with
concentric zones of lysis could be suppressed by the mutation of genes
within the PQS synthetic region (7). Included in the genes that affected
autolysis were: gene PA0996, which encodes a hydroxybenzoate CoA ligase
homolog; gene PA0997, which encodes a beta-keto-acylacyl-carrier protein
E
.
C
.
P
E
S
C
I
28
synthase homolog; PA0998, PA0999, PA1003, and PA2587 (the latter four
genes were identified above) (7). All of these genes were found to be neces-
sary for PQS production (7). To simplify the nomenclature of these genes,
genes PA0996 through PA1000 were named pqsABCDE (7, 13). Gene
PA1003 was previously published as mvf R (4), and was renamed pqsR
because of its location in the PQS synthetic region and its role in regulating
PQS production (discussed below) (7, 13). Gene PA2587 was subsequently
named pqsH (7, 13). In addition, gene PA4444, which was responsible for
the autolytic phenotype discussed above and encodes a homolog of a mono-
oxygenase (like pqsH), was named pqsL (7). The loss of this gene actually
causes PQS production to be increased 4-fold (7) and it has been shown that
pqsH and pqsL may be competing to convert 2-heptyl-4-quinolone to PQS or
an alternate compound (21).
Overall, this group of genes appears to encode much of what is required
for the synthesis of PQS from basic precursor molecules. For the sake
of caution, it must be pointed out that this statement is based only on
homology, and true enzymatic roles for the encoded proteins have not been
determined. Our proposed synthesis scheme is included in Figure 2.2.
THE REGULATION OF PQS SYNTHESIS
Mutant complementation studies and reverse transcriptase PCR
experiments showed that pqsABCDE and phnAB are transcribed as two
separate polycistronic operons (13, 24). As mentioned above, insertions in
pqsA, pqsB, pqsC, pqsD, or phnA all lead to the loss of PQS (7, 13).
The necessity of the phnB gene for PQS synthesis has not been determined;
a mutant with an insertion in pqsE, which encodes a hypothetical protein,
still makes a normal amount of PQS (13). Most interestingly, the pqsE
mutant was still defective in pyocyanin production (13). This mutant
was also found to be unable to respond to exogenous PQS, indicating that
PqsE is important for the cell to respond to PQS (13). Further studies are
necessary to determine the role of pqsE in the cellular response to PQS.
Preliminary studies on the expression of the pqsABCDE operon have
shown that it is regulated in a very complex manner. A pqsA
0
lacZ fusion
was not induced in either a lasI or a pqsR mutant, indicating that pqsABCDE
expression is positively controlled by the las quorum sensing system and
PqsR (24). The production of PQS was greatly reduced in these mutant
strains, thereby confirming the reporter fusion data (24). The reliance of
pqsA on a functional pqsR gene was also confirmed in a separate study (9).
Most interestingly, when the pqsA
0
lacZ reporter was placed in a rhlI
29
T
H
E
P
.
A
E
R
U
G
I
N
O
S
A
Q
U
I
N
O
L
O
N
E
S
I
G
N
A
L
mutant, it was induced to a level that was greater than 7-fold higher than
that seen in the wild type strain (24). PQS production was also increased
6-fold in this strain (24). These results indicated that pqsABCDE is regulated
in a negative manner by the rhl quorum sensing system. Whether these
regulation events are the result of direct or indirect interactions of LasR,
RhlR, and/or PqsR with the promoter region of pqsA is not known. It is
worthy of note that the pqsA promoter region has two sequences that are
similar to quorumsensing operator sequences, which might allowfor dual or
alternate binding of both LasR and RhlR (24). Although the importance of
these sequences has not been directly investigated, there are data that suggest
that some type of competition is occurring at the pqsApromoter. The addition
of exogenous C
4
-HSL was able to inhibit the induction of pqsABCDE by
exogenous 3-oxo-C
12
-HSL in a mutant that produces neither signal (24).
In addition, the production of PQS, which was induced by 3-oxo-C
12
-HSL,
was inhibited by C
4
-HSL (24). Taken together, these data imply that
a competition between C
4
-HSL and 3-oxo-C
12
-HSL occurs during the
induction of pqsABCDE. A model for the proposed regulation scheme for
PQS is presented in Figure 2.3.
The second operon of the PQS synthetic region is also tightly
controlled. The expression of phnAB has been shown to be directly
regulated by PqsR. A pqsR mutant does not express phnAB and PqsR was
shown to bind specifically to the phnAB promoter region (4). PqsR also
appeared to have no effect on the expression of lasR or rhlR (4). Overall, the
available data suggest that the main role of PqsR is to act as a master
regulator for the two operons of the PQS synthetic region to which it is
adjacent.
Finally, the regulation of PqsR is also quite interesting. It has been
found that this regulator is inactivated through cleavage. This regulatory
event was discovered when cells expressing a PqsRGST fusion protein
were exposed for a short time to sterile, spent supernatant from a stationary-
phase culture. The spent supernatant caused PqsR to be cleaved at amino
acid 147 (total length is 332 amino acids) (4). This effect was found to
be dependent on the bacterial growth phase: spent supernatant from
log-phase cultures did not cause PqsR cleavage (4). This is apparently an
autoregulation event, because spent supernatant from a pqsR mutant had
no effect on cleavage (4). These data indicate that PqsR is negatively auto-
regulated by a stationary-phase factor responsible for site-specific cleavage of
the regulator. Overall, the regulation of PQS production is both interesting
and complex; further studies are necessary to fully understand PQS
production.
E
.
C
.
P
E
S
C
I
30
THE TIMING OF PQS PRODUCTION
One of the unique features of PQS, compared with other quorum
sensing signals, is the timing of its production. Unlike 3-oxo-C
12
-HSL and
C
4
-HSL, the major production of which is started during the mid to late log
phase of growth (27, 28), PQS production occurs at a later stage of growth.
McKnight et al. (25) showed that PQS production began during the end of
log-phase growth, and greatly increased during the stationary phase of
growth. The production was at a maximal level when cultures had grown
pqsABCDE phnAB pqsR
LasR
3-oxo-C
12
-HSL
pqsH
C
4
-HSL
RhlR
PqsR
N
H
O
OH
+
+
+
+
+
lasB
pyocyanin
hcnABC
lecA
rhamnolipid
RpoS
others?
+
PQS
+
+
Figure 2.3. Proposed model for the regulation of PQS production. The las and rhl quorum
sensing systems have a positive and negative effect, respectively, on the pqsABCDE operon.
Whether these are direct or indirect effects is not clear. The las quorumsensing systemalso
positively affects the transcription of pqsH. PqsR is required for the production of
pqsABCDE; this regulator also directly interacts with the phnAB promoter to induce
transcription. It is possible that the effects of the las and rhl quorum sensing systems are
being directed through pqsR. This is currently being determined. PqsR is autoregulated
either directly or indirectly through site-specific cleavage as indicated by the split protein.
Together, pqsH, pqsABCDE, and phnAB produce enzymes that are responsible for the
synthesis of PQS. PQS has positive effects on several genes or products including the rhl
quorum sensing system. The mechanism of action for PQS is presumably through an
unidentified regulatory protein.
31
T
H
E
P
.
A
E
R
U
G
I
N
O
S
A
Q
U
I
N
O
L
O
N
E
S
I
G
N
A
L
for 3042 h and then greatly decreased after 48 h of growth (25). These
cultures were grown in a rich medium, PTSB, and PQS was indirectly
detected by using a P. aeruginosa bioassay. Most interestingly, PQS was
produced in this manner despite the use of a P. aeruginosa strain that
contained a constitutively expressed, mutated LasR protein which induced
las quorum-sensing-controlled genes in the absence of 3-oxo-C
12
-HSL (30).
This indicated that PQS production required a stationary-phase factor that
was not regulated by the las quorum sensing system (25). Not surprisingly,
this expression pattern is similar to that of phnAB, which is also maximally
expressed during stationary phase with a large decrease in expression
thereafter (4). This decrease in phnAB expression, and thus in PQS pro-
duction, is most likely due to the stationary-phase-dependent cleavage of
PqsR (4). In addition to these data, two other studies (10, 20) have
shown that PQS production starts during the late log phase of growth,
becomes maximal during the stationary phase of growth, and decreases
after reaching a peak concentration. Although PQS production was found
to be slightly earlier in the studies of Lepine et al. (20), their more sensitive
liquid chromatography/mass spectrometry detection assay and the use
of LB media still showed a stationary-phase peak concentration of PQS
that then declined. Most interestingly, this study found that a similar
P. aeruginosa secondary metabolite, 2-heptyl-4-hydroxyquinoline N-oxide,
was produced in a similar time frame but its concentration did not decrease
after reaching a maximal level (20). This suggests that a specific
PQS alteration may occur. Finally, Diggle et al. (10) used a thin layer
chromatography detection assay to confirm that PQS production in LB
media begins in the late log phase of growth and becomes maximal later
during the stationary phase of growth. Their growth-curve study was
stopped before PQS concentrations would have begun to decrease (10).
The studies of Diggle et al. (10) also showed that the addition of exogenous
PQS would induce lecA expression by P. aeruginosa. However, unlike other
acyl homoserine lactone signals, PQS did not advance the timing of a gene
that it controlled (lecA) (10). (Note: lecA encodes for the virulence deter-
minant PA-IL lectin.) Once again, it is apparent that PQS activity relies on a
stationary-phase factor that has not yet been identified.
Overall, the later timing of PQS production compared with other
cell-to-cell signals suggests a role in responding to stationary-phase growth.
P. aeruginosa has devoted numerous control mechanisms to ensure that
cell-to-cell signaling occurs at the proper time (see (10) for a summary of
quorum sensing timing), thereby leading one to conclude that, when it
comes to cell-to-cell signaling, timing is everything.
E
.
C
.
P
E
S
C
I
32
PQS AND P. AERUGINOSA VIRULENCE
Many cell-to-cell signals have been shown to be important for virulence
(see (8) for review); PQS is not an exception. Strains that contain mutations
within genes required for PQS production have been identified in many
virulence gene identification experiments. PQS mutants are greatly
reduced in the ability to produce paralytic killing in the nematode
Caenorhabditis elegans (12, 13, 22). This was determined to be caused
by a lack of hydrogen cyanide production, owing to the positive control
that PQS exerts over the hcnABC operon (12, 13). A pqsR mutant
was also unable to produce rotting in a lettuce leaf virulence assay
and was greatly reduced in virulence for the burned mouse model of
P. aeruginosa infection (32). In addition, this strain was found to be less
virulent when tested in both an acute and a chronic model of mouse lung
infection (18).
The importance of PQS exhibited in the virulence assays described
above apparently stems from its ability to control the production of several
virulence factors. In addition to hydrogen cyanide, which was mentioned
previously, PQS controls the production of LasB elastase (3, 10, 25, 30)
and pyocyanin (4, 12, 13, 32). Pyocyanin is important in P. aeruginosa
pathogenesis (18) in that, when introduced into mouse lungs, it caused a
large influx of neutrophils. However, the virulence of a pqsR mutant could
not be complemented by the addition of exogenous pyocyanin, indicating
that PQS regulates multiple important virulence factors (18). To this
end, PQS has also been shown to control the production of hemolytic
activity (32), PA-IL lectin (10), rhamnolipid (10, 16), Rhl R (10), Rpo S (10),
and C
4
-HSL (10, 25). It has been proposed that PQS acts directly or
indirectly through RhlR (30) and controls primarily rhl quorum-sensing-
regulated genes (10), but this theory has not yet been tested in a microarray
experiment.
At the bacterial community level, PQS is known to have an effect on
the growth of P. aeruginosa on stainless steel coupons (10); the overpro-
duction of PQS causes autolysis, possibly through the activation of
lysogenic phage or bacteriocin (7). These effects imply that PQS is likely
to be involved in the formation of P. aeruginosa communities such as
biofilms.
With regard to human infections, PQS has been found in sputum
samples from cystic fibrosis patients infected with P. aeruginosa (5).
The amount of PQS in sputum correlated nicely with the density of
P. aeruginosa in the sample (5). PQS was also seen in bronchial alveolar
33
T
H
E
P
.
A
E
R
U
G
I
N
O
S
A
Q
U
I
N
O
L
O
N
E
S
I
G
N
A
L
lavage fluid from infected CF patients and in mucopurulent airway fluid
from a lung resected from a CF transplant patient (5). Not surprisingly, the
majority (9 out of 10) of P. aeruginosa isolates from CF patients produced
PQS in laboratory cultures (5). One study has also shown that 4 out of
5 P. aeruginosa CF strains actually produced more PQS than the laboratory
strain PAO1 (15). Furthermore, these strains produced PQS earlier (log
phase) than the laboratory strain (stationary phase). This same study
found that growing P. aeruginosa in low-magnesium media, which are
thought to simulate the CF lung, caused PQS production to be increased
5-fold (15). Taken together, these data can allow one to theorize that PQS
production increases, perhaps permanently, once a P. aeruginosa strain
enters the lung of a CF patient.
Overall, numerous studies have shown that PQS is important for the
virulence of P. aeruginosa. How this signal functions during infections is
not known, but it is apparently providing some type advantage as
P. aeruginosa adapts to its environment in vivo.
THE POTENTIAL OF PQS AS A DRUG TARGET
One of the most exciting aspects of cell-to-cell signaling is that
the signals and their synthetic pathways are attractive targets for drug
development. Agents that target these pathways would most likely not be
bactericidal or bacteriostatic, but they hopefully will decrease virulence and
augment a known antibiotic and/or allow the immune system to better
clear the infecting organism. With this in mind, preliminary experiments
have shown that the PQS synthetic pathway is a viable target. Calfee et al. (3)
showed that an anthranilate analog, methyl anthranilate, inhibited the
synthesis of PQS (3). This presumably would occur by the analog entering
the PQS synthetic pathway before the condensation of anthranilate and the
fatty acid chain (see Figure 2.2). Methyl anthranilate also caused a major
decrease in the production of elastase activity by P. aeruginosa, suggesting
that the analog interfered with the signaling pathway and thereby inhibited
the induction of a PQS-controlled gene (lasB) (3). The effect of methyl
anthranilate was also confirmed when Diggle et al. (10) showed this
analog inhibited lecA induction and pyocyanin production, both of which
are PQS-controlled virulence factors. These studies have been expanded
upon to show that multiple anthranilate analogs can inhibit PQS signaling
(S. McKnight and E. Pesci, unpublished data). This promising line of
research will require a better understanding of the functions of different
enzymes in the PQS synthetic pathway.
E
.
C
.
P
E
S
C
I
34
OTHER PQS-LIKE MOLECULES SYNTHESIZED BY P. AERUGINOSA
The 4-quinolones (pyo compounds) produced by P. aeruginosa were first
discovered because of the antibiotic activity they exhibited (6, 19). PQS was
overlooked because it apparently does not have antibiotic activity, and this was
at least partly provenby showing that it has no effect on E. coli or Staphylococcus
aureus (30). However, PQS is one of at least 56 quinolone-type compounds
produced by P. aeruginosa (21). These compounds all appear to fall under the
control of pqsR and are most likely synthesized by the genes of the PQS
synthetic region (9). The roles of these different secondary metabolites must
be assessed on an individual basis. At this point, many of the compounds are
known to have antibiotic activity; except for PQS, none has been shown to act
directly as a cell-to-cell signal.
CONCLUDING REMARKS
Only five years have passed since the Pseudomonas quinolone signal was
identified (30). In that time, a great deal has been learned about the synthesis
and regulation of PQS. The signal has also been found to play an important
role in the virulence of P. aeruginosa. Despite what has been learned, there is
obviously a great deal that is not yet known about this fascinating P. aeruginosa
cell-to-cell signal. The mechanism by which it causes gene induction, its role
during infections, and the exploitation of its synthetic pathway for drug devel-
opment are all future directions that will provide a wealth of knowledge about
howand why P. aeruginosa uses PQS to help ensure survival. As we continue to
keep our collective ears turned toward the P. aeruginosa culture plate, it is likely
that this bacterium will once again prove to be a fascinating conversationalist.
ACKNOWLEDGEMENTS
E. C. Pesci is supported by a research grant fromthe National Institutes
of Allergy and Infectious Disease (grant R01-AI46682). A thank-you
is extended to T. R. de Kievit, E. A. Ling, D. S. Wade, J. P. Coleman, and
A. J. Pesci for help in chapter preparation and thoughtful insight.
REFERENCES
1 Blackwood, L. L., R. M. Stone, B. H. Iglewski and J. E. Pennington 1983.
Evaluation of Pseudomonas aeruginosa exotoxin A and elastase as virulence factors
in acute lung infection. Infect. Immun. 39: 198201.
35
T
H
E
P
.
A
E
R
U
G
I
N
O
S
A
Q
U
I
N
O
L
O
N
E
S
I
G
N
A
L
2 Brint, J. M. and D. E. Ohman 1995. Synthesis of multiple exoproducts in
Pseudomonas aeruginosa is under the control of RhlR-RhlI, another set of regu-
lators in strain PAO1 with homology to the autoinducer-responsive LuxR-LuxI
family. J. Bacteriol. 177: 715563.
3 Calfee, M. W., J. P. Coleman and E. C. Pesci 2001. Interference with Pseudomonas
quinolone signal synthesis inhibits virulence factor expression by Pseudomonas
aeruginosa. Proc. Natn. Acad. Sci. USA 98: 116337.
4 Cao, H., G. Krishnan, B. Goumnerov et al. 2001. A quorum sensing-associated
virulence gene of encodes a LysR-like transcription regulator with a unique self-
regulatory mechanism. Proc. Natn. Acad. Sci. USA 98: 1461318.
5 Collier, D. N., L. Anderson, S. L. McKnight et al. 2002. A bacterial cell to
cell signal in the lungs of cystic fibrosis patients. FEMS Microbiol. Lett.
215: 416.
6 Cornforth, J. W. and A. T. James 1956. Structure of a naturally occurring antago-
nist of dihydrostreptomycin. Biochem. J. 63: 12430.
7 DArgenio, D. A., M. W. Calfee, P. B. Rainey and E. C. Pesci 2002. Autolysis
and autoaggregation in Pseudomonas aeruginosa colony morphology mutants.
J. Bacteriol. 184: 64819.
8 de Kievit, T. R. and B. H. Iglewski 2000. Bacterial quorum sensing in pathogenic
relationships. Infect. Immun. 68: 483949.
9 Deziel, E., F. Lepine, S. Milot, et al. 2004. Analysis of Pseudomonas aeruginosa
4-hydroxy-2-alkylquinolines (HAQs) reveals a role for 4-hydroxy-2-heptylquinoline
in cell-to-cell communication. Proc. Natn. Acad. Sci. USA 101: 133944.
10 Diggle, S. P., K. Winzer, S. R. Chhabra et al. 2003. The Pseudomonas aeruginosa
quinolone signal molecule overcomes the cell density-dependency of the
quorum sensing hierarchy, regulates rhl-dependent genes at the onset of
stationary phase and can be produced in the absence of LasR. Molec. Microbiol.
50: 2943.
11 Essar, D. W., L. Eberly, A. Hadero and I. P. Crawford 1990. Identification and
characterization of genes for a second anthranilate synthase in Pseudomonas
aeruginosa: interchangeability of the two anthranilate synthases and evolutionary
implications. J. Bacteriol. 172: 884900.
12 Gallagher, L. A. and C. Manoil 2001. Pseudomonas aeruginosa PAO1 kills
Caenorhabditis elegans by cyanide poisoning. J. Bacteriol. 183: 620714.
13 Gallagher, L. A., S. L. McKnight, M. S. Kuznetsova, E. C. Pesci and C. Manoil
2002. Functions required for extracellular quinolone signaling by Pseudomonas
aeruginosa. J. Bacteriol. 184: 647280.
14 Gambello, M. J. and B. H. Iglewski 1991. Cloning and characterization of
the Pseudomonas aeruginosa lasR gene, a transcriptional activator of elastase
expression. J. Bacteriol. 173: 30009.
15 Guina, T., S. O. Purvine, E. C. Yi et al. 2003. Quantitative proteomic analysis
indicates increased synthesis of a quinolone by Pseudomonas aeruginosa isolates
from cystic fibrosis airways. Proc. Natn. Acad. Sci. USA 100: 27716.
E
.
C
.
P
E
S
C
I
36
16 Kohler, T., C. van Delden, L. K. Curty, M. M. Hamzehpour and J. C. Pechere
2001. Overexpression of the MexEF-OprN multidrug efflux system affects
cell-to-cell signaling in Pseudomonas aeruginosa. J. Bacteriol. 183: 521322.
17 Latifi, A., M. Foglino, K. Tanaka, P. Williams and A. Lazdunski 1996. A
hierarchical quorum-sensing cascade in Pseudomonas aeruginosa links the trans-
criptional activators LasR and RhlR (VsmR) to expression of the stationary-phase
sigma factor RpoS. Molec. Microbiol. 21: 113746.
18 Lau, G. W., H. Ran, F. Kong, D. J. Hassett and D. Mavrodi 2004. Pseudomonas
aeruginosa pyocyaninis critical for lung infectioninmice. Infect. Immun. 72: 42758.
19 Leisinger, T. and R. Margraff. 1979. Secondary metabolites of the fluorescent
pseudomonads. Microbiol. Rev. 43: 42242.
20 Lepine, F., E. Deziel, S. Milot and L. G. Rahme 2003. A stable isotope dilution
assay for the quantification of the Pseudomonas quinolone signal in Pseudomonas
aeruginosa cultures. Biochim. Biophys. Acta 1622: 3641.
21 Lepine, F., S. Milot, E. Deziel, J. He and L. G. Rahme 2004. Electrospray/mass
spectrometric identification and analysis of 4-hydroxy-2-alkylquinolines (HAQs)
produced by Pseudomonas aeruginosa. J. Am. Soc. Mass Spectrom. 15: 8629.
22 Mahajan-Miklos, S., M. W. Tan, L. G. Rahme and F. M. Ausubel 1999. Molecular
mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa-
Caenorhabditis elegans pathogenesis model. Cell 96: 4756.
23 Mavrodi, D. V., R. F. Bonsall, S. M. Delaney et al. 2001. Functional analysis of
genes for biosynthesis of pyocyanin and phenazine-1-carboxamide from
Pseudomonas aeruginosa PAO1. J. Bacteriol. 183: 645465.
24 McGrath, S., D. S. Wade and E. C. Pesci 2004. Dueling quorum sensing systems
in Pseudomonas aeruginosa control the production of the Pseudomonas quinolone
signal (PQS). FEMS Microbiol. Lett. 230: 2734.
25 McKnight, S. L., B. H. Iglewski and E. C. Pesci 2000. The Pseudomonas quinolone
signal regulates rhl quorum sensing in Pseudomonas aeruginosa. J. Bacteriol. 182:
27028.
26 Passador, L., K. D. Tucker, K. R. Guertin et al. 1996. Functional analysis of the
Pseudomonas aeruginosa autoinducer PAI. J. Bacteriol. 178: 59956000.
27 Pearson, J. P., K. M. Gray, L. Passador et al. 1994. Structure of the autoinducer
required for expression of Pseudomonas aeruginosa virulence genes. Proc. Natn.
Acad. Sci. USA 91: 197201.
28 Pearson, J. P., L. Passador, B. H. Iglewski and E. P. Greenberg 1995. A second
N-acylhomoserine lactone signal produced by Pseudomonas aeruginosa. Proc.
Natn. Acad. Sci. USA 92: 14904.
29 Pearson, J. P., E. C. Pesci and B. H. Iglewski 1997. Roles of Pseudomonas
aeruginosa las and rhl quorum-sensing systems in control of elastase and
rhamnolipid biosynthesis genes. J. Bacteriol. 179: 575667.
30 Pesci, E. C., J. B. Milbank, J. P. Pearson et al. 1999. Quinolone signaling in the
cell-to-cell communication system of Pseudomonas aeruginosa. Proc. Natn. Acad.
Sci. USA 96: 1122934.
37
T
H
E
P
.
A
E
R
U
G
I
N
O
S
A
Q
U
I
N
O
L
O
N
E
S
I
G
N
A
L
31 Pesci, E. C., J. P. Pearson, P. C. Seed and B. H. Iglewski 1997. Regulation of las
and rhl quorum sensing in Pseudomonas aeruginosa. J. Bacteriol. 179: 312732.
32 Rahme, L. G., M. W. Tan, L. Le et al. 1997. Use of model plant hosts to identify
Pseudomonas aeruginosa virulence factors. Proc. Natn. Acad. Sci. USA94: 1324550.
33 Tamura, Y., S. Suzuki and T. Sawada 1992. Role of elastase as a virulence factor
in experimental Pseudomonas aeruginosa infection in mice. Microb. Pathogen. 12:
23744.
34 Whiteley, M., K. M. Lee and E. P. Greenberg 1999. Identification of genes
controlled by quorum sensing in Pseudomonas aeruginosa. Proc. Natn. Acad. Sci.
USA 96: 139049.
E
.
C
.
P
E
S
C
I
38
CHAPTER 3
Quorum-sensing-mediated regulation of
plantbacteria interactions and Agrobacterium
tumefaciens virulence
Catharine E. White and Stephen C. Winans
Department of Microbiology,
Cornell University, Ithaca, NY, USA
INTRODUCTION
Plant-associated bacteria have a wide range of interactions with their
hosts, from non-specific associations to more dedicated symbiotic or patho-
genic interactions. Many complex interactions take place between plant
roots and associated bacteria, fungi, and protozoa in a highly diverse and
dense community within the rhizosphere. Bacterial cell-to-cell communi-
cation systems in this ecological niche appear to affect biofilm formation,
pathogenesis, and production of siderophores and antibiotics. These activ-
ities are no doubt important in root colonization as well as in symbiosis and
pathogenesis. Exciting developments and current studies in understanding
the many complex interactions in the rhizosphere include both the char-
acterization of the microbial communities involved and the responses of
the plant hosts to these communities. Cell-to-cell signaling between
members of the community is no doubt critical for these interactions to
sense population densities and diffusion barriers in the rhizosphere. Such
studies are beyond the scope of this chapter, but we refer the reader to
recent reviews of this field (43, 65, 82).
Perhaps the best-characterized group of soil bacteria that serves as the
model for understanding plantbacteria associations is the Rhizobiaceae.
This family, in the alpha subgroup of the Proteobacteria, includes members
of the genera Rhizobium, Sinorhizobium, Mesorhizobium, Azorhizobium,
and Bradyrhizobium (collectively referred to here as rhizobia), which form
symbiotic relationships with host plants, and several pathogenic species of
the genus Agrobacterium (including A. tumefaciens, A. rhizogenes, A. vitis,
and A. rubi, here referred to as agrobacteria). Rhizobia form symbiotic
relationships with specific host plants by inducing formation of nodules
39
Bacterial Cell-to-Cell Communication: Role in Virulence and Pathogenesis, ed. D. R. Demuth and
R. J. Lamont. Published by Cambridge University Press. #Cambridge University Press 2005.
on the plant roots. Colonizing bacteria are restricted to these nodules, and
benefit the host by fixing atmospheric nitrogen. In contrast, pathogenic
agrobacteria cause tumors or other neoplasias on a wide variety of host
plants. Although rhizobia are beneficial to their plant hosts and agrobac-
teria are plant pathogens, their initial interactions with the host plants are
very similar. The colonizing bacteria must respond to host-released signals
during the initial stages of infection and attach to the plant surface. In both
cases, these bacteria synthesize and respond to diffusible chemical signals
called acyl-homoserine lactones (AHLs). AHL-mediated cell-to-cell com-
munication in rhizobia is reviewed elsewhere (30, 65, 84). For the remain-
der of this chapter we will focus on A. tumefaciens.
THE Ti PLASMIDS OF A. TUMEFACIENS AND THE DISCOVERY OF
AHLs AS CONJUGAL PHEROMONES
A. tumefaciens are primarily soil-dwelling bacteria, but many isolates
carry large (200kb) plasmids that are called tumor-inducing (Ti) plasmids,
which are required for the formation of crown gall tumors on infected
plants. There is significant variation between strains of A. tumefaciens;
isolates are most often classified according to the opines that they can
catabolize (despite the fact that Ti plasmids can generally catabolize more
than one type of opine) (94). The best-characterized A. tumefaciens strains
contain either so-called octopine-type Ti plasmids (including strains A6,
B6, Ach5, 15966, and R10) or nopaline-type Ti plasmids (including strains
C58 and T37). The full genome sequence of strain C58 has been completed
by two different groups (32, 87). Its circular chromosome shows striking
synteny with that of Sinorhizobium meliloti, whereas its linear chromosome
and two plasmids appear unique. A composite sequence of the octopine-
type Ti plasmid has also been published (89).
Almost all of the genes that are required for tumor formation are
located on these Ti plasmids. Tumor formation requires the products of
approximately 25 vir genes (71, 85), which process and transfer oncogenic
fragments of DNA (T-DNA) from the Ti plasmid into the host cell, where
they are integrated into the host genomic DNA. Sequence analysis indicates
that the T-DNA transfer apparatus evolved from a bacterial conjugation
system (42, 48, 49, 68). In the host cell, the T-DNA-encoded genes direct
the overproduction of phytohormones that cause the cell proliferation that
is the hallmark of this disease (56). The T-DNA also carries a number of
genes whose products synthesize opines in the infected plant cells. These
compounds are released from the plant cells, taken up by the agrobacteria
C
.
E
.
W
H
I
T
E
A
N
D
S
.
C
.
W
I
N
A
N
S
40
via dedicated ABC-type uptake systems, and used as sources of energy,
carbon, and, in some cases, nitrogen or phosphorus (17). The genes
required for opine uptake and catabolism are also located on the Ti plasmid
and are positively regulated by the cognate opine (17). Although there is a
remarkable diversity in the types of opine used by A. tumefaciens, there is
always a perfect match between the types of opine encoded on the T-DNA
and the opine-catabolic genes of a Ti plasmid.
Ti plasmids have a second complete set of DNA transfer genes. These
tra and trb genes direct the interbacterial conjugal transfer of the entire Ti
plasmid (24) and are organized into three operons (Figure 3.1) (1). The
traAFBH and the traCDG operons are divergently transcribed with the
origin of transfer (oriT) lying within the intergenic region between these
operons. The third operon includes the traI and trbBCDEJKL genes, most
of which are expected to be involved in mating pair formation and synthesis
of the conjugal pili. Some of these genes share a common ancestry with a
number of the vir genes, although sequence similarities between the tra
and vir genes are generally rather weak. Ti plasmid conjugation is reviewed
in more detail elsewhere (24, 86).
Ti plasmid conjugation played a critical role in research on the mechan-
ism of A. tumefaciens virulence. In early experiments, it was discovered that
the formation of crown gall tumors on plants by A. tumefaciens required a
genetic element that could be horizontally transferred by cellcell contact,
suggesting that this trait was plasmid-encoded (44, 45). This plasmid was
subsequently visualized by gel electrophoresis (79). Later, a portion of this
plasmid (the T-DNA) was found in infected plant cells in the bacteria-
induced tumors (57).
In these early studies, conjugal transfer of the Ti plasmid was detect-
able only in crown gall tumors (44, 45, 79), suggesting that these tumors
produce some factor that is essential for conjugation. Following the dis-
covery that crown gall tumors produce opines, Kerr and colleagues soon
demonstrated that conjugation could occur ex planta in the presence
of these compounds (31, 46). In these experiments, conjugation of the
octopine-type Ti plasmids (such as pTiR10) was stimulated by the opine
octopine, whereas conjugation of nopaline-type Ti plasmids (such as
pTiC58) required agrocinopine A or B. Opines that stimulate conjugation
are referred to as conjugal opines.
In 1991, Kerr and colleagues discovered a second compound that stimu-
lated conjugal transfer of Ti plasmids; however, unlike opines, this compound
was produced by the bacteria themselves (91). This diffusible compound,
originally called conjugation factor (CF), stimulated conjugation in
41
P
L
A
N
T
B
A
C
T
E
R
I
A
I
N
T
E
R
A
C
T
I
O
N
S
A. tumefaciens strains carrying octopine-type plasmids but only when they were
cultured in the presence of octopine. Conjugation of Ti plasmids that other-
wise transferred with low efficiency was dramatically stimulated by CF, but
only when it was provided to the conjugal donors. Not long after the discovery
that CF stimulates conjugation, it was shown that this compound could
specifically increase the transcription of a tralacZ fusion (66). By using this
fusionas a reporter, four bioactive compounds were identified, including 3-oxo-
C8-homoserine lactone (OOHL), 3-oxo-C6-homoserine lactone (OHHL),
Octopine Mannopine
NH
NH
HO
H
N
N
H
NH
+
NH
3
NH
2
N
H
O
O O
O
O
O
O O
O
O
O O O
O
H-(CHOH)
5
-CH
2
OccR-Octopine
Complex
MocR-Mannopine
Complex
mocR mot trlR
tral trb (Mating Pore)
occR traR traM tra (Mobilization) occ
PP
PP PP
PP
P P
repC B
Autoinducer
Synthase
TraR
Dimer
(Active)
TraR-TrlR
Heterodimer
(Inactive)
TraR-TraM
Heterodimer
(Inactive)
AttM
Active
Inactive
A
Figure 3.1. The TraRTraI quorum sensing system of Agrobacterium tumefaciens. TraI
synthesizes OOHL, which diffuses across the cellular envelope. At high population density,
OOHL accumulates in the cell and binds to TraR. TraR activates expression of the two tra
promoters, the trb operon which includes traI, traM, and repABC. OccR activates
transcription of traR in the presence of octopine, and MocR activates trlR in the presence of
mannopine. TraM and TrlR are anti-activators of TraR. Finally, at the stationary phase of
growth, attM is transcribed, resulting in inactivation of OOHL.
C
.
E
.
W
H
I
T
E
A
N
D
S
.
C
.
W
I
N
A
N
S
42
and two chemical derivatives of those compounds that may have been
produced during purification (90). Following the identification of these com-
pounds as the CF of octopine-type plasmids, it was shown that nopaline-type
plasmids produce OOHL as the only active compound (38).
N-acyl-homoserine lactones (AHLs) have also been discovered in many
other proteobacteria, beginning with Vibrio fischeri (21). These compounds
are released and detected by populations of bacteria and are thought to
permit cell-to-cell communication within a population, leading to coordi-
nation of a wide variety of behaviors. These signaling systems are thought
to allow cells to estimate their population densities and to carry out various
types of behavior only at high population densities, a phenomenon often
referred to as autoinduction or quorum sensing.
IDENTIFICATION OF A Ti-PLASMID-ENCODED AHL SYNTHASE
AND AHL RECEPTOR
The genes required for the synthesis and detection of the AHLs in the
nopaline- and octopine-type plasmids were discovered concurrently by two
different groups. In a study using random Tn5 mutagenesis, Farrand and
colleagues isolated an insertion that eliminated the requirement of inducing
opines for conjugation (3). Sequence analysis indicated that this transposon
had inserted upstream of a gene called traR and was probably being over-
expressed fromanoutward-reading promoter onthe transposon (66). The role
of traR in tra gene expression was verified by expressing this gene from a
constitutive promoter along with a tralacZ fusion in a Ti-plasmid-less strain
of A. tumefaciens. b-Galactosidase expression was induced only in the presence
of OOHL or OHHL, although the former inducer was far more potent. This
experiment suggested that TraR was indeed a receptor for OOHL, and that it
activated expression of conjugation genes.
Bioassays using a tralacZ reporter strain indicated that A. tumefaciens
synthesizes AHLs, suggesting that it encoded a protein homologous to LuxI of
V. fischeri. To search for such a gene, Farrand and colleagues tested random
Tn3 insertions in the nopaline-type Ti plasmid for production of OOHL (39).
All of the insertions that disrupted OOHL synthesis mapped to one gene, traI,
which was indeed a luxI homolog. TraR upregulated the expression of traI in
the presence of exogenous autoinducer, strongly increasing OOHL produc-
tion. The traI gene is the first gene in the trb operon, which encodes a type IV
secretion system that is required for conjugation.
The traR and traI genes of the octopine-type Ti plasmid were identified
at about the same time. The traR gene was discovered in a random Tn5gus
43
P
L
A
N
T
B
A
C
T
E
R
I
A
I
N
T
E
R
A
C
T
I
O
N
S
mutagenesis study designed to identify genes that were inducible by octo-
pine (912). As octopine was known to stimulate Ti plasmid conjugation,
all octopine-inducible fusions were screened for defects in conjugation.
Although none of themcaused a decrease in conjugation, one of the fusions
unexpectedly showed enhanced conjugation (29). This transposon inser-
tion had disrupted a gene called traM, which is adjacent to traR. From this
fusion, traR was eventually identified and found to stimulate conjugation
when overexpressed. The reason that a traM null mutation elevated
conjugation was unraveled in later studies (see below).
The luxI homolog traI on the octopine-type Ti plasmid was identified
by screening a cosmid library for the synthesis of OOHL (29). Like traI of
nopaline-type Ti plasmids, this traI gene appeared to be the first gene in the
trb operon. Both OOHL production and conjugation were disrupted by a Tn5
insertion that mapped to the traI gene. However, when traI was expressed in
trans in the same strain, OOHL production was restored but conjugation was
not. These results indicated that traI was indeed the first gene of the trb operon.
In an effort to identify the reaction mechanism for OOHL synthesis,
TraI was purified as a His6-tagged fusion and found to produce OOHL
in vitro when added to a complex extract of bacterial proteins and small
molecules (55). TraI also synthesized OOHL in a defined buffer supple-
mented with 3-oxooctanoyl-ACP and S-adenosylmethionine (SAM). This
was the first time that the activity of any LuxI-type protein had been
reconstituted in vitro and the substrates identified. 3-Oxooctanoyl-CoA
was inactive as a fatty acid group donor. Similarly, a variety of possible
precursors for the homoserine lactone ring were tested, but only SAM was
active. In the same study, purified TraI could transfer a radiolabeled car-
boxyl carbon of SAM to the OOHL product, providing further evidence that
SAM is the precursor for the homoserine lactone ring. A similar reaction
mechanism was later described for other LuxI-type proteins (64, 78).
Recently, the crystal structures of two proteins from this family were
solved, EsaI of Pantoea stewartii and LasI of Pseudomonas aeruginosa (33,
83). As EsaI and LasI synthesize different AHLs, 3-oxo-C6- and 3-oxo-C12-
homoserine lactone, respectively, comparisons of these two structures are
useful for understanding not only the reaction mechanism but also the
determinants of acyl-ACP specificity.
REGULATION OF traR EXPRESSION
The discovery of the TraRTraI quorum sensing system of the Ti
plasmids helped explain previous observations that conjugation of these
C
.
E
.
W
H
I
T
E
A
N
D
S
.
C
.
W
I
N
A
N
S
44
plasmids requires opines. For octopine-type plasmids such as pTiR10, the
traR gene is at the distal end of the occ operon, which is activated by
octopine via OccR (Figure 3.1) (28). When traR is expressed from a consti-
tutive promoter, conjugation does not require octopine. Therefore, regula-
tion of traR transcription by OccR fully explains the requirement of
octopine for conjugation. In the nopaline-type plasmids, traR expression
is also directly regulated by opines but through a different mechanism. In
pTiC58, the conjugal opines agrocinopine A and B induce expression of
the acc genes and the divergently transcribed arc operon, which includes
traR (2). In early studies of this system it was found that a null mutation of
accR causes constitutive expression of these genes, and traR overexpression
also results inconstitutive conjugation but has no effect onthe acc genes. More
recent evidence from experiments with purified AccR and promoter DNA
indicates that the expression of the arc and acc operons is directly repressed
by AccR, and that this repression is relieved by agrocinopines (67).
The regulation of traR by opines appears to have evolved independently
several times. OccR is an activator of transcription when it binds to the
conjugal opine octopine, whereas AccR acts as a repressor in the absence of
agrocinopines. OccR and AccR are not related proteins: OccR is in the LysR
family of transcriptional regulators but AccR is related to the Lac repressor
(2, 28). Finally, these traR genes are located within completely dissimilar
operons.
Regulation of traR expression by opines has since been described for a
number of other plasmids in A. tumefaciens, and in general these follow
the models described above for octopine- and nopaline-type plasmids
(Figure 3.2). On pTiChry5, traR is in a two gene operon called arc (58).
The expression of this operon is induced by the agrocinopines C and D,
which are thought to relieve repression by an AccRhomolog that is encoded
nearby (58). Agrocinopines Cand Dare also known to induce the transfer of
the agropine-type Ti plasmid pTiBo542 (23). Another nopaline-type
plasmid is pATK84b from A. radiobacter isolate K84 (15, 34, 35). This
Agrobacterium strain is unable to induce the formation of crown gall
tumors, and in fact pATK84b does not carry the vir genes or T-DNA of
the Ti plasmids. However, pATK84b does allow this strain to compete for
opines as a source of nutrients, as it has functional copies of nopaline and
agrocinopine A and B catabolic genes (15, 16). Interestingly, pATK84b also
has two copies of traR (59). One copy, traR
noc
, is the last gene of the nox
operon and is induced by nopaline, whereas traR
acc
is induced by agroci-
nopines A and B. Each of these two traR genes is required for induction of
transfer by the cognate opine (59).
45
P
L
A
N
T
B
A
C
T
E
R
I
A
I
N
T
E
R
A
C
T
I
O
N
S
POST-TRANSCRIPTIONAL REGULATION OF TraR ACTIVITY
The TraRTraI regulatory system is inhibited by a surprising number
of proteins, one of which is TraM. A null mutation in traM elevates tra gene
transcription and conjugation, whereas overexpression of traM abolishes
tra gene expression in a strain expressing wild-type levels of TraR (26, 38).
Providing high levels of OOHL did not stimulate tra gene expression.
However, tra gene transcription was restored by overexpressing TraR,
suggesting that TraM and TraR may interact stoichiometrically.
TraR was demonstrated by yeast two-hybrid assays and far western
immunoblots to interact directly with TraM (40). Deletion and point muta-
tions showed that binding is mediated by the C-termini of both proteins
(40). TraMcould both prevent the interaction of TraR with its DNAbinding
site and bind to TraR in proteinDNA complexes to cause release of TraR
Figure 3.2. Regulation of traR on an octopine-type Ti plasmid and two nopaline-type Ti
plasmids. Also shown is pAtK84b, which does not have vir genes or T-DNA but does carry
opine catabolic genes. On octopine-type Ti plasmids, traR is activated by OccR in response
to octopine. On the nopaline-type Ti plasmids, traR is transcribed when repression by AccR
is relieved by agrocinopines. pAtK84b has two traR genes: one is thought to be activated by
NocR in reponse to nopaline, and the other is repressed by AccR.
C
.
E
.
W
H
I
T
E
A
N
D
S
.
C
.
W
I
N
A
N
S
46
from DNA (51). Analysis by surface plasmon resonance showed that
TraRTraM binding is stable and has an affinity in the nanomolar range
(75). TraRTraM complexes eluted from a gel filtration column at a mole-
cular mass of approximately 60kDa in one study (75) or 157 kDa in a second
study (80). The former is consistent with a TraR monomer binding one or
two TraM monomers; the latter is consistent with two TraR dimers binding
two TraM dimers. This discrepancy must be due to differences in experi-
mental conditions. Several TraM point mutants were isolated that still
bound TraR but did not inhibit TraR activity (46, 70), suggesting that
binding and inactivation may occur in two sequential steps. The TraM
structure was solved by two groups using X-ray crystallography (75, 8).
TraM crystallized as a dimer, with each monomer consisting largely of
two antiparallel a-helices. The monomers were intimately associated in
the dimer, and significant hydrophobic surface was buried upon
dimerization.
It is not clear how TraMTraR interactions disrupt TraRDNA inter-
actions; however, two different mechanisms have been suggested. Chen
and colleagues proposed that the TraM and TraR homodimers may dis-
sociate upon binding to each other so that a TraRTraM anti-activation
complex can form, perhaps interacting through the surface of TraM that
is otherwise buried in the homodimer interface (8). Evidence for this model
is that TraM dimers, when their subunits are covalently cross-linked to
each other, can bind to TraR but are unable to inactivate the protein (8).
Mutational analyses of TraM also suggest that residues involved in initial
binding to TraR are different from those required for TraR inactivation
(51, 75). A second study reached different conclusions, proposing that two
dimers of TraM are clamped between two dimers of TraR, with part of
each of the four TraR DNA-binding domains bound into one of two narrow
grooves on the surface of each TraM dimer (80). This complex would
physically inhibit the TraR dimers from binding to DNA. Structural ana-
lysis of TraRTraM complexes will help to resolve the intriguing question
of how TraM mediates inactivation of TraR, although the static structure
will not provide a complete picture, inasmuch as TraR binding and inacti-
vation are thought to occur in several sequential steps.
The adaptive significance of TraMis not understood. On both octopine-
and nopaline-type plasmids, expression of traM is positively regulated by
TraR and OOHL (25, 36), indicating that this quorum-sensing regulon
induces its own antagonist and suggesting that TraM may be acting as a
governor to limit expression of this regulon (Figure 3.1). TraM is a highly
conserved member of TraRTraI quorum-sensing systems, and is even
47
P
L
A
N
T
B
A
C
T
E
R
I
A
I
N
T
E
R
A
C
T
I
O
N
S
associated with these systems on the symbiosis megaplasmids of
Rhizobium spp. (36).
Another TraR inhibitor, designated TrlR, is encoded only on octopine-
type Ti plasmids. These Ti plasmids incite tumors that synthesize several
opines, including mannopine. In the course of analyzing the mot operon,
which is required for the utilization of mannopine, a gene, designated trlR,
was identified. This gene is virtually identical to traR except for a frameshift
mutation between the N-terminal pheromone binding domain and the
C-terminal DNA binding domain (60). As might be expected, TrlR is inactive
in tra gene expression, whereas correction of the frameshift mutation by
site-directed mutagenesis resulted in a trlR mutant that encoded a fully
functional protein (95). Identical genes were subsequently identified on a
number of other octopine-type Ti plasmids, indicating that the frameshift
within trlR is not a laboratory artefact but in fact is disseminated in nature
(95). TrlR is not only non-functional but also inhibits TraR activity by
forming inactive heterodimers (7). Similar truncated alleles of LuxR (made
in the laboratory) have similar properties in that they block the function of
native LuxR, probably by forming inactive heterodimers (14).
Expression of trlR is induced in response to mannopine, probably via
the MocR protein (Figure 3.1) (60, 95). Mannopine decreases conjugation
specifically due to trlR, as expressing this gene froma constitutive promoter
also blocked conjugation (7). In the same study it was found that expression
of trlR was strongly repressed by favored catabolites, including succinate,
glutamine, and tryptone. As these nutrients could restore TraR activity by
blocking trlR gene expression, it was speculated that TrlR functions as an
inhibitor of the energetically expensive process of conjugation when nutri-
ents are limiting.
TraRactivity is regulated by a third gene, attM, although in this case the
mechanism of inhibition is more indirect than described above. This gene
is a homologue of aiiA from Bacillus cereus (32, 87); both genes direct the
inactivation of AHLs by hydrolyzing their lactone ring, forming the corres-
ponding N-acyl homoserine (Figure 3.1) (18, 19, 89). The attM gene lies
within the attKLM operon, where attK and attL encode a predicted semi-
aldehyde dehydrogenase and alcohol dehydrogenase, respectively (88). If
these enzymes form a pathway, the predicted final product of OOHL
metabolism would likely be N-(3-oxooctanoyl)aspartate.
The attKLM operon is repressed by the product of the divergent attJ
gene; expression is induced at stationary phase in response to either carbon
or nitrogen limitation (83). This provides suggestive evidence that attKLM
is a catabolic operon that is induced only if its natural substrates are present
C
.
E
.
W
H
I
T
E
A
N
D
S
.
C
.
W
I
N
A
N
S
48
and favored carbon sources are absent. It is likely that the natural substrates
interact with AttJ to derepress expression of this operon. However, AHLs
are not necessarily the natural substrates for these enzymes, as expression
of the attKLM operon is not induced by any tested AHLs (89) (Y. Chai and
S. C. Winans, unpublished data). Even if this pathway is not dedicated to
inactivation and catabolism of OOHL, it is possible that A. tumefaciens can
recycle these signal molecules. AHL recycling as an energy and nitrogen
source has been demonstrated in Variovorax paradoxus and in Pseudomonas
aeruginosa (37, 47).
THE ROLE OF OOHL IN TraR MATURATION
TraRactivity is checked at yet another level, in that the protein is rapidly
degraded by cytoplasmic proteases in the absence of OOHL. When TraR is
strongly overexpressed in E. coli or in A. tumefaciens, it accumulates in the
insoluble fraction of cell lysates. This led one group to suggest that, in the
absence of OOHL, TraR binds to the cytoplasmic membrane and that it is
released by OOHL to the cytoplasm, where it dimerizes and binds DNA
(70). However, another group had a different interpretation, in which this
insoluble protein accumulated in inclusion bodies that formed owing to
TraR overproduction and were biologically irrelevant. When traR was
mildly overexpressed, the protein accumulated only when OOHL was pre-
sent, and was otherwise degraded by cytoplasmic proteases. This finding
was first made by western immunoblots and confirmed by pulsechase
experiments (97). These data led us to conclude that OOHL rescues TraR
from proteolysis during or directly after translation, and may act as a
scaffold for TraR folding. In addition, purified apo-TraR was rapidly
degraded by trypsin to oligopeptides, whereas TraROOHL complexes
were more resistant to the proteases and were cleaved only at the accessible
interdomain linkers of the protein (97). Again, this indicates that TraR
absolutely requires OOHL to fold into its native and stable conformation.
Contrary to the well-established lock-and-key model of proteinligand
recognition, it is becoming increasingly evident that ligand binding
induces conformational changes in many other protein receptors, from
ordering of short loops to disorder-to-order transitions of the entire poly-
peptide chain (20). In many cases these proteins do not accumulate in the
absence of a regulatory signal. The term intrinsically unstructured was
coined by Dyson and Wright (20) to signify the importance of these pro-
teins in cellular processes and as models for studying protein-folding
mechanisms. Like TraR, many proteins that are intrinsically unstructured
49
P
L
A
N
T
B
A
C
T
E
R
I
A
I
N
T
E
R
A
C
T
I
O
N
S
are involved in highly time-dependent processes. These include cell-cycle
regulators required for inducing apoptosis, regulatory RNA binding pro-
teins, proteins involved at various points in signal transduction pathways,
and many other transcriptional regulators involved in activation or repres-
sion (20). It has also been suggested that one function of a disorder-to-order
transition upon binding is to increase the binding rates for a faster response
to the stimulus by increasing the likelihood that initial long-range interac-
tions will occur (72). Incorporation of OOHL into the folding process may
also optimize the specificity of the proteinligand interaction, as has been
suggested for some other intrinsically unstructured proteins (20).
STRUCTURE AND FUNCTION STUDIES OF TraR
Knowing that TraR requires OOHL for solubility enabled purification
of amounts sufficient for X-ray crystallography. There are now two crystal
structures of TraR available: both are ternary complexes of TraR, OOHL,
and the DNA binding site (called a tra box) for TraR (81, 92). These
structures support previous biochemical data but also have some unex-
pected features (Figure 3.3). They confirm earlier findings that TraR
binds OOHL via its N-terminal domain in a 1:1 mole ratio, and that it
binds DNA as a dimer via its C-terminal domain (70, 97). The N-terminal
domain has an aba structure, with one molecule of OOHL embedded
between a layer of a-helix and the b-sheet (81, 92). OOHL is therefore
deeply buried within the N-terminal pheromone-binding domain of each
TraR subunit (Figure 3.3). The hydrophobic atoms of OOHL pack with
hydrophobic residues in the core of the domain; the polar oxo-groups and
amine form hydrogen bonds with nearby residues. When bound to TraR,
the pheromone appears to be completely protected from solvent (81, 92).
This engulfment of the ligand in the core of the N-terminal domain sup-
ports our previous model that apo-TraR is to at least some degree unstruc-
tured and that OOHL participates in the protein-folding process.
The main dimerization interface of TraR is composed of a long a-helix
in the N-terminal domain of each subunit that is parallel with the same
helix of the opposite subunit. Contributions of residues buried in this
interface to dimer formation were confirmed by mutational analysis (52).
Although the N-terminal domains are sufficient for dimer formation, the
C-terminal domains also dimerize via two parallel helices, although the
interface is not as extensive (81, 92). The structure of the C-terminal
domains, each a four-helix bundle containing a helixturnhelix DNA
binding motif, is highly conserved and places the LuxR family members
C
.
E
.
W
H
I
T
E
A
N
D
S
.
C
.
W
I
N
A
N
S
50
in the larger NarLFixJ family of transcriptional regulators (53). The DNAis
in B-form and the consensus tra box, an 18 bp sequence with perfect dyad
symmetry, has a 308 bend toward the sides of the dimer (81, 92). Although
there is an extensive interface between the protein and the DNA, the main
contributors to specificity and affinity of binding are two arginine resi-
dues in the recognition helix that have hydrogen bonds with two bases in
the major groove of each half site (81, 92) (C. E. White and S. C. Winans,
(a)
(b)
(c )
T4
G5
210
1
3
1
3
9
9
N
C
C
N
206
Figure 3.3. Ternary structure of TraR, OOHL, and tra box DNA. (a) Just the N-terminal
domains of a dimer. The dimerization interface is highlighted, and is along the length of
a-helix 9 of each monomer. The OOHL and water molecule bound in each N-terminal
domain are shown in space-fill and can be seen most clearly in the right-most monomer.
The linker between the N-terminal domains and the C-terminal domains is marked with a
C. (b) Just the C-terminal domains of the TraR dimer bound to DNA. Hydrogen bonds
between the side-chains of arginine 206 and 210 of the recognition helix and bases T4 and
G5 of the binding site are shown. The dimerization interface is also highlighted, along
a-helix 13 of each monomer, and the linker between the NTD and CTD of each monomer is
marked with an N. (c) A view of a full dimer down the long axis of the DNA, showing the
asymmetry of the crystallized protein due to the flexible linkers. Coordinates for these
models are from references 81 and 92. (See also color plate section)
51
P
L
A
N
T
B
A
C
T
E
R
I
A
I
N
T
E
R
A
C
T
I
O
N
S
unpublished data). One of these residues had been previously shown as
critical for DNA binding affinity (50). TraR had also been shown to bind to
target DNA sequences with high specificity (96). In fact there is little
variation in most of the native tra boxes of the Ti plasmid, and the two
bases that make direct contacts with two arginines of TraR as described
above are absolu tely cons erved ( se e F igu re 3.4 b ).
The N-terminal pheromone-binding domain and the C-terminal DNA-
binding domain of each monomer are connected by a 12-residue unstruc-
tured linker (81, 92). This flexibility may be the reason for a pronounced
asymmetry of the crystallized protein. The C-terminal domains of each dimer
have a two-fold axis of symmetry, and the N-terminal domains also have a
two-fold axis of symmetry, but these axes lie at a 908 angle to each other (81,
92). The presence of the flexible linkers connecting the C-terminal domains of
the dimer to the N-terminal domains suggests that there is a high degree of
flexibility between the two domains in vivo. This has been proposed to play a
role at divergently transcribed promoters, as discussed in the next section.
There is significant interest in understanding how AHLs convert their
receptors from inactive to active forms, and how these proteins can dis-
criminate between their cognate ligand and similar AHLs found in nature.
When TraR is expressed at native levels in the cell it binds to its cognate
ligand, OOHL, with high specificity (93). There are four hydrogen bonds
between residues in the binding pocket of TraR and the polar groups of
OOHL, in addition to numerous hydrophobic and packing interactions
surrounding the ligand (81, 92). Mutational analyses confirm that the
polar interactions between residues of TraR and the OOHL are critical for
binding and stability of TraR (6, 52). One of these polar interactions is of
considerable interest as it involves a variable group on the OOHL. The 3-oxo
group of OOHL is not common to all AHLs and therefore could be an
important determinant of specificity of binding. In the binding pocket,
this group makes a water-mediated hydrogen bond to a threonine residue.
In an attempt to alter binding specificity for a 3-unsubstituted AHL
(C8-homoserine lactone), point mutations were made of this residue to increase
hydrophobicity and displace the water molecule from its binding site (6).
These mutations resulted in a broadened specificity of binding rather than
in altered specificity. In the same study, point mutations were also con-
structed to change the preference of binding to AHLs with shorter fatty acid
tails, by increasing hydrophobic bulk in the binding pocket. Some of the
mutations did alter specificity of binding but the stability of these mutants
was also decreased. These data suggest that the residues in the binding
pocket that contact the OOHL play dual roles in folding or stability of the
C
.
E
.
W
H
I
T
E
A
N
D
S
.
C
.
W
I
N
A
N
S
52
N-terminal domain and ligand recognition. As these residues are buried in
the hydrophobic core of the protein, they make many contributions to pack-
ing interactions with surrounding residues in addition to OOHL. Therefore,
incorporating OOHL into the protein-folding process may be important not
only for regulation of TraR activity but also for specificity of the protein
ligand interaction.
TraR AS AN ACTIVATOR OF TRANSCRIPTION
Seven TraR-dependent promoters have been identified on the octopine-
type Ti plasmid (Figure 3.4). These include all of the genes required
for conjugal transfer, arranged in three operons: traAFBH and traCDG-yci,
both required for conjugal DNA processing, and the traItrb operon (27).
The TraR anti-activator traM is also activated by TraR (C. Fuqua, personal
communication). More recently, three TraR-dependent promoters of the
repABC operon have been described (61). This operon is required for both
vegetative replication of the plasmid and partitioning into daughter cells.
Promoter structure at this operon is quite complex, as there is at least one
additional promoter for rep that is not TraR-dependent, but is repressed by
RepA (62). This ensures plasmid maintenance and partitioning when TraR
is inactive. Activation of repABC by TraR increases Ti plasmid copy number
about seven-fold, thereby enhancing the expression of all Ti-plasmid-
encoded genes (61). This could lead to enhanced uptake and catabolism of
opines as well as enhanced conjugation and possibly enhanced T-DNA
transfer.
The transcription start sites at all of these TraR-dependent promoters
have been mapped; each has an identifiable tra box (27, 61) (C. Fuqua,
personal communication). The traA and traC promoters are divergently
transcribed from tra box I (the consensus sequence); the traI and two rep
promoters (repAP1 and repAP2) are divergently transcribed from tra box II
(Figure 3.4). The tra boxes of PtraA, PtraC, PtraI, PrepA1, and PrepA3 are
centered at approximately 45 nucleotides upstream from the transcrip-
tion start site and overlap the 35 element of each promoter. In contrast,
the tra boxes of the PtraM and PrepA2 promoters are centered at 66
nucleotides from the transcription start site (Figure 3.5). These promoters
are reminiscent of the class I and class II promoters first described for
CRP (5). At class II promoters the activator overlaps the 35 element and
can make multiple contacts with RNA polymerase. These contacts recruit
RNA polymerase to the promoter and possibly affect later steps in tran-
scription initiation. At class I promoters the activator binds farther
53
P
L
A
N
T
B
A
C
T
E
R
I
A
I
N
T
E
R
A
C
T
I
O
N
S
Class I promoter
Class II promoter
61.5
"CTD
"CTD
Sigma
Sigma
"NTD
"NTD
41.5
35 10
10
(a)
(b)
Activator
Activator
Figure 3.5. Predicted models of TraR at class I (a) and class II (b) type promoters. These
models are based on studies of other activators (5).
(a)
(b)
<<+1
G
T T T T T T T T T T T T T T TT TTT T T T T T T T G G G G G G G G G G G G G G G G G G G C C C C C C C C C C C C T T T A
G G T TT TTT
T
T T T T
T TT T T TT T T TT T T T T TT T T T
T T T T T T TT T TT TT T TT T T G G G
G
G G
G
GTG
TG
TG
TG
G G GA
A A A A
AAAA A A A A A A AA A A A A A A G G G G G
G G G G G G GG G C
C
C C C A C
A C
A C
A C
T T
T
TT
T
T
T
T
T
T G
G
G
G
G
G A A
T
T
G A
A
AAAA
AAA
A
G
G
C
C
C
C
C
C
C
C
C
C C C C C C C CC C C CCC C C C G GG G G G GG G C C
C C C C C C CC C C C A A AAA A A A A A A A A A A A A A
A A AA A A A A GC C C C A A AT A A A A A A A AAAAA A A A A C C C C C C GG G G G G GG GG
CACG G G G G GGG A A AAA AA A A A A AA A T T T T T G G G G C C C C C C C CC C C G GGA A A T T T C CC CCG G GG G G T TTT G T T G CC CC C CC C A AAT T
10 35 35 10
10 35 35 10
10
35 10
35
35
+1>>
+1>>
+1>>
10 +1>>
+1>>
T
tra
tra
tra
tra
box
box
box
box
P traC P traA
P repA1
P repA3
P repA2
P traM
P traI
tra box I
tra box II
tra box III
tra box IV
I
II
III
IV
<<+1
Figure 3.4. (a) DNA sequences and tra boxes of TraR-dependent promoters. The tra box for
each promoter is highlighted, transcription start sites are marked with a 1, and the first
gene of the operon is marked above each start site (translation starts are not shown). Each of
the three TraR-dependent rep promoters (repA1, repA2, and repA3) is indicated.
(b) Alignment of the four known tra boxes of pTiR10. The two positions of each half-site that
make sequence-specific contacts with Arg206 and Arg210 of TraR are highlighted.
C
.
E
.
W
H
I
T
E
A
N
D
S
.
C
.
W
I
N
A
N
S
54
upstream on the same face of the DNA as polymerase and can contact only
the a C-terminal domain, which is connected to the rest of the polymerase
by a flexible linker (5).
As TraR can activate transcription at both class I- and class II-like pro-
moters, the activator is predicted to contact at least the a C-terminal domain of
RNA polymerase. At class II promoters TraR is thought to make additional
contacts with s70. This prediction is based on the observation that LuxR,
which also activates transcription froma class II promoter, interacts with both
the a C-terminal domain and s70 of RNA polymerase (25, 41, 73). A potential
RNA polymerase contact site, or activating region, has been identified on the
surface of the TraR C-terminal domain and overlaps with a patch on the LuxR
surface that is also critical for activation (22) (C. E. White and S. C. Winans,
unpublished data). Mutations of residues in this position do not disrupt
protein stability and DNA binding but are required for activation. However,
this patch on LuxR is predicted to interact with s70 (76), whereas the same
region of TraR is predicted to contact the a C-terminal domain of RNA
polymerase (C. E. White and S. C. Winans, unpublished data). Two additional
residues have been identified on the TraRN-terminal domain that are thought
to contact the a C-terminal domain (50, 69). Owing to the high degree of
flexibility between the TraR domains, these residues could lie very close to the
patch of residues that we identified on the C-terminal domain (81, 92). Both
sets of residues could together forma contact site for the a C-terminal domain.
This potentially novel activating region, formed from two different sets of
residues fromdifferent parts of the TraR protein, may be critical in the activity
of TraR at divergent promoters. However, further studies are required to fully
understand the interactions of TraR with RNA polymerase at TraR-dependent
promoters.
PERSPECTIVES AND FUTURE STUDIES
In this chapter we have discussed the details of how the cell-to-cell
signaling system of A. tumefaciens is regulated, what genes are activated by
TraR, and how TraR functions as a quorum-sensing transcriptional regu-
lator. However, many of the biochemical details of this system remain to be
solved. One major question involves the inactivation of TraR by its anti-
activator TraM. Although the mutagenesis studies of TraM suggest that
there are two steps in its activity, binding to TraR and then deactivation, the
mechanism of inhibition remains elusive (51, 75). These studies along with
the structural studies of TraM led to the model that, following complex
formation, the TraM dimer dissociates to inactivate TraR (8). Further
55
P
L
A
N
T
B
A
C
T
E
R
I
A
I
N
T
E
R
A
C
T
I
O
N
S
structural studies of TraMTraR complexes are critical to understanding
this mechanism.
Although the mechanisms by which TrlR acts are fairly well resolved,
we really have very little idea of why TrlR is adaptive. Why does one opine,
octopine, stimulate Ti plasmid conjugation and replication whereas
another, mannopine, inhibits both activities? The third gene we described
that inhibits TraR activity, attM, offers even more puzzles. Did this gene
evolve to degrade AHLs specifically, or some other substrate? If AttM
catalyzes the first step in OOHL degradation and AttK and AttL are also
involved, what is the enzymatic pathway? Can OOHL be mineralized and
used by A. tumefaciens as a carbon and nitrogen source, or is the function of
AttM only to regulate the cellular concentration of OOHL?
We also do not fully understand how OOHL protects TraR against
proteolysis. Even if OOHL does not act as a scaffold in the folding process,
major rearrangements must occur in the N-terminal domain of TraR upon
binding to the ligand to sequester the molecule in the core of the domain
and help the protein to evade proteolysis. Future biophysical studies of the
interaction of apo-TraR with OOHL will be very exciting and reveal not only
how OOHL contributes to TraR stability but also the specificity of the
interaction. The LuxR family members have evolved to be highly selective
in AHL binding; structural studies of other receptors and comparisons of
these to TraR are critical to understanding binding specificity and how
these proteins recognize their targets. A number of other LuxR homologs,
including LuxR and RhlR, have been purified; unlike TraR, they do not bind
to their cognate AHLs irreversibly (54, 77).
Although a possible RNA polymerase contact site has been identified
on the C-terminal domain of TraR, it is very likely that there is at least one
more patch critical to activation at class II-like promoters that has not yet
been identified. The details of how TraR interacts with RNA polymerase at
TraR-dependent promoters, particularly the divergent traAtraC and
traIrepABC promoters, remain to be determined. Although we often use
models of transcription activation that are based on CRP, it is already
apparent that there are major differences in how these two proteins interact
with RNA polymerase. The predicted contact site with the a C-terminal
domain of RNA polymerase on TraR is between the dimerization interface
and the edge of the protein on the C-terminal domain, whereas on CRP this
same activating region is on the edge of the dimer, contacting the a-subunit
as it lies adjacent to CRP in the minor groove of the DNA (4). Moreover, the
DNA bend in the activator binding site is also likely to influence how it
interacts with polymerase. CRP induces an 808 bend in the DNA, resulting
C
.
E
.
W
H
I
T
E
A
N
D
S
.
C
.
W
I
N
A
N
S
56
in kinks in each half-site, whereas the angle is only 308 in TraRDNA
complexes (63, 81, 92). Finally, although CRP can activate transcription
at divergent promoters, the complex promoter architecture at tra box II is
unique (5, 27, 61), with two class II-type and one class I-type promoter all
being activated from one TraR-binding site! There are also a number of
differences in the mechanism of activation between LuxR and TraR. The
LuxR C-terminal domain is sufficient for activation, whereas two residues
have been identified on the TraR N-terminal domain that are predicted to
contact RNA polymerase (13, 50, 74). TraR requires a supercoiled template
for transcription activation, but LuxR does not (77, 96).
In this chapter we have focused on the biochemistry of this system,
but there are many intriguing questions of how the quorum-sensing
system of A. tumefaciens relates to its role as a plant pathogen. As the
quorum-sensing system is induced only in the presence of opines, it is
active only on transformed plants and only after infection. This in itself
seems to be an anomaly, as most signaling systems in plant pathogens are
thought to be important in measuring a population of sufficient size before
inducing virulence so that pathogenesis might be successful. Perhaps
increase in Ti plasmid copy number by conjugation and replication in a
plant-associated population benefits A. tumefaciens by increasing gene
dose of the virulence and opine import and catabolic genes. As the traI
and traR genes are both on the Ti plasmid, then all conjugal donors in the
population both release and detect the OOHL signal. The obvious result of
this is that donors are counting other donors instead of possible recipients
that do not carry the Ti plasmid, so perhaps donors conjugate with each
other to increase overall Ti plasmid copy number in the population. In
support of this, sequence examination suggests that the Ti plasmid may
not have a potent entry-exclusion system. Conjugation between donor
cells would also serve to increase copy number of all Ti plasmid genes in
bacteria colonizing a tumor, including all opine catabolic operons, and
conjugation operons. This would also increase the gene dosage of T-DNA
and vir genes, which could stimulate further rounds of tumorigenesis on
infected plants.
ACKNOWLEDGEMENTS
The authors thank the members of their laboratory for helpful
discussions and review of the paper. Research in the authors laboratory
is supported by grants from NIH (GM42893) and NSF (MCB-9904917).
57
P
L
A
N
T
B
A
C
T
E
R
I
A
I
N
T
E
R
A
C
T
I
O
N
S
REFERENCES
1 Alt-Morbe, J., J. L. Stryker, C. Fuqua et al. 1996. The conjugal transfer system of
Agrobacterium tumefaciens octopine-type Ti plasmids is closely related to the
transfer system of an IncP plasmid and distantly related to Ti plasmid vir
genes. J. Bacteriol. 178: 424857.
2 Beck von Bodman, S., G. T. Hayman and S. K. Farrand 1992. Opine catabolism
and conjugal transfer of the nopaline Ti plasmid pTiC58 are coordinately regu-
lated by a single repressor. Proc. Natn. Acad. Sci. USA 89: 6437.
3 Beck von Bodman, S., J. E. McCutchan and S. K. Farrand 1989. Characterization
of conjugal transfer functions of Agrobacterium tumefaciens Ti plasmid pTiC58.
J. Bacteriol. 171: 52819.
4 Benoff, B., H. Yang, C. L. Lawson et al. 2002. Structural basis of transcription
activation: the CAP-alpha CTD-DNA complex. Science 297: 15626.
5 Busby, S. and R. H. Ebright 1999. Transcription activation by catabolite activator
protein (CAP). J. Molec. Biol. 293: 199213.
6 Chai, Y. and S. C. Winans 2004. Site-directed mutagenesis of a LuxR-type
quorum-sensing transcription factor: alteration of autoinducer specificity.
Molec. Microbiol. 51: 76576.
7 Chai, Y., J. Zhu and S. C. Winans 2001. TrlR, a defective TraR-like protein of
Agrobacterium tumefaciens, blocks TraR function in vitro by forming inactive
TrlR:TraR dimers. Molec. Microbiol. 40: 41421.
8 Chen, G., J. W. Malenkos, M. R. Cha, C. Fuqua and L. Chen 2004. Quorum-
sensing antiactivator TraM forms a dimer that dissociates to inhibit TraR. Molec.
Microbiol. 52: 164151.
9 Cho, K., C. Fuqua, B. S. Martin and S. C. Winans 1996. Identification of
Agrobacterium tumefaciens genes that direct the complete catabolism of octopine.
J. Bacteriol. 178: 187280.
10 Cho, K., C. Fuqua and S. C. Winans 1997. Transcriptional regulation and loca-
tions of Agrobacterium tumefaciens genes required for complete catabolism of
octopine. J. Bacteriol. 179: 18.
11 Cho, K. and S. C. Winans 1993. Altered-function mutations in the Agrobacterium
tumefaciens OccR protein and in an OccR-regulated promoter. J. Bacteriol. 175:
771519.
12 Cho, K. and S. C. Winans 1996. The putA gene of Agrobacterium tumefaciens is
transcriptionally activated in response to proline by an Lrp-like protein and is not
autoregulated. Molec. Microbiol. 22: 102533.
13 Choi, S. H. and E. P. Greenberg 1991. The C-terminal region of the Vibrio fischeri
LuxR protein contains an inducer-independent lux gene activating domain. Proc.
Natn. Acad. Sci. USA 88: 1111519.
14 Choi, S. H. and E. P. Greenberg 1992. Genetic evidence for multimerization of
LuxR, the transcriptional activator of Vibrio fischeri luminescence. Molec. Mar.
Biol. Biotechnol. 1: 40813.
C
.
E
.
W
H
I
T
E
A
N
D
S
.
C
.
W
I
N
A
N
S
58
15 Clare, B. G., A. Kerr and D. A. Jones 1990. Characteristics of the nopaline
catabolic plasmid in Agrobacterium strains K84 and K1026 used for biological
control of crown gall disease. Plasmid 23: 12637.
16 Dessaux, Y., A. Petit, S. K. Farrand and P. J. Murphy 1998. Opines and opine-
like molecules involved in plant/Rhizobiaceae interactions. In H. P. Spaink,
A. Kondorosi and P. J. Hooykaas (eds), The Rhizobiaceae, pp. 17397. Dordrecht,
The Netherlands: Kluwer Academic Publishers.
17 Dessaux, Y., A. Petit and J. Tempe 1992. Opines in Agrobacterium biology. In
D. P. S. Verma (ed.), Molecular Signals in Plant-Microbe Communications, pp. 10936.
Ann Arbor, MI: CRCPress.
18 Dong, Y. H., A. R. Gusti, Q. Zhang, J. L. Xu and L. H. Zhang 2002. Identification
of quorum-quenching N-acyl homoserine lactonases from Bacillus species. Appl.
Environ. Microbiol. 68: 17549.
19 Dong, Y. H., L. H. Wang, J. L. Xu et al. 2001. Quenching quorum-sensing-
dependent bacterial infection by an N-acyl homoserine lactonase. Nature 411:
81317.
20 Dyson, H. J. and P. E. Wright 2002. Coupling of folding and binding for
unstructured proteins. Curr. Opin. Struct. Biol. 12: 5460.
21 Eberhard, A., A. L. Burlingame, C. Eberhard et al. 1981. Structural identification
of autoinducer of Photobacterium fischeri luciferase. Biochemistry 20: 24449.
22 Egland, K. A. and E. P. Greenberg 2001. Quorum sensing in Vibrio fischeri:
analysis of the LuxR DNA binding region by alanine-scanning mutagenesis.
J. Bacteriol. 183: 3826.
23 Ellis, J. G., A. Kerr, A. Petit and J. Tempe 1982. Conjugal transfer of nopaline
and agropine Ti-plasmids: the role of agrocinopines. Molec. Gen. Genet. 186:
26973.
24 Farrand, S. K. 1998. Conjugal plasmids and their transfer. In H. P. Spaink,
A. Kondorosi and P. J. J. Hooykaas (eds), The Rhizobiaceae: Molecular Biology of
Model Plant-associated Bacteria, pp. 199233. Dordrecht, The Netherlands: Kluwer
Academic Publishers.
25 Finney, A. H., R. J. Blick, K. Murakami, A. Ishihama and A. M. Stevens 2002.
Role of the C-terminal domain of the alpha subunit of RNA polymerase in LuxR-
dependent transcriptional activation of the lux operon during quorum sensing.
J. Bacteriol. 184: 45208.
26 Fuqua, C., M. Burbea and S. C. Winans 1995. Activity of the Agrobacterium Ti
plasmid conjugal transfer regulator TraR is inhibited by the product of the traM
gene. J. Bacteriol. 177: 136773.
27 Fuqua, C. and S. C. Winans 1996. Conserved cis-acting promoter elements are
required for density-dependent transcription of Agrobacterium tumefaciens con-
jugal transfer genes. J. Bacteriol. 178: 43540.
28 Fuqua, C. and S. C. Winans 1996. Localization of OccR-activated and TraR-
activated promoters that express two ABC-type permeases and the traR gene of
Ti plasmid pTiR10. Molec. Microbiol. 20: 1199210.
59
P
L
A
N
T
B
A
C
T
E
R
I
A
I
N
T
E
R
A
C
T
I
O
N
S
29 Fuqua, W. C. and S. C. Winans 1994. A LuxR-LuxI type regulatory system
activates Agrobacterium Ti plasmid conjugal transfer in the presence of a plant
tumor metabolite. J. Bacteriol. 176: 2796806.
30 Gage, D. J. 2004. Infection and invasion of roots by symbiotic, nitrogen-fixing
rhizobia during nodulation of temperate legumes. Microbiol. Molec. Biol. Rev. 68:
280300.
31 Genetello, C., N. Van Larebeke, M. Holsters et al. 1977. Ti plasmids of
Agrobacterium as conjugative plasmids. Nature 265: 5613.
32 Goodner, B., G. Hinkle, S. Gattung et al. 2001. Genome sequence of the plant
pathogen and biotechnology agent Agrobacterium tumefaciens C58. Science 294:
23238.
33 Gould, T. A., H. P. Schweizer and M. E. Churchill 2004. Structure of the
Pseudomonas aeruginosa acyl-homoserinelactone synthase LasI. Molec. Microbiol.
53: 113546.
34 Hayman, G. T. and S. K. Farrand 1990. Agrobacterium plasmids encode struc-
turally and functionally different loci for catabolism of agrocinopine-type opines.
Molec. Gen. Genet. 223: 46573.
35 Hayman, G. T. and S. K. Farrand 1988. Characterization and mapping of the
agrocinopine-agrocin 84 locus on the nopaline Ti plasmid pTiC58. J. Bacteriol.
170: 175967.
36 He, X., W. Chang, D. L. Pierce, L. O. Seib, J. Wagner and C. Fuqua 2003. Quorum
sensing in Rhizobium sp. strain NGR234 regulates conjugal transfer (tra) gene
expression and influences growth rate. J. Bacteriol. 185: 80922.
37 Huang, J. J., J. I. Han, L. H. Zhang and J. R. Leadbetter 2003. Utilization of acyl-
homoserine lactone quorum signals for growth by a soil pseudomonad and
Pseudomonas aeruginosa PAO1. Appl. Environ. Microbiol. 69: 59419.
38 Hwang, I., D. M. Cook and S. K. Farrand 1995. A new regulatory element
modulates homoserine lactone-mediated autoinduction of Ti plasmid conjugal
transfer. J. Bacteriol. 177: 44958.
39 Hwang, I., P. L. Li, L. Zhang et al. 1994. TraI, a LuxI homologue, is responsible
for production of conjugation factor, the Ti plasmid N-acylhomoserine lactone
autoinducer. Proc. Natn. Acad. Sci. USA 91: 463943.
40 Hwang, I., A. J. Smyth, Z. Q. Luo and S. K. Farrand 1999. Modulating quorum
sensing by antiactivation: TraM interacts with TraR to inhibit activation of Ti
plasmid conjugal transfer genes. Molec. Microbiol. 34: 28294.
41 Johnson, D. C., A. Ishihama and A. M. Stevens 2003. Involvement of region 4 of
the sigma 70 subunit of RNA polymerase in transcriptional activation of the lux
operon during quorum sensing. FEMS Microbiol. Lett. 228: 193201.
42 Kado, C. I. 1994. Promiscuous DNA transfer system of Agrobacterium tume-
faciens: role of the virB operon in sex pilus assembly and synthesis. Molec.
Microbiol. 12: 1722.
43 Kent, A. D. and E. W. Triplett 2002. Microbial communities and their interac-
tions in soil and rhizosphere ecosystems. A. Rev. Microbiol. 56: 21136.
C
.
E
.
W
H
I
T
E
A
N
D
S
.
C
.
W
I
N
A
N
S
60
44 Kerr, A. 1971. Acquisition of virulence by non-pathogenic isolates of
Agrobacterium radiobacter. Physiol. Plant Pathol. 1: 2416.
45 Kerr, A. 1969. Transfer of virulence between isolates of Agrobacterium. Nature
223: 11756.
46 Kerr, A., P. Manigault and J. Tempe 1977. Transfer of virulence in vivo and in vitro
in Agrobacterium. Nature 265: 5601.
47 Leadbetter, J. R. and E. P. Greenberg 2000. Metabolism of acyl-homoserine
lactone quorum-sensing signals by Variovorax paradoxus. J. Bacteriol. 182:
69216.
48 Lessl, M., D. Balzer, W. Pansegrau and E. Lanka 1992. Sequence similarities
between the RP4 Tra2 and the Ti VirB region strongly support the conjugation
model for T-DNA transfer. J. Biol. Chem. 267: 2047180.
49 Lessl, M. and E. Lanka 1994. Common mechanisms in bacterial conjugation and
Ti-mediated T-DNA transfer to plant cells. Cell 77: 3214.
50 Luo, Z. Q. and S. K. Farrand 1999. Signal-dependent DNA binding and func-
tional domains of the quorum-sensing activator TraR as identified by repressor
activity. Proc. Natn. Acad. Sci. USA 96: 900914.
51 Luo, Z. Q., Y. Qin and S. K. Farrand 2000. The antiactivator TraM interferes
with the autoinducer-dependent binding of TraR to DNA by interacting with
the C-terminal region of the quorum-sensing activator. J. Biol. Chem. 275:
771322.
52 Luo, Z. Q., A. J. Smyth, P. Gao, Y. Qin and S. K. Farrand 2003. Mutational
analysis of TraR. Correlating function with molecular structure of a quorum-
sensing transcriptional activator. J. Biol. Chem. 278: 1317382.
53 Maris, A. E., M. R. Sawaya, M. Kaczor-Grzeskowiak et al. 2002. Dimerization
allows DNA target site recognition by the NarL response regulator. Nat. Struct.
Biol. 9: 7718.
54 Medina, G., K. Juarez, B. Valderrama and G. Soberon-Chavez 2003. Mechanism
of Pseudomonas aeruginosa RhlRtranscriptional regulation of the rhlABpromoter.
J. Bacteriol. 185: 597683.
55 More, M. I., L. D. Finger, J. L. Stryker et al. 1996. Enzymatic synthesis of a
quorum-sensing autoinducer through use of defined substrates. Science 272:
16558.
56 Morris, R. O. 1990. Genes specifying auxin and cytokinin biosynthesis in prokar-
yotes. In P. J. Davies (ed.), Plant Hormones and Their Role in Plant Growth and
Development, pp. 63655. Dordrecht, The Netherlands: Kluwer Academic
Publishers.
57 Nester, E. W., D. J. Merlo, M. H. Drummond et al. 1977. The incorporation and
expression of Agrobacterium plasmid genes in crown gall tumors. Basic Life Sci.
9: 18196.
58 Oger, P. and S. K. Farrand 2001. Co-evolution of the agrocinopine opines and the
agrocinopine-mediated control of TraR, the quorum-sensing activator of the Ti
plasmid conjugation system. Molec. Microbiol. 41: 117385.
61
P
L
A
N
T
B
A
C
T
E
R
I
A
I
N
T
E
R
A
C
T
I
O
N
S
59 Oger, P. and S. K. Farrand 2002. Two opines control conjugal transfer of an
Agrobacteriumplasmid by regulating expression of separate copies of the quorum-
sensing activator gene traR. J. Bacteriol. 184: 112131.
60 Oger, P., K. S. Kim, R. L. Sackett, K. R. Piper and S. K. Farrand 1998. Octopine-
type Ti plasmids code for a mannopine-inducible dominant-negative allele of
traR, the quorum-sensing activator that regulates Ti plasmid conjugal transfer.
Molec. Microbiol. 27: 27788.
61 Pappas, K. M. and S. C. Winans 2003. A LuxR-type regulator from Agrobacterium
tumefaciens elevates Ti plasmid copy number by activating transcription of plas-
mid replication genes. Molec. Microbiol. 48: 105973.
62 Pappas, K. M. and S. C. Winans 2003. The RepA and RepB autorepressors and
TraR play opposing roles in the regulation of a Ti plasmid repABC operon. Molec.
Microbiol. 49: 44155.
63 Parkinson, G., C. Wilson, A. Gunasekera et al. 1996. Structure of the CAP-DNA
complex at 2.5 angstroms resolution: a complete picture of the protein-DNA
interface. J. Molec. Biol. 260: 395408.
64 Parsek, M. R., D. L. Val, B. L. Hanzelka, J. E. Cronan, Jr. and E. P. Greenberg
1999. Acyl homoserine-lactone quorum-sensing signal generation. Proc. Natn.
Acad. Sci. USA 96: 43605.
65 Pierson, L. S. I., D. W. Wood and S. B. von Bodman 1999. Quorum sensing in
plant-associated bacteria. In G. M. Dunny and S. C. Winans (eds), Cell-Cell
Signaling in Bacteria, pp. 10115. Washington, DC: ASM Press.
66 Piper, K. R., S. Beck von Bodman and S. K. Farrand 1993. Conjugation factor of
Agrobacterium tumefaciens regulates Ti plasmid transfer by autoinduction. Nature
362: 44850.
67 Piper, K. R., S. Beck Von Bodman, I. Hwang and S. K. Farrand 1999. Hierarchical
gene regulatory systems arising from fortuitous gene associations: controlling
quorumsensing by the opine reguloninAgrobacterium. Molec. Microbiol. 32: 107789.
68 Pohlman, R. F., H. D. Genetti and S. C. Winans 1994. Common ancestry
between IncN conjugal transfer genes and macromolecular export systems of
plant and animal pathogens. Molec. Microbiol. 14: 65568.
69 Qin, Y., Z. Q. Luo and S. K. Farrand 2004. Domains formed within the
N-terminal region of the quorum-sensing activator TraR are required for tran-
scriptional activation and direct interaction with RpoA from agrobacterium.
J. Biol. Chem. 279: 4084451.
70 Qin, Y., Z. Q. Luo, A. J. Smyth et al. 2000. Quorum-sensing signal binding
results in dimerization of TraR and its release from membranes into the cyto-
plasm. EMBO J. 19: 521221.
71 Sheng, J. and V. Citovsky 1996. Agrobacterium-plant cell DNA transport: have
virulence proteins, will travel. Plant Cell 8: 1699710.
72 Shoemaker, B. A., J. J. Portman and P. G. Wolynes 2000. Speeding molecular
recognition by using the folding funnel: the fly-casting mechanism. Proc. Natn.
Acad. Sci. USA 97: 886873.
C
.
E
.
W
H
I
T
E
A
N
D
S
.
C
.
W
I
N
A
N
S
62
73 Stevens, A. M., N. Fujita, A. Ishihama and E. P. Greenberg 1999. Involvement of
the RNA polymerase alpha-subunit C-terminal domain in LuxR-dependent activ-
ation of the Vibrio fischeri luminescence genes. J. Bacteriol. 181: 47047.
74 Stevens, A. M. and E. P. Greenberg 1997. Quorum sensing in Vibrio fischeri:
essential elements for activation of the luminescence genes. J. Bacteriol. 179:
55762.
75 Swiderska, A., A. K. Berndtson, M. R. Cha et al. 2001. Inhibition of the
Agrobacterium tumefaciens TraR quorum-sensing regulator. Interactions with
the TraM anti-activator. J. Biol. Chem. 276: 4944958.
76 Trott, A. E. and A. M. Stevens 2001. Amino acid residues in LuxR critical for its
mechanismof transcriptional activation during quorumsensing in Vibrio fischeri.
J. Bacteriol. 183: 38792.
77 Urbanowski, M. L., C. P. Lostroh and E. P. Greenberg 2004. Reversible acyl-
homoserine lactone binding to purified Vibrio fischeri LuxR protein. J. Bacteriol.
186: 6317.
78 Val, D. L. and J. E. Cronan, Jr 1998. In vivo evidence that S-adenosylmethionine
and fatty acid synthesis intermediates are the substrates for the LuxI family of
autoinducer synthases. J. Bacteriol. 180: 264451.
79 Van Larebeke, N., G. Engler, M. Holsters et al. 1974. Large plasmid in
Agrobacterium tumefaciens essential for crown gall-inducing ability. Nature 252:
16970.
80 Vannini, A., C. Volpari and S. Di Marco 2004. Crystal structure of the quorum-
sensing protein TraM and its interaction with the transcriptional regulator TraR.
J. Biol. Chem. 279: 242916.
81 Vannini, A., C. Volpari, C. Gargioli et al. 2002. The crystal structure of the
quorum sensing protein TraR bound to its autoinducer and target DNA. EMBO
J. 21: 4393401.
82 Walker, T. S., H. P. Bais, E. Grotewold and J. M. Vivanco 2003. Root exudation
and rhizosphere biology. Plant Physiol. 132: 4451.
83 Watson, W. T., T. D. Minogue, D. L. Val, S. Beck von Bodman and M. E. Churchill
2002. Structural basis and specificity of acyl-homoserine lactone signal produc-
tion in bacterial quorum sensing. Molec. Cell 9: 68594.
84 Whitehead, N. A., A. M. Barnard, H. Slater, N. J. Simpson and G. P. Salmond
2001. Quorum-sensing in Gram-negative bacteria. FEMS Microbiol. Rev. 25:
365404.
85 Winans, S. C. 1992. Two-way chemical signaling in Agrobacterium-plant inter-
actions. Microbiol. Rev. 56: 1231.
86 Winans, S. C., J. Zhu and M. I. More 1999. Cell density-dependent gene expres-
sion by Agrobacterium tumefaciens during colonization of crown gall tumors. In
G. M. Dunny and S. C. Winans (eds), Cell-Cell Signaling in Bacteria, pp. 11728.
Washington, DC: ASM Press.
87 Wood, D. W., J. C. Setubal, R. Kaul et al. 2001. The genome of the natural genetic
engineer Agrobacterium tumefaciens C58. Science 294: 231723.
63
P
L
A
N
T
B
A
C
T
E
R
I
A
I
N
T
E
R
A
C
T
I
O
N
S
88 Zhang, H. B., C. Wang and L. H. Zhang 2004. The quormone degradation
system of Agrobacterium tumefaciens is regulated by starvation signal and stress
alarmone (p)ppGpp. Molec. Microbiol. 52: 1389401.
89 Zhang, H. B., L. H. Wang and L. H. Zhang 2002. Genetic control of quorum-
sensing signal turnover in Agrobacterium tumefaciens. Proc. Natn. Acad. Sci.
USA 99: 463843.
90 Zhang, L., P. J. Murphy, A. Kerr and M. E. Tate 1993. Agrobacteriumconjugation
and gene regulation by N-acyl-L-homoserine lactones. Nature 362: 4468.
91 Zhang, L. H. and A. Kerr 1991. A diffusible compound can enhance conju-
gal transfer of the Ti plasmid in Agrobacterium tumefaciens. J. Bacteriol. 173:
186772.
92 Zhang, R. G., T. Pappas, J. L. Brace et al. 2002. Structure of a bacterial quorum-
sensing transcription factor complexed with pheromone and DNA. Nature
417: 9714.
93 Zhu, J., J. W. Beaber, M. I. More et al. 1998. Analogs of the autoinducer
3-oxooctanoyl-homoserine lactone strongly inhibit activity of the TraR protein of
Agrobacterium tumefaciens. J. Bacteriol. 180: 5398405.
94 Zhu, J., P. M. Oger, B. Schrammeijer et al. 2000. The bases of crown gall
tumorigenesis. J. Bacteriol. 182: 388595.
95 Zhu, J. and S. C. Winans 1998. Activity of the quorum-sensing regulator TraR
of Agrobacterium tumefaciens is inhibited by a truncated, dominant defective
TraR-like protein. Molec. Microbiol. 27: 28997.
96 Zhu, J. and S. C. Winans. 1999. Autoinducer binding by the quorum-sensing
regulator TraR increases affinity for target promoters in vitro and decreases TraR
turnover rates in whole cells. Proc. Natn. Acad. Sci. USA 96: 48327.
97 Zhu, J. and S. C. Winans 2001. The quorum-sensing transcriptional regulator
TraRrequires its cognate signaling ligand for protein folding, protease resistance,
and dimerization. Proc. Natn. Acad. Sci. USA 98: 150712.
C
.
E
.
W
H
I
T
E
A
N
D
S
.
C
.
W
I
N
A
N
S
64
CHAPTER 4
Jamming bacterial communications: new
strategies to combat bacterial infections
and the development of biofilms
Michael Givskov
Center for Biomedical Microbiology, BioCentrum Technical University of Denmark
Morten Hentzer
Carlsberg Biosector, Carlsberg A/S, Valby, Denmark
INTRODUCTION
The growth and activity of microorganisms affect our lives in both
positive and negative ways. We have, since early times, tried to combat
unwanted microbes and utilize those expressing useful traits.
Microorganisms can cause diseases and chronic infections in humans,
animals, and plants. In medicine, agriculture and fish farming, treatment
scenarios are based on antimicrobial compounds such as antibiotics, with
toxic and growth-inhibitory properties. Control of growth by eradication
of bacteria is one of the most important scientific achievements.
Unfortunately, bacteria have become gradually more and more resistant
to antibiotics, and infections caused by resistant bacteria are on a dramatic
increase. It has recently become apparent that the bacterial lifestyle also
contributes significantly to this problem. The traditional way of culturing
bacteria as planktonic, liquid cultures imprinted the view that bacteria live
as unicellular organisms. Although it must be emphasized that such test-
tube studies have led to fundamental insights into basic life processes and
have unraveled complex intracellular regulatory networks, it is now clear
that in nature microbial activity is mainly associated with surfaces and we
as scientists must therefore turn our attention to this sessile mode of
growth (33). It appears that the ability to formsurface-associated, structured
and cooperative consortia (referred to as biofilms) is one of the most
remarkable and ubiquitous characteristics of bacteria (12). In this sessile
life form, bacteria can cause various problems in industrial settings, rang-
ing from corrosion and biofouling to food contamination. In clinical
microbiology, the biofilm mode of bacterial growth has attracted particular
attention. Many persistent and chronic infections (including pulmonary
65
Bacterial Cell-to-Cell Communication: Role in Virulence and Pathogenesis, ed. D. R. Demuth and
R. J. Lamont. Published by Cambridge University Press. #Cambridge University Press 2005.
infections of cystic fibrosis (CF) patients, periodontitis, otitis media, biliary
tract infection, and endocarditis) as well as the colonization of medical
implants (catheters, artificial heart valves, etc.) are now believed to be
intrinsically linked to the formation of bacterial biofilms (15).
Biofilm infections are becoming more and more common owing to the
more frequent insertion of artificial medical implants. Taking the change
in age distribution (as the proportion of elderly people increases) in the
developed world into account, it will be of the utmost importance to address
this major medical and public health problem in the twenty-first century.
A recent public announcement from the US National Institutes of Health
stated that more than 80% of all microbial infections involve biofilms (17).
The capability of forming a biofilm within the human body is therefore
considered to represent a pathogenic trait per se. Biofilm infections (often
caused by opportunistic pathogenic bacteria) are particularly problematic
as they give rise to chronic infections, inflammation, and tissue damage.
For the clinician, the major problem is that bacteria living in biofilms can
often withstand the host defense systems and are markedly tolerant to
antibiotics, often exceeding the highest deliverable doses of antibiotics
and thus making an efficient treatment impossible. Treatment of Biofilm
infections therefore calls for new strategies.
WHY QS INHIBITORS?
The most obvious alternative to antibiotic-mediated killing or growth
inhibition would be to attenuate the bacteria with respect to their patho-
genicity. The ability to organize structurally and to distribute activities between
the different bacteria demands a high degree of coordinated cellcell inter-
action reminiscent of that seen in multicellular organisms. Such interactions
involve cell-to-cell communication systems to adjust the various functions
of specialized members of the population. In fact, many bacteria employ
intercellular communication systems that rely on small signal molecules to
monitor their ownpopulationdensities ina process knownas quorumsensing
(QS) as described in detail in previous chapters. Signal molecules that are
released by the cells modulate the activity of other cells in the vicinity, thus
regulating collective activities. Cell-to-cell signaling is referred to as QS
because the system enables a given bacterial species to sense when a critical
(i.e. quorate) population density has been reached in the host and in response
activate the expression of target genes required for succession (32).
A diverse range of bacterial metabolites is now recognized as intercel-
lular QS signals. The list includes peptides, butyrolactones, palmitic acid
M
.
G
I
V
S
K
O
V
A
N
D
M
.
H
E
N
T
Z
E
R
66
methyl esters, quinones, and cyclic dipeptides. Although the principle
behind signal-mediated gene expression in both Gram-positive and
Gram-negative bacteria is shared, the molecular mechanisms and signal
molecules differ. Peptides serve as the signal molecules in many Gram-
positive bacteria; the signals are sensed via two component phosphorelay
systems (54). Among Gram-negative bacteria, N-acyl-L-homoserine lactone
(AHL)-dependent QS systems are particularly widespread. These systems
are used to coordinate expression of traits that are fundamental to the
interaction of bacteria with each other, with their environment, and particu-
larly with higher organisms, covering a variety of functions ranging from
pathogenic to symbiotic interactions. These include expression of biolumi-
nescence in the specialized light organs of squids and fish, surface
colonization, and biofilm development, as well as production of virulence
factors and hydrolytic enzymes during infection of eukaryotic hosts.
Back in the mid 1990s, the strictly cell-density-dependent formation of
a swarm colony observed in Serratia liquefaciens led to the hypothesis that a
QS system triggered colony expansion once a critical size, the quorum, had
been attained. The behavior of the swrI knockout mutant on swarm media
in the presence or absence of exogenously added BHL (N-butanoyl-L-
homoserine lactone) clearly supported this hypothesis (27). The swr system
controls swarming but not swimming motility and was therefore the first
published example of a surface-associated behavior that is controlled by
means of QS. Production of several virulence factors was in fact controlled
by the swr QS system by means of the QS-controlled lipB transporter (94).
lipB is part of an operon encoding a type I secretion system, which is
responsible for the secretion of extracellular lipase, metalloprotease, and
S-layer protein. Accordingly, QS systems seem to link virulence with sur-
face activity, which has opened a new perspective for controlling undesired
microbial activity. Throughout the years, we and our collaborators have
documented that blockade of AHL-mediated communication represents an
effective approach to interfere with surface colonization and to attenuate
the virulence of bacterial pathogens (34, 43, 89). We have denoted com-
pounds capable of this as anti-pathogenic drugs. QS systems regulate (in
the classical sense) non-essential phenotypes, so if the new drugs could be
based on QS inhibitor (QSI) compounds the bacteria should not, at least in
theory, meet the same hard selective pressure as is imposed by antibiotics.
The major advantage of this creative strategy for antipathogenic therapy is
that it is likely to circumvent the problem of resistance, which is intimately
connected to the use of conventional antibacterial agents such as antibio-
tics. Although resistant mutants may arise, they are not expected to have
67
J
A
M
M
I
N
G
B
A
C
T
E
R
I
A
L
C
O
M
M
U
N
I
C
A
T
I
O
N
S
a selective growth advantage per se and thus should not outcompete the
parental strain. Furthermore, QSI compounds are not expected to elimi-
nate communities of helpful and beneficial bacteria present in the host (for
example, the gut flora). The antipathogenic drug approach is generic in
nature and relevant to a broad spectrum of scientists such as microbio-
logists and medical doctors working in the field of infectious diseases and
artificial implants and those engineers who are involved in maintenance of
industrial facilities and water pipelines.
PSEUDOMONAS AERUGINOSA AND QS
Pseudomonas aeruginosa is an increasingly prevalent opportunistic
human pathogen and is the most common Gram-negative bacterium
found in nosocomial and life-threatening infections of immunocompro-
mised patients (114). Patients with cystic fibrosis (CF) are especially dis-
posed to P. aeruginosa infections and for these persons the bacterium is
responsible for high rates of morbidity and mortality (46, 60). P. aeruginosa
makes several virulence factors that contribute to its pathogenesis, as
described in Chapter 1 of this volume. QS plays a key role in orchestrating
the expression of many of these virulence factors, such as exoproteases,
siderophores, exotoxins, and several secondary metabolites, and partici-
pates in the development of biofilms (18, 43, 81, 121). P. aeruginosa pos-
sesses two QS systems: the LasRLasI and the RhlRRhlI, with the cognate
signal molecules OdDHL (N-[3-oxo-dodecanoyl]-L-homoserine lactone) and
BHL, respectively. The two systems do not operate independently: the las
system positively regulates expression of the rhl system (57, 86).
Intertwined in this QS hierarchy is the quinolone signal (PQS) system,
which provides a link between the las and rhl QS systems (85) (70).
In addition to mediate communication between bacteria, immuno-
assays in vitro on human leukocytes have shown that OdDHL possesses
immunomodulatory properties, e.g. inhibition of lymphocyte prolifera-
tion and downregulation of tumor necrosis factor alpha and IL-12 produc-
tion (110). OdDHL has been demonstrated to activate T-cells in vivo to
produce the inflammatory cytokine g-interferon (104), thereby potentially
promoting a Th-2 dominated response leading to increased tissue damage
and inflammation. OdDHL also possesses proinflammatory, immuno-
modulatory, and vasorelaxant properties (7). In vivo evidence has left little
doubt that QS controlled gene expression plays an important role in the
development of P. aeruginosa infections (29, 82, 125, 126).
M
.
G
I
V
S
K
O
V
A
N
D
M
.
H
E
N
T
Z
E
R
68
THE INVOLVEMENT OF QS IN P. AERUGINOSA BIOFILM
DEVELOPMENT
Abiofilm is a structured community of bacterial cells enclosed in a self-
produced polymeric matrix and adherent to an inert or living surface.
Bacterial biofilms are considered ubiquitous in nature (12). In most cases
biofilms form at the interface between a solid surface and an aqueous
phase. According to the prevailing model, biofilm development is believed
to proceed through a temporal series of stages (79). This hypothesis has
gained momentum from the isolation of mutants that appear to be arrested
at certain stages of this development (37, 62, 75, 87, 113). In the initial
phase, bacteria attach to a surface, grow, and then proliferate to form
microcolonies. These microcolonies develop into hydrated structures in
which bacterial cells are enmeshed in a matrix of self-produced slime
(58). For reviews see (109, 120). This slime is commonly referred to as
exopolymeric substances (EPS) and may, dependent on the type of bacteria
and their overall metabolic status, consist of all major classes of macro-
molecules (proteins, polysaccharides, DNA, and RNA) in addition to pepti-
doglycan, lipids, and phospholipids (118, 124). Mature biofilms typically
consist of towers and mushrooms of cells enmeshed in copious
amounts of EPS, separated by channels and interstitial voids to allow
convective flow to transport nutrients to interior parts of the biofilm and
remove waste products. This structural heterogeneity is commonly referred
to as the biofilm architecture.
The involvement of QS in P. aeruginosa biofilm architecture is based on
circumstantial evidence. Davies et al. (18) demonstrated that a lasI mutant
formed flat and undifferentiated biofilms in contrast to the wild type, which
formed the characteristic biofilm architecture. The authors also found that
the flat biofilms formed by the quorum mutant were eradicated with SDS
treatment, suggesting that development of the characteristic biofilm toler-
ance to antimicrobial treatment would in fact require proper biofilm differ-
entiation, which in turn would rely on QS-dependent gene expression.
Studies by others revealed no differences between the biofilms of the
wild type and those formed by signal-negative mutants (44, 108). Purevdorj
et al. (88) reported minor structural differences between wild-type and mutant
biofilms, but these differences were only apparent when particular hydro-
dynamic conditions were used for growing the biofilms. This indicates that
the experimental settings influence the look of the biofilm.
One of the key issues for biofilm structure seems to be the growth
conditions. OToole et al. (74) showed the catabolite repression control (Crc)
69
J
A
M
M
I
N
G
B
A
C
T
E
R
I
A
L
C
O
M
M
U
N
I
C
A
T
I
O
N
S
protein to be involved; Klausen et al. (53) demonstrated that the availability of
different carbon sources affected P. aeruginosa biofilm structures. In general,
glucose-grown biofilms are very heterogeneous, exhibiting discrete towers and
mushroomstructures separated by water channels and voids. On the contrary,
biofilms grown under identical conditions but withcitrate as the carbon source
appear flat and uniform. In addition, when the mediumis supplemented with
nitrate as alternative electron acceptor to oxygen, compact and less differen-
tiated biofilms are obtained (authors unpublished results).
The involvement of QS in biofilm formation has also been demon-
strated for Burkholderia cepacia (48, 49), Aeromonas hydrophila (61),
Pseudomonas putida (105) and S. liquefaciens (56). AHL-negative mutants
of B. cepacia and A. hydrophila showed defects in the late stages of biofilm
development and thus were unable to form typical structured biofilms.
Recent work on S. liquefaciens MG1 has demonstrated that expression of
QS-controlled genes is crucial at a specific stage for the development of its
characteristic filamentous biofilm (56).
The advent of cDNA microarray technology has provided great insight
into differential gene expression in biofilm bacteria. Despite the striking
differences between the lifestyles of planktonic and biofilm bacteria, only
1%3%of the 5,570 predicted genes in P. aeruginosa PAO1 show differential
expression in the two modes of growth (39, 41, 43, 119). The gene expres-
sion profile of P. aeruginosa biofilms exhibited greater similarity to that of
planktonic cultures in stationary phase than to that of planktonic cultures
in mid exponential growth or early stationary phase, hence supporting the
view that biofilms are dominated by bacteria with stationary-phase physio-
logy. The genes upregulated during biofilm growth are involved in many
different cellular processes, such as transcription and translation, energy
metabolism, intermediate metabolism, transport, cofactor biosynthesis,
amino acid biosynthesis, and cell-wall synthesis. Notably, a large number
of genes related to denitrification and anaerobic respiration were upregu-
lated in biofilms, indicating that anaerobiosis is important in microbial
biofilm physiology. A study of the transient gene expression during biofilm
development showed that many genes involved in anaerobic respiration
became further activated as the biofilm matured. At late stages of biofilm
development, transcription of a gene cluster related to the filamentous
phage Pf1 became strongly activated (more than 200-fold) (39, 41, 119).
The Pf1-like genes have been shown to be involved in bacterial cell death
and biofilm dispersal (117).
The involvement of QS in biofilm formation and development has
been established by several research groups (18, 20, 95) but the identity
M
.
G
I
V
S
K
O
V
A
N
D
M
.
H
E
N
T
Z
E
R
70
of a class of specific QS-controlled genes that influence biofilm formation
has remained elusive. It is noteworthy that most attempts to identify QS-
controlled genes in P. aeruginosa have been performed on planktonic
cultures and not on biofilm-growing cells, hence neglecting the possibility
that the constitution of the QS regulon can be influenced by environmental
factors. In our laboratory, we performed a parallel identification of QS-
controlled genes in planktonic and biofilm-growing P. aeruginosa. We
found that, indeed, the QS regulon is influenced by environmental condi-
tions; a number of biofilm-specific QS-controlled genes could clearly be
identified. These genes are of course prime suspects for mediating the role
of QS in biofilm development (39, 41). Interestingly, many of the biofilm-
specific quorum-sensing-controlled genes were related to responses to
iron-limitation. We hypothesize that in the biofilm mode of growth either
the availability of iron is reduced, owing to binding to the EPS matrix, or,
alternatively, biofilm cells require elevated amounts of iron relative to
planktonic cells to support growth. The increased demand for iron during
biofilm growth could be due to anaerobiosis as many of the genes compris-
ing the nitrate respiratory pathway, which we found to be differentially
upregulated in biofilms, are iron-containing proteins.
NATURAL BLOCKERS: A EUKARYOTIC DEFENSE STRATEGY
AGAINST BIOFILMS AND BIOFOULING
The ability of bacteria to form biofilms is a major challenge for living
organisms such as humans, animals, and marine eukaryotes (55, 59).
Marine plants are, in the absence of more advanced immune systems,
prone to disease (11, 30). Bacteria can be highly detrimental to marine
algae and other eukaryotes (59). The Australian red macroalga Delisea
pulchra (23) produces a range of halogenated furanone compounds (for
structures and numbering see Figure 4.1), which display antifouling and
antimicrobial properties (21, 22, 92). This particular alga originally
attracted the attention of marine biologists because it was devoid of exten-
sive surface colonization, i.e. biofouling, unlike other plants in the same
environment. Biofouling is primarily caused by marine invertebrates and
plants, but bacteria are believed to be the first colonizers of submerged
surfaces, providing an initial conditioning biofilm to which other marine
organisms may attach (93). Therefore, the abundance and composition of
the bacterial community on the surface will significantly affect the sub-
sequent development of a biofouling community (4, 38). To cope with this,
eukaryotes have developed chemical defense mechanisms (19, 22, 116)
71
J
A
M
M
I
N
G
B
A
C
T
E
R
I
A
L
C
O
M
M
U
N
I
C
A
T
I
O
N
S
which in several cases are secondary metabolites that inhibit bacterial
colonization-relevant phenotypes (52, 67, 100).
The effect of furanones on bacterial colonization phenotypes is due to
interference with specific cell processes rather than to general toxicity or
surface modification (52, 68). The D. pulchra furanone compounds consist
of a furan ring structure with a substituted acyl chain at the C-3 position and
a bromine substitution at the C-4 position. The substitution at the C-5
position may vary in terms of side-chain structure. The natural furanones
are halogenated at various positions by bromide, iodide, or chloride (23).
For furanone structures, see Figure 4.1. D. pulchra produces a minimum of
BHL
O
O
O
O
O
O
O
O
O
O
O
S S
S
N
Br
Br Br
Br
Br
Br
Br Br
Br
S
NO
2
O
O
O
O
OH
OH
HO
O
O
O
O
O
O
O
O
O O
O O
O
O
O
O
O
H H
N
H
N
H
N
H
N
H
N
H
H H
O
O
O
OHHL OdDHL
furanone C-2 C-4 C-8 C-30 C-56
patulin penicillic acid GC-7
C(6)
C(3)
C(1)
O(1)
C(4)
C(3)
C(5)
C(1) C(3)
2-heptylthioacetyl-homoserine lactone N -pentylsulfonyl-homoserine lactone
4-nitropyridine-N -oxide
Figure 4.1. AHL signals and QSI compounds. The upper line shows the Pseudomonas
aeruginosa signal molecules BHL and OdDHL and the Vibrio fischeri signal OHHL with
carbon atom numbering. The rest are QSI compounds. The second line shows the two
synthetic sulfur compounds developed from AHL by rational drug design. The third line
shows the fungal metabolites patulin and penicillic acid, a metabolite (GC-7) isolated from
garlic, and the synthetic compound 4-NPO. The bottom line shows three natural furanone
compounds, C-2 (with carbon atomnumbering), C-4 and C-8, isolated fromDelisea pulchra,
and two synthetic derivatives, C-30 and C-56.
M
.
G
I
V
S
K
O
V
A
N
D
M
.
H
E
N
T
Z
E
R
72
30 different species of halogenated furanone compound, which are stored in
specialized vesicles. The compounds are released at the surface of the thallus at
concentrations ranging from 1 to 100 ngcm
2
(26, 93). Field experiments
have demonstrated that the surface concentration of furanones is inversely
correlated to the degree of colonization by marine bacteria (52).
Several of the furanone compounds that exhibit structural similarity to the
short-chain AHL molecules inhibited swarming motility of S. liquefaciens MG1
(34). This, taken together with inhibition of LuxR-controlled transcriptional
fusions, strongly suggested that furanone compounds competed with the
cognate signals for the SwrRand the LuxRreceptors. Based on the observation
that biofilm formation on submerged surfaces precedes the attraction of
higher fouling organisms, Givskov et al. (34) hypothesized that the D. pulchra
furanones constitute a specific means of eukaryotic interference with bacterial
communication, surface colonization and virulence factor expression, i.e.
multicellular behavior. Extensive experimental evidence in support of this
hypothesis has accumulated during the years and include the observations
that furanones inhibit QS-regulated expression of Vibrio fischeri biolumines-
cence (63), virulence factor production and pathogenesis in P. aeruginosa (42,
43), luminescence and virulence in vivo of the black tiger prawn pathogen
Vibrio harveyi (64), and finally virulence of Erwinia carotovora (66).
Furanone-mediated displacement of
3
H-labeled OHHL molecules
from LuxR-overproducing Escherichia coli cells supported the assumption
of a direct interaction between furanones and LuxR homologs (63). At the
same time it was puzzling that there was no substantial affinity of a labeled
furanone for E. coli cells overproducing LuxR (65). This apparent paradox
was resolved with the finding that halogenated furanones accelerate the
degradation of the LuxR protein (65). The authors discovered that the half-
life of the protein is reduced up to 100-fold in the presence of halogenated
furanones. This suggests that halogenated furanones modulate LuxR activ-
ity by destabilization, rather than by protecting the transcriptional activator
from interaction with the cognate signal. The furanone-dependent reduc-
tion in the cellular concentration of the LuxR protein correlated with a
reduction in expression of a plasmid encoded P
luxI
-gfp(ASV) fusion, sug-
gesting that the reduction in LuxR concentration is the mechanism by
which furanones control QS (65).
SYNTHETIC ANALOGS
AHL-dependent QS systems may be jammed inseveral ways, inparticular
by inhibition of AHL signal synthesis, increased AHL signal degradation, and
73
J
A
M
M
I
N
G
B
A
C
T
E
R
I
A
L
C
O
M
M
U
N
I
C
A
T
I
O
N
S
blockade of AHL signal reception. Although it is conceivable that AHL
biosynthesis could be effectively obstructed by blockade of AHL synthases,
no specific inhibitors for this class of enzymes have yet been derived (80).
Dong et al. (24) isolated an enzyme, named AiiA, from Bacillus sp. that
inactivates AHLs by hydrolyzing the lactone bond. It was shown that trans-
genic plants expressing AiiAexhibit enhanced resistance to Erwinia carotovora
infections. The authors suggested that, because this bacterium employs
AHL-dependent QS to control expression of plant pathogenic traits, the atten-
uated virulence is likely to be a direct consequence of signal degradation.
Whether this strategy is applicable to the treatment of human infections
remains to be seen.
Molecules capable of antagonizing binding of the cognate AHL signal
to the LuxR-type receptor would block signal transduction and therefore
jam the communication system. Competitive inhibitors are likely to be
structurally related to the native AHL signal in order to bind to and occupy
the AHL binding site but fail to activate the LuxR-type receptor.
Non-competitive inhibitors may show little or no structural similarity to
AHL signals, as these molecules are thought to bind differently to the
receptor protein. However, the recent finding by Chun et al. (9) that the
human airway might protect itself by producing a lactonase which targets
and inactivates certain derivatives of AHLs (in particular OdDHL) might
limit the value of putative drugs based on agonist design.
Synthetic AHL analogs described so far mainly fall into two categories:
(i) compounds differing from the cognate inducers by the length and
composition of the acyl side chain; and (ii) compounds in which the lactone
ring has been substituted by other heterocycles or carbocycles. With respect
to (i), Hanzelka and Greenberg (36) performed a series of detailed studies
of analogs to OHHL in experimental scenarios including E. coli harboring a
ptacluxR overexpression system or the lux operon devoid of the luxI gene.
From these studies, it was obvious that the length of the acyl side chain
plays a critical role in binding to the LuxR receptor and in agonistic as well
as antagonistic activity. Passador et al. (129) performed a similar series of
studies with homologs of the OdDHL signal on recombinant Escherichia
coli with plasmid-borne ptaclasR (for competitive binding assays) or lasR,
PlasBlacZ fusions (for agonistic activity). For interaction with the LasR
protein, the authors found that the lower limit for the acyl chain length
consisted of eight carbons. The substitution at the C(3
0
)-position (see
Figure 4.1), which is often referred to as 3-oxo-, is important for the
agonistic activity of AHLs, but so far no clear prediction on the antagonistic
effect of a modification of this position can be made (96, 69, 128).
M
.
G
I
V
S
K
O
V
A
N
D
M
.
H
E
N
T
Z
E
R
74
The C(1
0
), on the other hand, is sensitive to substitution with sulfur such as
the n-pentylsulfonyl-homoserine lactone shown in Figure 4.1. Sulfonamide
derivatives of AHLs show QSI activity against the LuxR protein (73) but not
the LasR or RhlR proteins (authors unpublished observations). However,
substitution of the C(3
0
) atom with sulfur, as in the 2-heptylthioacetyl-
homoserine lactone (Figure 4.1) shows strong activity against both LuxR-
and LasR-controlled QS systems (84).
With respect to chirality, natural AHL signals are L-isomers whereas
D-isomers are generally devoid of biological activity (8, 50, 69). Importantly,
D-isomers do not function as antagonists, indicating that they do not bind to
the LuxR-type receptor (50).
With respect to (ii), the effects of changes in the composition and size
of the homoserine lactone ring with either a 12-carbon (carrying a 3-oxo-
substitution at the C(3
0
), or a four-carbon acyl side chain were recently
investigated by Smith et al. (102, 103). From the screening and testing of
combinatory libraries it was concluded that ring size, the keto group (at
C(1
0
)) and the presence of saturated carbons in the ring strongly affected the
inhibitory activity of the molecule on the LasR system of P. aeruginosa. Only
slight variations in these key positions, such as a change from a saturated
ring to an aromatic benzene ring, transformed the molecule from an
agonist into an antagonist (102). Based on these data, it was suggested
that the presence of an aromatic ring interferes with the ability to activate
LasR. Accordingly, we recently found that the compound 4-nitropyridine-
N-oxide inhibited the P. aeruginosa QS systems (91). Substitution of the
O(1) with sulfur creates a thiolactone structure, which also antagonizes
LuxR activation as demonstrated by Schaefer et al. (96); we have recently
isolated the garlic compound C-7, carrying two sulfur atoms in the ring,
with similar activity (84).
The natural D. pulchra furanones were also used as scaffolds for
synthetic libraries. Manefield et al. (65) found that the longer the aliphatic
side chain protruding from the furan ring, the less active are the furanone
compounds. On the other hand, removal of the side chain of the natural
furanones such as C-30 and C-56 increased their inhibitory activity
(Figure 4.1). Concurrent with this ranking was the finding that C-30
promotes a more rapid LuxR turnover than C-8 (65). Furthermore, C-56
and C-30 were the only furanone compounds capable of significant repres-
sion of QS-regulated gene expression in P. aeruginosa. This was initially
based on measurement of the virulence factors and later verified by
DNA-microarray-based transcriptomics (42, 43). The inhibitory effect was
competitive with that of OdDHL. The bromine atoms also influence
75
J
A
M
M
I
N
G
B
A
C
T
E
R
I
A
L
C
O
M
M
U
N
I
C
A
T
I
O
N
S
inhibitory activity (Figure 4.1). C-8 and C-56 both lack the C(4) Br-atom in
comparison with C-2 and C-30, the result of which was found to be a
decrease in the QSI activity. However, replacing the single Br atom in
C-56 with a methyl group completely abolishes the QSI function.
SCREENS FOR QS INHIBITORS
Throughout the past decade, a number of genetic constructs have been
employed to test compounds for their effect on QS systems. The majority of
these studies have been performed on the V. fischeri, Erwinia carotovora,
P. aeruginosa, Chromobacterium violaceum and Agrobacterium tumefaciens
quorum sensors. The experimental tools and scenarios include binding of
3
H-labeled AHL signals and their homologs to recombinant Escherichia coli
cells overexpressing the respective receptor proteins as well as activation or
competitive inhibition of QS target genes and their reporter fusions. A classic
reporter system is QS-controlled violacein production in C. violaceum (69).
Violacein is the purple compound with antibiotic properties produced by
certain derepressed strains of C. violaceum. The I-mutant CVO26 has played
an important role as AHL monitor for a number of laboratories and has also
been used to describe D. pulchra and furanone action as illustrated on the front
cover of Microbiology by Manefield et al. (63). Escherichia coli containing the
plasmid pSB401 has been used to measure the induction of luminescence by
various AHL analogs as well as reduction in luminescence in the presence of
both AHL signal and a QSI compound. In pSB401, the luxRand the P
luxI
(luxI
promoter from V. fischeri) have been coupled to the entire lux structural
operon (luxCDABE) from Photorhabdus luminescens (122). However, there are
limitations to these two systems: the CVO26 only responds to a few AHL
signals such as BHL and HHL (N-hexanoyl-L-homoserine lactone) and may
therefore also be narrow range with respect to various natural QS inhibitors.
Expression of bioluminescence is a complex phenotype sensitive to almost
anything that affects the physiology of the host bacterium. The A. tumefaciens
reporter composed by a traG::lacZ fusion and traRis relatively promiscuous in
its choice of AHL molecules and therefore widely used for thin-layer
chromatography overlays to identify AHL molecules. With the exception of
BHL, this monitor detects AHLs with 3-oxo-, 3-hydroxy-, and 3-unsubstituted
side chains of all lengths tested (99).
We have constructed a number of green fluorescent quorum sensors,
which consist of luxRP
luxI
fused to a modified version of the gfpmut3*
gene encoding an unstable green fluorescent protein (GFP) variant of the
jellyfish Aequorea victoria as a reporter for non-invasive, real-time detection
M
.
G
I
V
S
K
O
V
A
N
D
M
.
H
E
N
T
Z
E
R
76
of gene expression without the addition of chemical substrates (see
Figure 4.2) (1). This system opened up unprecedented possibilities for
studies in situ of QS and QS inhibition in ecologically and clinically relevant
scenarios at the macroscopic as well as at the microscopic, single-cell level.
Unstable versions of the GFP had previously been constructed to enable on
line measurements in a non-cumulative fashion (2). Furthermore, it
allowed for monitoring of fluctuations in gene expression and even
repeated measurements of the same cells to continually assess bacterial
activity. Colonies of E. coli harboring a luxRP
luxI
-gfp(ASV)-cassette on a
high-copy-number pUC-derived plasmid appeared completely dark under
Green fluorescent cells Dark cells
(a)
(b)
No
signal
or
signal
block
+
signal
R* R
R
e
s
p
o
n
s
e
t
i
m
e
s
:
1
0
1
5
m
i
n
4
5
h
R
R
R
R
lasR
P
lasB
Gfp(ASV)
luxR
P
luxl
Gfp(ASV)
R
R*
R
R*
+
+
luxR
P
luxl
Gfp(ASV)
lasR
P
lasB
Gfp(ASV)
Active receptor Blocked receptor AHL signal QSI
Figure 4.2. (a) Molecular details of two green fluorescent QS monitors. The LuxR-based
monitor responds to a variety of AHL signals except for BHL, whereas the LasR-based
monitor primarily responds to OdDHL. (b) Microscopic inspection of Escherichia coli cells
carrying the LuxR-based monitor (right panels show fluorescent microscopy). The cells
respond to the addition of 10 nM OHHL by producing detectable amounts of the unstable
GFP protein. If the OHHL is removed by washing, or if a QSI compound is added which
blocks GFP synthesis, growing cells lose the GFP signal in 45 hours. (See also color plate
section)
77
J
A
M
M
I
N
G
B
A
C
T
E
R
I
A
L
C
O
M
M
U
N
I
C
A
T
I
O
N
S
the epifluorescence microscope. In striking contrast, the same strain pro-
duced bright green fluorescent colonies when cultivated under identical
conditions in the presence of 1 nM OHHL. The lesson learned from
numerous attempts to construct functional gfp gene fusions is that a
relatively high level of gene expression followed by efficient translation is
required for this to function at the single cell level: 15 min after addition of
10 nM OHHL to a planktonic culture, single cells appeared bright
green fluorescent under the epi-fluorescence microscope. This monitor
has a relatively broad-spectrum AHL detection limit in the range of
1 nM for OHHL, 10 nM for HHL, 10 nM for OHL, 10 nM for OdDHL
and 1000 nM for BHL, with a rapid (15 min) response time at the single-
cell level (1).
As with TraR, LuxR overexpression seems to increase agonistic activ-
ities of the various AHL analogs (128). The present GFP had a 45 min half-
life and consequently the monitor systemexhibited a less impressive 4 h lag
before the signal had been reduced to below the detection limit (126).
QS-regulated gene expression in Pseudomonas aeruginosa can be studied
in the same way by means of a QS monitor, which consists of a
fusion between the lasB elastase gene and gfp (PlasBgfp(ASV)). By means
of a mini-transposon this construct was placed on the chromosome of
P. aeruginosa to ensure stable segregation and a constant gene dosage of the
reporter system (42). Both monitor strains have been further modified to
carry a constitutively expressed dsred gene encoding the red fluorescent
protein RFP (see Figure 4.5). Red fluorescence therefore correlates to bacterial
biomass accumulation, green to bacterial communication. These systems
have been used to quantify the efficacy of a number of natural and
synthetic furanone compounds (42) as well as a number of novel QSI
compounds (90, 91).
NOVEL QSI SCREENS
The ability of the above-mentioned reporter fusions to be operated in
simple microtiter tray assays offers the researcher a reasonable high-
throughput facility. As well as being able to detect inducing signals, they
can also be used to detect the presence of QSI activity. However, the
systems are problematic in that they often require more than one test to
verify the result of the screen. The test compound may exert its effect on the
reporter itself, or alternatively interfere with precursors, substrates, or
environmental conditions for proper function of the reporter, or it might
simply affect growth without being bactericidal. Another obstacle is the
M
.
G
I
V
S
K
O
V
A
N
D
M
.
H
E
N
T
Z
E
R
78
adjustment of the concentration of the test QSI compound in such a way
that it does not lead to any of the above mentioned side effects. This
requires that a single test compound must be probed at several different
concentrations. A functional QSI is a compound that blocks QS (of a
selected QS-controlled monitor system) in the low micromolar range.
Furthermore, the inhibitor should be chemically stable and non-toxic.
In our view, the last point is essential since new anti-pathogenic drugs
against, for example, P. aeruginosa should circumvent the problem of
development of resistance that is found with conventional antimicrobial
compounds.
To meet the above requirements, we recently designed screening sys-
tems based on a novel concept, i.e. the bacteria require the presence of a
QSI for growth (91). The basic principle of these so-called QSI selectors is
that a toxic gene product is placed under QS control (see Figure 4.3). For
example, QSI selector 1 (QSIS1) is based on the luxR gene and PluxI fused
to the phlA gene from S. liquefaciens MG1. Expression of phospholipase
leads to lysis of the E. coli host cell (35). Therefore, in the presence of
externally added OHHL, the phlA gene is expressed from PluxI and the
cells are killed. If, however, a QSI compound is present along with the AHL,
the cells survive. QSI selector 2 (QSIS2) is based on the las system from
P. aeruginosa: the lasB promoter has been fused to the sacB gene. When
established on the chromosome in a rhlIlasI P. aeruginosa background,
expression causes cell death in the presence of exogenous BHL OdDHL
and sucrose. Presence of a QSI rescues the selector bacteria. The screen is
performed as a diffusion assay. Test samples are added to wells made in the
agar. The components of the sample diffuse out into the agar, creating a
diffusion gradient with the highest concentration closest to the well. If QS
is blocked, the cells survive and form a ring of growth around the sample
app li cat ion point (Figure 4.3b ). In our expe rience, th e s creen works well on
everything from pure compounds and extracts with organic solvents to
freshly collected samples.
NOVEL NATURAL QSIs
Many plants and fungi have coevolved and established carefully regu-
lated symbiotic associations with bacteria. Exudates from pea (Pisum
sativum) contain several separable activities able to stimulate, whereas
others inhibited, expression of AHL-regulated traits (111). Finding healing
powers in plants is an ancient idea. Curiously, since the advent of anti-
biotics in the 1950s, the use of plant derivatives as antimicrobial agents has
79
J
A
M
M
I
N
G
B
A
C
T
E
R
I
A
L
C
O
M
M
U
N
I
C
A
T
I
O
N
S
been virtually non-existent. The developed world has relied on bacterial and
fungal sources for these activities. However, recent studies have shown that
a number of foods contain furanone compounds with similarity to the
D. pulchra compounds described above (101). Inspired by this, we have
surveyed various herbs, plants and fungal extracts for AHL-inhibitory
activity. It is worth while noting that both plants and fungi are devoid of
Cell death
(a)
(b)
Active receptor
R
Rescue
R
R
R
R
lasR
P
lasB
sacB
lasR
P
lasB
sacB
R
R
R
R
+
+
luxR
P
luxl
phlA
luxR
P
luxl
phlA
Blocked receptor
Sample application
Rescue
ring
AHL signal QSI
Figure 4.3. (a) Molecular details and principles of the two QSI selectors QSIS1 and QSIS2.
QSIS1 is based on the luxR gene and the target promoter PluxI fused to the phlA gene from
Streptococcus liquefaciens MG1. In Escherichia coli, expression of the PhlA phospholipase
leads to rapid lysis of the host cell in the presence of exogenous OHHL. QSIS2 is based on
the las system from Pseudomonas aeruginosa; the lasB promoter has been fused to the sacB
gene. When established on the chromosome in a rhlI lasI P. aeruginosa background,
expression causes cell death in the presence of exogenous BHLOdDHL and sucrose.
(b) Agar cast with OHHL and E. coli cells carrying the QSIS1. A50ml volume of C-30 sample
was added to the sample application point and incubated overnight. C-30 diffuses out into
the agar, creating a diffusion gradient with the highest concentration closest to the well. The
clear zone surrounding the application hole indicates that the compound is toxic at high
concentrations; this is again surrounded by a rescue ring formed by bacterial growth where
the concentration of C-30 is sufficiently high to overcome and block OHHL activation of the
phospholipase gene.
M
.
G
I
V
S
K
O
V
A
N
D
M
.
H
E
N
T
Z
E
R
80
active immune systems, as seen in mammals, but rather rely on chemical
defense systems to deal with bacteria in the environment. Plants and fungi
may therefore utilize chemical compounds to inhibit (or in other cases, to
stimulate) bacterial AHL-mediated communication.
Plants have an almost limitless ability to synthesize aromatic sub-
stances, of which at least 12,000 have been isolated, a number estimated
to be less than 10% of the total (97). Bean sprouts, camomile, carrot, chili
habanero, the bee wax propolis, yellow pepper, and garlic were recently
found by us to hold QSI activity (91). Although garlic (Allium sativum) has
been used for its medicinal properties for thousands of years, investigations
into its mode of action are relatively recent. Garlic has a wide spectrum of
actions: not only is it antibacterial, antiviral, antifungal, and antiprotozoal,
but it also has beneficial effects on the cardiovascular and immune systems.
Garlic extract scored positive with the QSIS1 and QSIS2. This strongly
suggests that the extract contains a QSI compound that inhibits QS in
Pseudomonas aeruginosa. Our result was recently confirmed by Affymetrix
GeneChip
1
-based transcriptomics (91). Some of the garlic QSI com-
pounds were recently identified by us (84) but they did not show activity
against P. aeruginosa (see Figure 4.1). The structure of the active compound
against P. aeruginosa is now known by us.
In a recent screening of 55 different Penicillium species conducted by
us, one third were found to produce QSI activity (90). Two compounds,
patulin and penicillic acid (see Figure 4.1) from Penicillium species, were
isolated and demonstrated to be the biologically active QSI compounds.
Their structural similarity to C-30 and C-56 is obvious. Accordingly they
were found to block the QS systems of Pseudomonas aeruginosa as con-
firmed by DNA-microarray-based transcriptomics (90).
TRANSCRIPTOMICS: THE ULTIMATE TOOL
FOR ANALYZING DRUG SPECIFICITY
DNA microarray technology is a cutting-edge molecular approach to
study global gene expression and can be employed to decipher complex
regulatory networks in both bacteria and eukaryotes. The technique per-
mits us to take snapshots of the involved organisms global gene expres-
sion profile during different stages of growth and treatments. Until
recently, comparison of gene expression levels was limited to tracking
one or a few genes at a time. The use of reporter fusions is generally
accepted as a suitable way to monitor gene expression. It should be kept
in mind that such gene fusions are based on hybrid genes and hence
81
J
A
M
M
I
N
G
B
A
C
T
E
R
I
A
L
C
O
M
M
U
N
I
C
A
T
I
O
N
S
produce hybrid mRNAs. Such molecules cannot be expected to have stabil-
ity similar to that of the native messenger, and therefore information
gained from such fusions should not a priori be considered more reliable
than to the microarray hybridization data that are gained from uninter-
rupted messengers. Recently, a number of studies using the Affymetrix
P. aeruginosa microarray have been published (3, 43, 98, 115, 127). In several
of these reports, the microarray data have been verified by an independent
method such as real-time PCR. It is noteworthy that in all studies the data
obtained from microarray experiments and the independent methods were
found to correlate well. These reports provide a solid proof of concept for
the future application of GeneChips
1
.
For example, the drug specificity of the furanone C-30 was evaluated by
using the Affymetrix P. aeruginosa GeneChip
1
(43). The study was per-
formed as a parallel identification of QS-controlled genes and furanone-
target genes and included sample points from OD
450
0.5 to approxi-
mately OD
450
3. In total, 163 genes were found to be controlled by QS.
This corresponds to 2.9% of all the predicted genes in P. aeruginosa PAO1.
Among these genes, most previously reported QS genes were present.
Growing P. aeruginosa in the presence of the furanone compound caused
a change in expression of 93 genes, among which 85 genes (1.5%) were
repressed and 8 genes (0.1%) were activated in response to C-30. A com-
parative analysis of the QS regulon and C-30 target genes showed that 80%
of the furanone-repressed genes are in fact controlled by QS. Furanone-
repressed genes are not restricted to genes regulated by either the las or the
rhl encoded systems but are found throughout the continuum of QS-
induced genes. In essence, the analysis showed a clear overlap between
QS-controlled genes and furanone-repressed genes (Figure 4.4.) The study
demonstrated that by using furanone compounds it is possible to synthesize
QS-inhibitors that specifically target the QS circuit and cause a dramatic
reduction in expression of the major P. aeruginosa virulence factors, includ-
ing elastase, hydrogen cyanide, rhamnolipid, chitinase, and phenazine.
Performed under similar growth conditions, Affymetrix GeneChip
1
-
based analysis demonstrated that garlic extract affected the expression of
167 (3%) genes in total (91). At the single sample point (OD
450
2) 34% of
the QS regulon was downregulated by the garlic treatment. Affected genes
were found among LasR-, RhlR-, and LasRRhlR-controlled genes, many
of which encode the major P. aeruginosa virulence factors. It is encouraging
that relatively crude extracts, provided they do not affect the growth rate of
the culture, can be applied for GeneChip
1
-based transcriptomics. Along
either drug isolation or drug development pipelines, where natural as well
M
.
G
I
V
S
K
O
V
A
N
D
M
.
H
E
N
T
Z
E
R
82
as synthetic compounds are employed as scaffolds for drug design, the
GeneChip
1
delivers the ultimate answer to the target specificity of the
compounds in question. This information is highly valuable at an early
stage of pipelines. In the former case, it allows a decision to be made as to
Figure 4.4. Gene expression atlas of QS-controlled genes and QSI target genes in
Pseudomonas aeruginosa PAO1. Upregulated genes are shown in green; downregulated
genes are red. QS-controlled gene expression is shown in the outer half of the atlas;
furanone C-30 target genes are indicated in the inner half. QS-controlled genes were
identified by growing a P. aeruginosa PAO1 lasIrhlI mutant with or without exogenous
AHL signals (2 mM OdDHL and 5 mM BHL) and retrieving samples for microarray analysis at
several culture densities. C-30 target genes were identified by growing P. aeruginosa PAO1
with or without 10 mM furanone C-30. P. aeruginosa PAO1 ORFs are shown in red (sense
strand) and blue (antisense strand) in the innermost circle. The outermost scale gives the
gene localization (in base pairs) in the genome. The color scale bar gives the correlation
between color coding and fold-change in gene expression. (see also color plate section)
83
J
A
M
M
I
N
G
B
A
C
T
E
R
I
A
L
C
O
M
M
U
N
I
C
A
T
I
O
N
S
whether to embark on the time-consuming process of purification of
natural compounds.
BIOFILM MODELS: WHAT QSI DRUGS DO TO A BIOFILM
During biofilm formation, cells aggregate and embed themselves in an
EPS (exopolymeric substances) matrix, which gives rise to a rigid 3-D
structure. Nickel et al. (72) demonstrated that the biofilm mode of growth
substantially increased P. aeruginosas tolerance to tobramycin treatment;
Costerton et al. (12) later expanded that to cover a number of other organ-
isms and antibiotics. Since then numerous studies have generalized this
finding; for reviews, see (15, 25, 47). Although several mechanisms (among
them diffusion barriers and special physiological conditions) have been
postulated to explain reduced susceptibility to antimicrobials in bacterial
biofilms, it is becoming evident that biofilm tolerance to antimicrobial
treatments is multifactorial.
To study the effect of QSI compounds on biofilm development, the
typical experimental scenario used by us is P. aeruginosa biofilms that have
been allowed to establish in flow chambers in the presence or absence of,
for example, furanone compounds. Scanning confocal laser microscopy
(SCLM)-based inspection of the GFP-based QS reporter systems revealed
that the compounds C-56 and C-30 penetrated the microcolonies, and
repressed QS in the majority of the biofilm cells. Importantly, the concen-
tration used was similar to what was found to inhibit QS in planktonic cells
without affecting growth or general gene expression (42, 43). By comparing
our sets of accumulated data we have found that, similar to the biofilms
formed by QS mutants (5), there is (under our experimental settings) no
obvious difference in the early stages of biofilm formation in the presence
or absence of furanones or any other QSI compound. The effect of QS
deficiency (either by mutation or by QSI treatment) becomes more obvious
at later stages. For example, at day 7 furanone-treated biofilms were less
persistent and more similar to the QS mutant biofilms (39, 42, 43) with the
impression of flat, less differentiated biofilms at day 10, which eventually
sloughed off (42).
P. aeruginosa biofilms grown in the presence of furanones were also
subsequently exposed to 0.1% SDS or tobramycin. Tobramycin is an anti-
biotic frequently used in the treatment of CF patients. Three days pre-
treatment with furanones sensitized the biofilms to dissolution such that
both the detergent and tobramycin were able to kill 90%95% of
P. aeruginosa cells (43). Similar data have been obtained with regulatory
M
.
G
I
V
S
K
O
V
A
N
D
M
.
H
E
N
T
Z
E
R
84
QS mutants (5). In comparison, the effects of SDS and tobramycin on
untreated (or wild-type) biofilms were superficial. We have obtained similar
results if the biofilm was treated with both garlic and tobramycin or patulin
and tobramycin (90, 91). These results strongly suggest that biofilm
sloughing and tolerance to antibiotics and disinfectants can be controlled
with QSI drugs. This synergistic effect of QSI drugs and antibiotics is
somewhat reminiscent of antibiofilm treatment based on electrical current,
which also enhances the efficacy of antibiotics (51).
The biofilmmode of growth also offers protection against the activity of
polymorphonuclear leucocytes (PMNs). A PMNP. aeruginosa biofilm
model was recently established by us (5). The typical experiment proceeds
thus. Biofilms three days old are exposed to freshly isolated PMNs by
inoculation into the biofilm flow chambers. The sets of biofilms with
PMNs are then inspected by means of SCLM; gradually, differences in
the biomass of the types of biofilm can be observed. By using this model,
we recently found that QS mutants as well as QSI-treated wild-type biofilms
are susceptible to PMN phagocytosis (5, 90).
Activated PMNs liberate oxygen radicals in the form of H
2
O
2
, which
has a bactericidal effect. P. aeruginosa biofilm cells tolerate high concentra-
tions (50100 mM), mainly owing to two protective mechanisms: the pre-
sence of katA-encoded catalase activity (28) and failure of H
2
O
2
to fully
penetrate the biofilm owing to a reactiondiffusion interaction as described
by Stewart et al. (107). These authors concluded that some protective, yet
unknown mechanism other than incomplete penetration is operative in
P. aeruginosa biofilms treated with H
2
O
2
. We have assessed tolerance of
biofilms to H
2
O
2
by introducing 100mM to the influent medium to bio-
films 3 days old (5). LIVE/DEAD BacLight staining demonstrated that the
wild-type biofilm cells were left unharmed by the treatment in contrast to
the QS mutant, which was highly sensitive. Furthermore, we also gener-
ated data that suggested this tolerance could result from the amount of
oxygen radicals produced by the PMNs, which in turn depends on the
magnitude of activation caused by the bacteria. We found that only QS
mutants, in contrast to wild-type biofilms, caused detectable activation of
the PMNs (5). Furthermore, wild-type biofilms treated with C-30 caused
detectable activation of the PMNs similar to that of the QS mutant. Our data
support a model where QS signals directly affect the magnitude of the
oxidative PMN burst. In other words, PMN activation can be blocked by
adding OdDHL and BHL to lasRrhlR double mutants. On the other hand,
PMN activation can be promoted by treatment of wild-type biofilm with
QSI compounds.
85
J
A
M
M
I
N
G
B
A
C
T
E
R
I
A
L
C
O
M
M
U
N
I
C
A
T
I
O
N
S
In concurrence with these results, Wu et al. (125) found that pulmonary
infections caused by a lasIrhlI mutant induced a faster and stronger
immune response against the bacterial infection in the early phase, as
judged from the severity of lung pathology, higher lung IFN-a production,
stronger oxidative burst of blood PMNs, and faster antibody response
compared with the wild-type counterpart. Similar data have recently been
obtained in vivo with the lasRrhlR double mutant (5).
PULMONARY DOSERESPONSE MODELS
For drug design and development, it is obvious that a direct study of
QSI functionality under complex conditions in vivo has tremendous poten-
tial. The QS monitors based on GFP reporters offered that possibility.
A pseudo-chronic lung infection can be established in mice with E. coli
carrying a LuxR-controlled PluxIgfp(ASV) system (126) or P. aeruginosa
equipped with a lasB-gfp(ASV) system (43). Healthy mice normally clear
introduced bacteria efficiently by means of the mucociliary escalator. The
intratracheal introduction of bacteria in the form of alginate beads (see
Figur e 4.5a ) reduces the abili ty to rapidly clea r th e b acteria b y m eans of th e
mucociliary escalator. Instead, PMNs will be recruited by the immune
system and su rrou nd the infected ar eas in the l ung ( see Figur e 4. 5 b ). As a
result, inflammation and partial tissue destruction occur. For a period of up
to a two wee ks , th is is re minis cent o f th e situ ation i n the infecte d h uma n
CF lung (45, 71, 83).
Usually the mice are infected one or two days before the doseresponse
experiment. On the day of the experiment combinations of OHHL and QSI
drugs are injected in the tail vein and animals are sacrificed at different
time points after the treatments. Sections of frozen lung tissue are prepared
for SCLM. Both types of QS monitor express RFP for easy detection and
localization in the lung tissue and additionally express GFP in response to
AHL-dep ende nt QS (F igu re 4.5c , d ) If, h owever, QS is blocked, no or only
little GFP signals can be recorded. As shown by Hentzer et al. (43) intro-
duction of OHHL into the mouse blood circulation caused activation of the
E. coli LuxR QS monitor in a concentration-dependent manner. This
demonstrates that OHHL is transported by the blood, penetrates the lung
tissue, and induces LuxR-controlled PluxIgfp(ASV) expression in the
infecting bacteria. This model system has been used by us to evaluate the
efficacy of the furanones as well as a number of other potential QSI drugs in
vivo. For example, furanone C-30 (given as 2 mg/g body mass (BM) or 10 mM
if the entire mouse volume is considered to be 20 ml), co-administered
M
.
G
I
V
S
K
O
V
A
N
D
M
.
H
E
N
T
Z
E
R
86
with OHHL, caused repression of OHHL-dependent activation of the QS
sensor (43). The furanone inhibition could be partly relieved by increasing
dosages of OHHL. This experimental setup shows whether a QSI test drug
is transported by the blood circulation to the lungs, penetrates the lung
tissues, enters the bacteria and in turn represses the OHHL-controlled
QS monitor, and it allows for calibration of the effective concentration of
the drug.
(a) (c) (b)
RFP GFP RFP GFP
(d )
R
R
+
R
dsred dsred lasR
P
lasB
P
lasB
R
R
Active receptor Blocked receptor OdDHL QSI
Time 0 6 h after injection
gfp(ASV) P
tac
gfp(ASV) P
tac
lasR
(e)
Figure 4.5. The pulmonary doseresponse model. (a) Mice are challenged intratracheally
with alginate beads containing P. aeruginosa. (b) Photomicrographs of mouse lung tissue
infected with P. aeruginosa. The arrow points at an alginate bead surrounded by numerous
PMNs. Adapted fromreference (126). (c) QSI drugs can be injected intravenously in the tail
vein. (d, e) Mouse lung tissue infected with P. aeruginosa carrying the LasR-based monitor
PlasBgfp for detection of cell-to-cell signaling (green fluorescence) and a tag for simple
identification in tissue samples (red fluorescence) examined by SCLM. (d) Mice were
administered C-30 via intravenous injection at time zero. (e) Infected animals were
sacrificed in groups of three at the time point indicated and the lung tissue samples were
examined by SCLM according to Hentzer et al. (43). Parts (d) and (e) are adapted from (43).
(See also color plate section)
87
J
A
M
M
I
N
G
B
A
C
T
E
R
I
A
L
C
O
M
M
U
N
I
C
A
T
I
O
N
S
As shown by Hentzer et al. (43), the ability of a test QSI drug to
suppress P. aeruginosa QS in vivo can be tested by infecting mouse lungs
with the P. aeruginosa QS monitor. The infection was allowed to establish
for 2 days before furanone C-30 (2 mg/g-BM) was introduced through the
tail ve in (Figure 4.5c ). In this model, no QS s ignals ar e intr odu ced be caus e
of the en dogeno us P. aeruginosa synt hesis (Figure 4.5d ). Over a time span of
46h after administration of C-30, the GFP signal from the P. aeruginosa
equipped with a lasBgfp(ASV) monitor was significantly reduced
(Figure 4. 5 e ). After 8 1 0 h, the GFP signal rea ppear ed, i ndica tin g th at th e
furanone was cleared from the mouse blood circulation and, hence,
de novo GFP synthesis recommenced. This experimental scenario reveals
important information about the mode of action of the test compound:
first, the effective concentration required to block wild-type P. aeruginosa
QS can be determined; and second, the stability of the compounds in the
mouse organism can be assessed. For example, this type of experiment
told us that a single furanone C-30 injection lasts approximately 6h (43).
This indicates that three doses per day are required for continuous
blocking of QS-controlled gene expression of the infecting bacteria.
There are many more questions that need to be answered by this
model before the treatment model is employed, such as whether the
test drug can or should be administered intravenously, intraperitoneally
or subcutaneously.
TREATMENT MODEL
The previous doseresponse models can be used to establish the con-
ditions required for QS inhibition in vivo. To assess the potential of a test
QSI compound in the treatment of P. aeruginosa infections, we have devel-
oped a mouse pulmonary infection model. Groups of mice are infected with
P. aeruginosa as described above. After this, the mice are typically split in
two groups, which receive injections of either the test QSI compound or
placebo for the following 35 days. The dosages and daily intervals are as
determined by the doseresponse models above. Groups of animals are
sacrificed on a daily basis; the lungs are removed and homogenized and the
contents spread on agar plates for determination of the number of bacteria.
Hentzer et al. (43) demonstrated convincing treatment with C-30: the
furanone-treated groups of animals displayed a bacterial content on average
three orders of magnitude lower than that of the placebo group, and the
efficiency of bacterial clearing correlated positively with the concentration
M
.
G
I
V
S
K
O
V
A
N
D
M
.
H
E
N
T
Z
E
R
88
of the drug. We have tested several other potential QSI compounds in this
model, together with garlic extract and a patulin; the former proved even
more efficient than C-30 (6).
ANTIBIOTICS AND QSI DRUGS: ALONE OR TOGETHER?
More than half of the infectious diseases that affect compromised
patients involve bacterial species that are commensal or are common
in the environment, such as Staphylococcus epidermidis and P. aeruginosa
(13, 14). Biofilm-based infections share clinical characteristics. Biofilms
develop commonly on inert surfaces of medical devices or on dead tissue,
but they can also form on living tissues, as in endocarditis. Numerous
investigations of the surfaces of medical devices (arteriovenous shunts,
urinary and other types of catheters, orthopedic devices, and mechanical
heart valves) that have been surgically removed owing to device-related
infections show the presence of exopolymer-embedded bacteria. Tissues
taken from non-device-related chronic infections also show the presence of
biofilm bacteria surrounded by an exopolymeric matrix. Such diseases
include dental caries, periodontitis, otitis media, biliary tract infections,
and bacterial prostatitis (for reviews see (15, 25, 47)).
The best investigated example of a disease in which biofilms play a
prominent role is the occurrence of chronic endobronchiolitis caused by
mucoid (alginate over-producing) variants of P. aeruginosa in patients
suffering from CF. CF is caused by mutations in the CFTR gene encoding
the 1480 amino acid CF transmembrane conductance regulator (CFTR)
(16). CFTR functions as a chloride ion channel at the apical membrane of
epithelial cells of the sweat ducts, pancreatic ducts, the crypts of the small
intestine, the reproductive organs, and the respiratory epithelial cells,
which impairs ciliary function (16). Although the endobronchial chronic
infection of the biofilm-growing P. aeruginosa is impossible to eradicate,
repetitive, aggressive antibiotic chemotherapy at the early stages (as prac-
ticed at the Danish CF-Centre) has proven to be efficient in postponing the
onset of the chronic infection, which is accompanied by deterioration of
pulmonary function (31, 112).
The flip side of the coin is the development of antibiotic-resistant
bacteria (10). The frequency with which resistant mutants develop in the
CF lung may be higher than normal. Oliver et al. (78) reported that 36% of a
group of CF patients were colonized by hypermutable (mutator) strains in
contrast to non-CF patients acutely infected with P. aeruginosa. Mutator
strains can appear due to inactivating mutations in DNA repair genes,
89
J
A
M
M
I
N
G
B
A
C
T
E
R
I
A
L
C
O
M
M
U
N
I
C
A
T
I
O
N
S
e.g. mutS, mutT (76, 77, 78). Such mutations are in turn caused by
reactive oxygen metabolites released from the activated PMNs in the lungs
(123). The high mutation frequency, 3 10
6
in CF patients versus 3 10
8
in non-CF patients, were associated with a significantly higher frequency
of resistance to several groups of antibiotics (78). Such increased
antibiotic resistance adds to the protection already offered by the biofilm
mode of growth (106).
This highlights the importance of development of non-pathogenic
therapies that limit the formation of persistent biofilms in the lungs. In
the biofilm mode of growth the colonizing bacteria are protected from the
host defense system and the action of antibiotics. It is therefore highly
interesting that QSI compounds that were found to efficiently eradicate
pulmonary infections also possess PMN-activating properties. The admin-
istration of QSI compounds will then be expected to lead to development of
less persistent biofilms but also inhibit expression of bacterial exoenzymes
that actively degrade components of the immune system. Taken together
with the synergistic effect of QS blockage and PMN activity, this might
promote clearance, which in turn will reverse the severity of infection
and improve the lung function. In addition, the synergistic effect of anti-
biotics and QSI drugs might turn out to be a useful combination in
future chemotherapies. In relation to the insertion of medical implants,
short-term prophylactic therapy or alternatively special surface coatings
liberating QSI compounds might prove efficient in reducing the risk of
developing detrimental biofilms on the devices. The recent finding by us
that QSI drugs are effective in treatment of vibriosis in a fish model system
illustrates that such compounds might be useful alternatives to antibiotics
in fish farming (89).
ACKNOWLEDGEMENT
Our work on QS inhibition has been supported by grants from the
Danish Technical Research Council and the Villum Kann Rasmussen
Foundation to MG.
REFERENCES
1 Andersen, J. B., A. Heydorn, M. Hentzer et al. 2001. gfp based N-acyl-homoserine-
lactone monitors for detection of bacterial communication. Appl. Environ.
Microbiol. 67: 57585.
M
.
G
I
V
S
K
O
V
A
N
D
M
.
H
E
N
T
Z
E
R
90
2 Andersen, J. B., C. Sternberg, L. K. Poulsen et al. 1998. New unstable variants of
green fluorescent protein for studies of transient gene expression in bacteria.
Appl. Environ. Microbiol. 64: 224046.
3 Bagge, N., M. Schuster, M. Hentzer et al. 2004. Pseudomonas aeruginosa
biofilms exposed to imipenem exhibit changes in global gene expression and
beta-lactamase and alginate production. Antimicrob. Agents Chemother. 48:
117587.
4 Belas, M. R. 2003. The swarming phenomenon of Proteus mirabilis. ASM News
58: 1522.
5 Bjarnsholt, T., P. . Jensen, M. Burmlle et al. 2005. Pseudomonas aeruginosa
tolerance to tobramycin, hydrogen peroxide and polymorphonuclear leucocytes is
quorum sensing depended. Microbiology 151: 37383.
6 Bjarnsholt, T., P. . Jensen, T. B. Rasmussen et al. 2005. Garlic jams Pseudomonas
aeruginosa communication and cures pulmonary infections. Infect. Immun.
(in press.)
7 Camara, M., P. Williams and A. Hardman 2002. Controlling infection by tuning
in and turning down the volume of bacterial small-talk. Lancet Infect. Dis. 2:
66776.
8 Chhabra, S. R., P. Stead, N. J. Bainton et al. 1993. Autoregulation of carbapenem
biosynthesis in Erwinia carotovora by analogues of N-(3-oxohexanoyl)-L-
homoserine lactone. J Antibiot.(Tokyo) 46: 44154.
9 Chun, C. K., E. A. Ozer, M. J. Welsh, J. Zabner and E. P. Greenberg 2004.
Inactivation of a Pseudomonas aeruginosa quorum-sensing signal by human
airway epithelia. Proc. Natn. Acad. Sci. USA 101: 358790.
10 Ciofu, O., B. Giwercman, S. S. Pedersen and N. Hoiby 1994. Development of
antibiotic resistance in Pseudomonas aeruginosa during two decades of antipseu-
domonal treatment at the Danish CF Center. Acta Pathol. Microbiol. Immunol.
Scand. 102: 67480.
11 Correa, J. A. 1996. Diseases in seaweeds: an introduction. Hydrobiologia 326: 878.
12 Costerton, J. W., K. J. Cheng, G. G. Geesey et al. 1987. Bacterial biofilms in nature
and disease. A. Rev. Microbiol. 41: 43564.
13 Costerton, J. W., Z. Lewandowski, D. E. Caldwell, D. R. Korber and H. M. Lappin-
Scott 1995. Microbial biofilms. A. Rev. Microbiol. 49: 71145.
14 Costerton, J. W., Z. Lewandowski, D. DeBeer et al. 1994. Biofilms, the custom-
ized microniche. J. Bacteriol. 176: 213742.
15 Costerton, J. W., P. S. Stewart and E. P. Greenberg 1999. Bacterial biofilms:
a common cause of persistent infections. Science 284: 131822.
16 Davidson, D. J. and D. J. Porteous 1998. Genetics and pulmonary medicine.
1. The genetics of cystic fibrosis lung disease. Thorax 53: 38997.
17 Davies, D. 2003. Understanding biofilm resistance to antibacterial agents. Nat.
Rev. Drug Discov. 2: 11422.
18 Davies, D. G., M. R. Parsek, J. P. Pearson et al. 1998. The involvement of cell-to-
cell signals in the development of a bacterial biofilm. Science 280: 2958.
91
J
A
M
M
I
N
G
B
A
C
T
E
R
I
A
L
C
O
M
M
U
N
I
C
A
T
I
O
N
S
19 Davis, A. R., Targett, N. M, O. J. McConnell and C. M. Young 1989. Epibiosis of
marine algae and benthic invertebrates: natural products chemistry and other
mechanisms inhibiting settlement and overgrowth. Bioorg. Mar. Chem. 3: 86114.
20 De Kievit, T. R., R. Gillis, S. Marx, C. Brown and B. H. Iglewski 2001. Quorum-
sensing genes in Pseudomonas aeruginosa biofilms: their role and expression
patterns. Appl. Environ. Microbiol. 67: 186573.
21 de Nys, R., P. Steinberg, C. N. Rogers, T. S. Charlton and M. W. Duncan 1996.
Quantitative variation of secondary metabolites in the sea hare Aplysia parvula
and its host plant, Delisea pulchra. Mar. Ecol. Prog. Ser. 130: 135146.
22 de Nys, R., P. D. Steinberg, P. Willemsen et al. 1995. Broad spectrum effects of
secondary metabolites from the red alga Delisea pulchra in antifouling assays.
Biofouling 8: 25971.
23 de Nys, R., A. D. Wright, G. M. Konig and O. Sticher 1993. New halogenated
furanones from the marine alga Delisea pulchra. Tetrahedron 49: 1121320.
24 Dong, Y. H., L. H. Wang, J. L. Xu et al. 2001. Quenching quorum-sensing-
dependent bacterial infection by an N-acyl homoserine lactonase. Nature 411:
81317.
25 Drenkard, E. 2003. Antimicrobial resistance of Pseudomonas aeruginosa biofilms.
Microbes Infect. 5: 121319.
26 Dworjanyn, S., R. de Nys, and P. D. Steinberg. 1999. Localization of secondary
metabolites in the red alga Delisea pulchra. Mar. Biol. 133: 72736.
27 Eberl, L., M. K. Winson, C. Sternberg et al. 1996. Involvement of N-acyl-L-
homoserine lactone autoinducers in controlling the multicellular behaviour of
Serratia liquefaciens. Molec. Microbiol. 20: 12736.
28 Elkins, J. G., D. J. Hassett, P. S. Stewart, H. P. Schweizer and T. R. McDermott
1999. Protective role of catalase in Pseudomonas aeruginosa biofilm resistance to
hydrogen peroxide. Appl. Environ. Microbiol. 65: 4594600.
29 Favre-Bonte, S., J. C. Pache, J. Robert et al. 2002. Detection of Pseudomonas
aeruginosa cell-to-cell signals in lung tissue of cystic fibrosis patients. Microb.
Pathogen. 32: 1437.
30 Fenical, W. 1997. New pharmaceuticals from marine organisms. Trends
Biotechnol. 15: 33941.
31 Frederiksen, B., C. Koch and N. Hoiby 1997. Antibiotic treatment of initial coloni-
zation with Pseudomonas aeruginosa postpones chronic infection and prevents
deterioration of pulmonary function in cystic fibrosis. Pediatr. Pulmonol. 23: 3305.
32 Fuqua, C., S. C. Winans and E. P. Greenberg 1994. Quorum sensing in bacteria:
the LuxR-LuxI family of cell density-responsive transcriptional regulators.
J. Bacteriol. 176: 26975.
33 Geesey, G. G., W. T. Richardson, H. G. Yeomans, R. T. Irvin and J. W Costerton
1997. Microscopic examination of natural sessile bacterial populations from an
alpine stream. Can. J. Microbiol. 23: 17336.
34 Givskov, M., R. de Nys, M. Manefield et al. 1996. Eukaryotic interference with
homoserine lactone-mediated prokaryotic signaling. J. Bacteriol. 178: 661822.
M
.
G
I
V
S
K
O
V
A
N
D
M
.
H
E
N
T
Z
E
R
92
35 Givskov, M. and S. Molin 1993. Secretion of Serratia liquefaciens phospholipase
from Escherichia coli. Molec. Microbiol. 8: 22942.
36 Hanzelka, B. L. and E. P. Greenberg 1995. Evidence that the N-terminal region of
the Vibrio fischeri LuxR protein constitutes an autoinducer-binding domain.
J. Bacteriol. 177: 81517.
37 Heilmann, C., C. Gerke, F. Perdreau-Remington and F. Gotz 1996.
Characterization of Tn917 insertion mutants of Staphylococcus epidermidis
affected in biofilm formation. Infect. Immun. 64: 27782.
38 Henschel, J. R. and P. A. Cook 1990. The development of a marine fouling
community in relation to the primary film of microorganisms. Biofouling
2: 111.
39 Hentzer, M., L. Eberl and M. Givskov 2004. Quorum sensing in biofilms: Gossip
in the slime world? In M. Ghannoum and G. OToole (eds.), Microbial Biofilms,
pp. Washington, DC: ASM Press.
41 Hentzer, M., L. Eberl and M. Givskov 2005. Transcriptome analysis of Pseudomonas
aeruginosa biofilms: anaerobic respiration and iron limitation. Biofilms. (In press.)
42 Hentzer, M., K. Riedel, T. B. Rasmussen et al. 2002. Inhibition of quorum
sensing in Pseudomonas aeruginosa biofilm bacteria by a halogenated furanone
compound. Microbiology 148: 87102.
43 Hentzer, M., H. Wu, J. B. Andersen et al. 2003. Attenuation of Pseudomonas
aeruginosa virulence by quorum sensing inhibitors. EMBO J. 22: 113.
44 Heydorn, A., B. Ersboll, J. Kato et al. 2002. Statistical analysis of Pseudomonas
aeruginosa biofilm development: impact of mutations in genes involved in twitch-
ing motility, cell-to-cell signaling, and stationary-phase sigma factor expression.
Appl. Environ. Microbiol. 68: 200817.
45 Hoiby, N. 1993. Antibiotic therapy for chronic infection of Pseudomonas in the
lung. A. Rev. Med. 44: 110.
46 Hiby, N. and B. Frederiksen 2000. Microbiology of cystic fibrosis. In M. E. Hodson
and D. M. Geddes (eds.), Cystic Fibrosis, pp. 83107. London: Edward Arnold.
47 Hoiby, N., J. H. Krogh, C. Moser et al. 2001. Pseudomonas aeruginosa and the in
vitro and in vivo biofilm mode of growth. Microbes Infect. 3: 2335.
48 Huber, B., K. Riedel, M. Hentzer et al. 2001. The cep quorum-sensing system of
Burkholderia cepacia H111 controls biofilm formation and swarming motility.
Microbiology 147: 251728.
49 Huber, B., K. Riedel, M. Kothe et al. 2002. Genetic analysis of functions involved
in the late stages of biofilm development in Burkholderia cepacia H111. Molec.
Microbiol. 46: 41126.
50 Ikeda, T., K. Kajiyama, T. Kita et al. 2001. The synthesis of optically pure
enantiomers of N-acyl-homoserine lactone autoinducers and their analogues.
Chem. Lett. 30: 31415.
51 Jass, J., J. W. Costerton and H. M. Lappin-Scott 1995. The effect of electrical
currents and tobramycin on Pseudomonas aeruginosa biofilms. J. Ind. Microbiol. 15:
23442.
93
J
A
M
M
I
N
G
B
A
C
T
E
R
I
A
L
C
O
M
M
U
N
I
C
A
T
I
O
N
S
52 Kjelleberg, S., P. D. Steinberg, M. Givskov et al. 1997. Do marine natural
products interfere with prokaryotic AHL regulatory systems? Aquat. Microb.
Ecol. 13: 8593.
53 Klausen, M., A. Aaes-Jorgensen, S. Molin and T. Tolker-Nielsen 2003.
Involvement of bacterial migration in the development of complex multicellular
structures in Pseudomonas aeruginosa biofilms. Molec. Microbiol. 50: 618.
54 Kleerebezem, M., L. E. Quadri, O. P. Kuipers and W. M. de Vos 1997. Quorum
sensing by peptide pheromones and two-component signal-transduction systems
in Gram-positive bacteria. Molec. Microbiol. 24: 895904.
55 Kushmaro, A., Y. Loya, E. Fine and E. Rosenberg 1996. Bacterial infection and
coral bleaching. Nature 380: 396.
56 Labatte, M., S. Y. Queck, S. A. Rice, M. Givskov and S. Kjelleberg 2004. Quorum
sensing controlled biofilm development in Serratia liquefaciens MG1. J. Bacteriol.
186: 6928.
57 Latifi, A., M. Foglino, K. Tanaka, P. Williams and A. Lazdunski 1996. A hier-
archical quorum-sensing cascade in Pseudomonas aeruginosa links the transcrip-
tional activators LasR and RhIR (VsmR) to expression of the stationary-phase
sigma factor RpoS. Molec. Microbiol. 21: 113746.
58 Lawrence, J. R., D. R. Korber, B. D. Hoyle, J. W. Costerton and D. E. Caldwell
1991. Optical sectioning of microbial biofilms. J. Bacteriol. 173: 655867.
59 Littler, M. M. and D. S. Littler 1995. Impact of CLOD pathogen on pacific coral
reefs. Science 267: 135660.
60 Lyczak, J. B., C. L. Cannon and G. B. Pier 2002. Lung infections associated with
cystic fibrosis. Clin. Microbiol. Rev. 15: 194222.
61 Lynch, M. J., S. Swift, D. F. Kirke et al. 2002. The regulation of of biofilm
development by quorum sensing in Aeromonas hydrophila. Environ. Microbiol.
4: 1828.
62 Mack, D., M. Nedelmann, A. Krokotsch et al. 1994. Characterization of trans-
poson mutants of biofilm-producing Staphylococcus epidermidis impaired
in the accumulative phase of biofilm production: genetic identification of a
hexosamine-containing polysaccharide intercellular adhesin. Infect. Immun.
62: 324453.
63 Manefield, M., R. de Nys, N. Kumar et al. 1999. Evidence that halogenated
furanones from Delisea pulchra inhibit acylated homoserine lactone (AHL)-
mediated gene expression by displacing the AHL signal from its receptor protein.
Microbiology 145: 28391.
64 Manefield, M., L. Harris, S. A. Rice, R. de Nys and S. Kjelleberg 2000. Inhibition
of luminescence and virulence in the black tiger prawn (Penaeus monodon)
pathogen Vibrio harveyi by intercellular signal antagonists. Appl. Environ.
Microbiol. 66: 207984.
65 Manefield, M., T. B. Rasmussen, M. Henzter et al. 2002. Halogenated furanones
inhibit quorum sensing through accelerated LuxR turnover. Microbiology 148:
111927.
M
.
G
I
V
S
K
O
V
A
N
D
M
.
H
E
N
T
Z
E
R
94
66 Manefield, M., M. Welch, M. Givskov, G. P. Salmond and S. Kjelleberg 2001.
Halogenated furanones from the red alga, Delisea pulchra, inhibit carbapenem
antibiotic synthesis and exoenzyme virulence factor production in the phyto-
pathogen Erwinia carotovora. FEMS Microbiol. Lett. 205: 1318.
67 Maximilien, R., R. de Nys, C. Holmstrom 1998. Chemical mediation of
bacterial surface colonisation by secondary metabolites of the red alga Delisea
pulchra. Aquat. Microb. Ecol. 15: 23346.
68 Maximilien, R. R., R. de Nys, C. Holmstrom et al. 1998. Chemical mediation of
bacterial surface colonisation by secondary metabolites from the red alga Delisea
pulchra. Aquat. Microb. Ecol. 15: 23346.
69 McClean, K. H., M. K. Winson, L. Fish et al. 1997. Quorum sensing and
Chromobacterium violaceum: exploitation of violacein production and inhibition
for the detection of N-acylhomoserine lactones. Microbiology 143: 370311.
70 McKnight, S. L., B. H. Iglewski and E. C. Pesci 2000. The Pseudomonas quinolone
signal regulates rhl quorum sensing in Pseudomonas aeruginosa. J. Bacteriol. 182:
27028.
71 Moser, C., H. K. Johansen, Z. J. Song et al. 1997. Chronic Pseudomonas aeruginosa
lung infection is more severe in Th2 responding BALB/c mice compared to Th1
responding C3H/HeNmice. Acta Pathol. Microbiol. Immunol. Scand. 105: 83842.
72 Nickel, J. C., I. Ruseska, J. B. Wright and J. W. Costerton 1985. Tobramycin
resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary
catheter material. Antimicrob. Agents Chemother. 27: 61924.
73 Nielsen, J. and Givskov, M. 2003. Compounds and methods for controlling
bacterial virulence. PCT WO 03/106445. [Patent]
74 OToole, G. A., K. A. Gibbs, P. W. Hager, P. V. Phibbs, Jr. and R. Kolter 2000. The
global carbon metabolism regulator Crc is a component of a signal transduction
pathway required for biofilm development by Pseudomonas aeruginosa. J.
Bacteriol. 182: 42531.
75 OToole, G. A. and R. Kolter. 1998. Initiation of biofilm formation in
Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signaling
pathways: a genetic analysis. Molec. Microbiol. 28: 44961.
76 Ochsner, U. A., M. L. Vasil, E. Alsabbagh, K. Parvatiyar and D. J. Hassett 2000.
Role of the Pseudomonas aeruginosa oxyR-recG operon in oxidative stress defense
and DNA repair: OxyR-dependent regulation of katB-ankB, ahpB, and ahpC-
ahpF. J. Bacteriol. 182: 453344.
77 Oliver, A., F. Baquero and J. Blazquez 2002. The mismatch repair system (mutS,
mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of
naturally occurring mutants. Molec. Microbiol. 43: 164150.
78 Oliver, A., R. Canton, P. Campo, F. Baquero and J. Blazquez 2000. High
frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infec-
tion. Science 288: 12514.
79 Palmer, R. J. Jr. and D. C. White 1997. Developmental biology of biofilms:
implications for treatment and control. Trends Microbiol. 5: 43540.
95
J
A
M
M
I
N
G
B
A
C
T
E
R
I
A
L
C
O
M
M
U
N
I
C
A
T
I
O
N
S
80 Parsek, M. R., D. L. Val, B. L. Hanzelka, J. E. J. Cronan and E. P. Greenberg 1999.
Acyl homoserine-lactone quorum-sensing signal generation. Proc. Natn. Acad.
Sci. USA 96: 43605.
81 Passador, L., J. M. Cook, M. J. Gambello, L. Rust and B. H. Iglewski 1993.
Expression of Pseudomonas aeruginosa virulence genes requires cell-to-cell com-
munication. Science 260: 112730.
82 Pearson, J. P., M. Feldman, B. H. Iglewski and A. Prince 2000. Pseudomonas
aeruginosa cell-to-cell signaling is required for virulence in a model of acute
pulmonary infection. Infect. Immun. 68: 43314.
83 Pedersen, S. S., G. H. Shand, B. L. Hansen and G. N. Hansen 1990. Induction of
experimental chronic Pseudomonas aeruginosa lung infection with P. aeruginosa
entrapped in alginate microspheres. Acta Pathol. Microbiol. Immunol. Scand.
98: 20311.
84 Persson, P., H. H. Hansen, T. B. Rasmussen et al. 2005. Rational design
and synthesis of new quorum sensing inhibitors derived from acylated
homoserine lactones and natural products from garlic. Org. Biomolec. Chem.
3: 25362.
85 Pesci, E. C., J. B. Milbank, J. P. Pearson et al. 1999. Quinolone signaling in the
cell-to-cell communication system of Pseudomonas aeruginosa. Proc. Natn. Acad.
Sci. USA 96: 1122934.
86 Pesci, E. C., J. P. Pearson, P. C. Seed and B. H. Iglewski 1997. Regulation of las
and rhl quorum sensing in Pseudomonas aeruginosa. J. Bacteriol. 179: 312732.
87 Pratt, L. A. and R. Kolter 1998. Genetic analysis of Escherichia coli biofilm
formation: roles of flagella, motility, chemotaxis and type I pili. Molec.
Microbiol. 30: 28593.
88 Purevdorj, B., J. W. Costerton and P. Stoodley 2002. Influence of hydrodynamics
and cell signaling on the structure and behavior of Pseudomonas aeruginosa
biofilms. Appl. Environ. Microbiol. 68: 445764.
89 Rasch, M., C. Buch, B. Austin et al. 2004. An inhibitor of bacterial quorum
sensing reduces mortalities caused by Vibriosis in rainbow trout
(Oncorhynchus mykiss, Walbaum). Syst. Appl. Microbiol. 27: 3509.
90 Rasmussen, T., M. E. Skinders, T. Bjarnsholt et al. 2005. Idendity and effects of
quorum sensing inhibitors produced by Penicillum species. Microbiology.
(in press.)
91 Rasmussen, T. B., T. Bjarnsholt, M. E. Skinders et al. 2005. Screening for
quorum sensing inhibitors using a novel genetic system the QSI selector.
J. Bacteriol. 187: 1799814.
92 Reichelt, J. L. and M. A. Borowitzka. 1984. Antimicrobial activity from marine
algae: results of a large-scale screening programme. Hydrobiology 116/117:
15868.
93 Rice, S. A., M. Givskov, P. Steinberg and S. Kjelleberg 1999. Bacterial signals
and antagonists: the interaction between bacteria and higher organisms. J. Molec.
Microbiol. Biotechnol. 1: 2331.
M
.
G
I
V
S
K
O
V
A
N
D
M
.
H
E
N
T
Z
E
R
96
94 Riedel, K., T. Ohnesorg, K. A. Krogfelt et al. 2001. N-acyl-L-homoserine lactone-
mediated regulation of the lip secretion system in Serratia liquefaciens MG1.
J. Bacteriol. 183: 18059.
95 Sauer, K., A. K. Camper, G. D. Ehrlich, J. W. Costerton and D. G. Davies 2002.
Pseudomonas aeruginosa displays multiple phenotypes during development as a
biofilm. J. Bacteriol. 184: 114054.
96 Schaefer, A. L., B. L. Hanzelka, A. Eberhard and E. P. Greenberg 1996. Quorum
sensing in Vibrio fischeri: probing autoinducer-LuxR interactions with autoindu-
cer analogs. J. Bacteriol. 178: 2897901.
97 Schultes, R. E. 1978. The kingdomof plants, p. 208. In W. A. R. Thompson (ed.),
Medicines from the Earth, p. 208. New York, NY: McGraw-Hill.
98 Schuster, M., C. P. Lostroh, T. Ogi and E. P. Greenberg 2003. Identification,
timing, and signal specificity of Pseudomonas aeruginosa quorum-controlled
genes: a transcriptome analysis. J. Bacteriol. 185: 206679.
99 Shaw, P. D., G. Ping, S. L. Daly et al. 1997. Detecting and characterizing N-acyl-
homoserine lactone signal molecules by thin-layer chromatography. Proc. Natn.
Acad. Sci. USA 94: 603641.
100 Slattery, M., J. B. McClintoch and J. N. Heine 1995. Chemical defences in
Antarctic soft corals: evidence for antifouling compounds. J. Exp. Mar. Biol.
Ecol. 190: 6177.
101 Slaughter, J. C. 1999. The naturally occurring furanones: formation and func-
tion from pheromone to food. Biol. Rev. 74: 25976.
102 Smith, K. M., Y. Bu and H. Suga 2003. Library screening for synthetic agonists
and antagonists of a Pseudomonas aeruginosa autoinducer. Chem. Biol.
10: 56371.
103 Smith, K. M., Y. Bu and H. Suga 2003. Induction and inhibition of Pseudomonas
aeruginosa quorum sensing by synthetic autoinducer analogs. Chem. Biol.
10: 819.
104 Smith, R. S., E. R. Fedyk, T. A. Springer et al. 2001. IL-8 production in human
lung fibroblasts and epithelial cells activated by the Pseudomonas autoinducer N-
3-oxododecanoyl homoserine lactone is transcriptionally regulated by NF-kappa
B and activator protein-2. J. Immunol. 167: 36674.
105 Steidle, A., K. Sigl, R. Schuhegger 2001. Visualization of N-acylhomoserine
lactone-mediated cell-cell communication between bacteria colonizing the
tomato rhizosphere. Appl. Environ. Microbiol. 67: 576170.
106 Stewart, P. S. and J. W. Costerton 2001. Antibiotic resistance of bacteria in
biofilms. Lancet 358: 1358.
107 Stewart, P. S., F. Roe, J. Rayner et al. 2000. Effect of catalase on hydrogen
peroxide penetration into Pseudomonas aeruginosa biofilms. Appl. Environ.
Microbiol. 66: 8368.
108 Stoodley, P., F. Jrgensen, P. Williams and H. M. Lappin-Scott 1999. The role of
hydrodynamics and AHL signaling molecules as determinants of the structure
of Pseudomonas aeruginosa biofilms. In R. Bayston, M. Brading, P. Gilbert,
97
J
A
M
M
I
N
G
B
A
C
T
E
R
I
A
L
C
O
M
M
U
N
I
C
A
T
I
O
N
S
J. Walker and J. W. T. Wimpenny (eds), Biofilms: the Good, the Bad, and the Ugly,
pp. 32330. Cardiff: J. W. T. Bioline.
109 Sutherland, I. W. 2001. Biofilm exopolysaccharides: a strong and sticky frame-
work. Microbiology 147: 39.
110 Telford, G., D. Wheeler, P. Williams et al. 1998. The Pseudomonas aeruginosa
quorum-sensing signal molecule N-(3-oxododecanoyl)-L-homoserine lactone
has immunomodulatory activity. Infect. Immun. 66: 3642.
111 Teplitski, M., J. B. Robinson and W. D. Bauer 2000. Plants secrete substances
that mimic bacterial N-acyl homoserine lactone signal activities and affect
population density-dependent behaviors in associated bacteria. Molec. Plant
Microbe Interact. 13: 63748.
112 Valerius, N. H., C. Koch and N. Hoiby 1991. Prevention of chronic Pseudomonas
aeruginosa colonisation in cystic fibrosis by early treatment. Lancet 338: 7256.
113 Vallet, I., J. W. Olson, S. Lory, A. Lazdunski and A. Filloux 2001. The chaperone/
usher pathways of Pseudomonas aeruginosa: identification of fimbrial gene clus-
ters (cup) and their involvement in biofilmformation. Proc. Natn. Acad. Sci. USA
98: 691116.
114 Van Delden, C. and B. H. Iglewski 1998. Cell-to-cell signaling and Pseudomonas
aeruginosa infections. Emerg. Infect. Dis. 4: 55160.
115 Wagner, V. E., D. Bushnell, L. Passador, A. I. Brooks and B. H. Iglewski 2003.
Microarray analysis of Pseudomonas aeruginosa quorum-sensing regulons:
effects of growth phase and environment. J. Bacteriol. 185: 208095.
116 Wahl, M. 2003. Marine epibiosis. Fouling and antifouling: some basic aspects.
Mar. Ecol. Prog. Ser. 58: 17589.
117 Webb, J. S., L. S. Thompson, S. James et al. 2003. Cell death in Pseudomonas
aeruginosa biofilm development. J. Bacteriol. 185: 458592.
118 Whitchurch, C. B., T. Tolker-Nielsen, P. C. Ragas and J. S. Mattick 2002.
Extracellular DNA required for bacterial biofilm formation. Science 295: 1487.
119 Whiteley, M., M. G. Bangera, R. E. Bumgarner et al. 2001. Gene expression in
Pseudomonas aeruginosa biofilms. Nature 413: 8604.
120 Wimpenny, J. W. T. and R. Colasanti 1997. A more unifying hypothesis for
biofilm structures a reply. FEMS Microbiol. Ecol. 24: 1856.
121 Winson, M. K., M. Camara, A. Latifi et al. 1995. Multiple N-acyl-L-homoserine
lactone signal molecules regulate production of virulence determinants and
secondary metabolites in Pseudomonas aeruginosa. Proc. Natn. Acad. Sci. USA
92: 942731.
122 Winson, M. K., S. Swift, L. Fish et al. 1998. Construction and analysis of
luxCDABE-based plasmid sensors for investigating N-acyl homoserine lactone-
mediated quorum sensing. FEMS Microbiol. Lett. 163: 18592.
123 Worlitzsch, D., G. Herberth, M. Ulrich and G. Doring 1998. Catalase, myeloper-
oxidase and hydrogen peroxide in cystic fibrosis. Eur. Respir. J. 11: 37783.
124 Wozniak, D. J., T. J. O. Wyckoff, M. Starkey et al. 2003. Alginate is not a
significant component of the extracellular polysaccharide matrix of PA14 and
M
.
G
I
V
S
K
O
V
A
N
D
M
.
H
E
N
T
Z
E
R
98
PAO1 Pseudomonas aeruginosa biofilms. Proc. Natn. Acad. Sci. USA 100:
790712.
125 Wu, H., Z. Song, M. Givskov et al. 2001. Pseudomonas aeruginosa mutations in
lasI and rhlI quorum sensing systems result in milder chronic lung infection.
Microbiology 147: 110513.
126 Wu, H., Z. Song, M. Hentzer et al. 2000. Detection of N-acylhomoserine
lactones in lung tissues of mice infected with Pseudomonas aeruginosa.
Microbiology 146: 248193.
127 Yoon, S. S., R. F. Hennigan, G. M. Hilliard et al. 2002. Pseudomonas aeruginosa
anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesis.
Dev. Cell 3: 593603.
128 Zhu, J., J. W. Beaber, M. I. More et al. 1998. Analogs of the autoinducer 3-oxo-
octanoyl-homoserine lactone strongly inhibit activity of the TraR protein of
Agrobacterium tumefaciens. J. Bacteriol. 180: 5398405.
129 Passador, L., K. D. Tucker, K. R. Guertin et al. 1996. Functional analysis of the
Pseudomonas aeruginosa autoinducer PAI. J. Bacterial. 178: 59956000.
99
J
A
M
M
I
N
G
B
A
C
T
E
R
I
A
L
C
O
M
M
U
N
I
C
A
T
I
O
N
S
CHAPTER 5
Quorum-sensing-mediated regulation of biofilm
growth and virulence of Vibrio cholerae
Jun Zhu
University of Pennsylvania School of Medicine
John J. Mekalanos
Harvard Medical School, Boston, MA, USA
INTRODUCTION
Many species of bacterium exchange chemical signals to help them
monitor their population densities, a phenomenon referred to as quorum
sensing. Quorum sensing was first described over two decades ago in two
luminescent marine bacterial species, Vibrio fischeri and V. harveyi (40),
which have served as model species for studies of cell-density-dependent
gene expression. In both species, the enzymes responsible for light produc-
tion are encoded by the luciferase structural operon luxCDABE (13, 39) and
light emission occurs only at high cell density in response to the accumula-
tion of secreted autoinducer signaling molecules (40). In the 1980s,
Eberhard et al. (11) purified the first homoserine lactone autoinducer
from V. fischeri and showed that it was indeed a specific inducer of lumi-
nescence. In 1983, the basic features of the autoinduction system were
revealed at the molecular level when the lux genes of V. fischeri were
successfully cloned and expressed in Escherichia coli (12).
Although quorum sensing regulation has been analyzed in great detail
in V. harveyi and V. fischeri, the study of quorum sensing phenotypes in the
clinically important Vibrio species V. cholerae was virtually non-existent
until quite recently. This was partly because, unlike V. fischeri and
V. harveyi, V. cholerae does not possess luciferase genes and it was therefore
unclear whether it possessed any genes that were regulated by quorum
sensing. However, when the V. cholerae genome sequence was completed
(22) it was revealed that V. cholerae contains several quorum-sensing genes
similar to those of V. harveyi. In this chapter, we summarize recent studies
on V. cholerae quorum sensing from various laboratories and discuss the
significance of quorum-sensing-mediated regulation of virulence gene
expression and biofilm formation.
101
Bacterial Cell-to-Cell Communication: Role in Virulence and Pathogenesis, ed. D. R. Demuth and
R. J. Lamont. Published by Cambridge University Press. #Cambridge University Press 2005.
VIBRIO CHOLERAE AS A HUMAN PATHOGEN AND ITS
INFECTIOUS CYCLE
Cholera is an acute dehydrating diarrheal disease caused principally by
a potent enterotoxin (cholera toxin) produced by toxigenic V. cholerae dur-
ing infection of the human host (15). Epidemic cholera caused by toxigenic
V. cholerae belonging to the O1 or O139 serogroup is a major public health
problem in developing countries, causing an estimated 120,000 deaths
worldwide and many non-fatal cases each year, the vast majority of which
occur in children (41). Cholera is also endemic in many parts of developing
countries, where outbreaks occur widely in a seasonal pattern and are
particularly associated with poverty and poor sanitation.
The pathogenesis of cholera is a complex process and involves a num-
ber of genes encoding virulence factors that aid the pathogen in reaching
and colonizing the epithelium of the small intestine and in producing
cholera toxin (CT) that disrupts ion transport in intestinal epithelial cells (42).
In V. cholerae, the major virulence genes exist in clusters ( 27, 46). These
include the CTX genetic element, which is the genome of a lysogenic
bacteriophage (CTX) that carries the CT genes, and the TCP pathogenicity
island, which carries the genes encoding a pilus colonization factor known as
the toxin coregulated pilus (TCP).
Virulence gene expression in V. cholerae is controlled by multiple
regulatory systems (46). Several critical virulence genes are coordinately
regulated by a cascading system of regulatory factors to respond in a
concerted fashion to specific environmental conditions (Figure 5.1). The
ToxRS and TcpPH membrane complexes are believed to sense environ-
mental cues and to modulate the expression of the AraC-like transcriptional
activator ToxT in response to these cues. ToxT in turn controls the tran-
scription of genes involved in the synthesis of virulence factors such as CT
and TCP. Recent work has identified AphA and AphB as additional activa-
tors of tcpPH expression (30, 46).
Analysis of these regulatory cascades has identified pH, osmolarity,
and temperature as environmental signals that affect virulence gene
expression in vitro. Several other regulatory genes and processes (e.g.
motility and iron acquisition) also influence expression of the ToxR regulon
(32). These different regulatory systems presumably allow V. cholerae bac-
teria to sense their environment and accordingly vary gene expression to
optimize survival under different conditions. Because V. cholerae is both a
human pathogen and part of the normal aquatic flora in estuarine and
brackish waters, the functional repertoire of the V. cholerae genome must be
J
.
Z
H
U
A
N
D
J
.
J
.
M
E
K
A
L
A
N
O
S
102
unusually broad to accommodate two very different lifestyles: as a pathogen
in the human intestine and as a long-term resident of aquatic habitats
during interepidemic periods (45). However, little is known about the
extracellular signals that affect virulence in vivo or survival in the aquatic
environment.
The ToxRS, TcpPH, and ToxT regulators were previously thought to
regulate only virulence factor expression. However, a recent study (3)
attempted to define the entire ToxR regulon by comparing the transcrip-
tional profiles of toxRS, tcpPH, and toxT mutants with those of their
isogenic parent strain under conditions in vitro that are optimized for
production of virulence factors. This study found that TcpPH and ToxRS
control genes involved in metabolism and nutrient uptake, as well as many
genes of unknown function, suggesting that these regulators are involved
in adaptive responses to the host environment as well as in virulence gene
regulation. In contrast, ToxT appears to regulate only the CT and TCP
genes, suggesting that ToxT is involved only in virulence processes.
Environmental signals
(pH, temperature, bile, amino acids, osmolarity)
TcpH
TcpP
AphA
ToxT
ToxS
ToxR
tcpl tcpPH tcpA-F toxT acf ctxA ctxB
TCP
(toxin coregulated pilus)
CT (cholera toxin)
Figure 5.1. Regulatory pathways influencing the expression of virulence genes in Vibrio
cholerae. Signal transduction cascades coordinately regulate virulence in V. cholerae. The
ToxRToxS and TcpPTcpHsignaling circuits detect and respond to environmental stimuli
and activate the expression of toxT. ToxT, in turn, activates the transcription of a variety of
genes required for virulence, including cholera toxin genes and genes in the TCP
pathogenicity island involved in TCP pilus biosynthesis.
103
B
I
O
F
I
L
M
G
R
O
W
T
H
A
N
D
V
I
R
U
L
E
N
C
E
O
F
V
.
C
H
O
L
E
R
A
E
V. cholerae infections begin with the ingestion of contaminated food or
water. The bacteria that survive passage through the acid barrier of the
stomach then colonize epithelial surfaces in the small intestine. They
multiply extensively at this site and produces toxic proteins that alter the
normal function of cells lining the intestine, causing these cells to secrete
water and solutes into the lumen. The resulting diarrhea is believed to
facilitate the spread of V. cholerae back into the environment to reinitiate the
cycle. V. cholerae also maintains a permanent environmental reservoir in
aqueous environments in association with various aquatic organisms.
More recently, Merrell and colleagues (36) reported that V. cholerae present
in stools shed by cholera patients were hyperinfectious for infant mice
compared with a laboratory strain grown in vitro to stationary phase. This
work provides evidence that passage of V. cholerae through the human host
may alter critical virulence phenotypic properties that promote the trans-
mission of the organism to new human hosts.
QUORUM SENSING REGULATION IN V. CHOLERAE
Bacteria utilize quorum-sensing regulation systems to control a var-
iety of physiological functions (17, 37). Many Gram-negative bacteria use
acyl-homoserine lactones, which are synthesized by LuxI-family proteins,
as interbacterial signals and LuxR-type proteins as transcriptional reg-
ulators. In these systems, the autoinducer is usually synthesized by a
protein related to the LuxI protein of V. fischeri and binds to an intracel-
lular receptor protein that resembles the V. fischeri LuxR protein.
Receptorautoinducer complexes are thought to bind to target promoters
to activate their transcription. These autoinducers diffuse rapidly across the
cell envelope and accumulate intracellularly only at high bacterial popula-
tion densities. In Gram-positive species, modified oligopeptides are
secreted and serve as signals when they accumulate at high cell density.
The detectors for the oligopeptide signals are two-component response
regulator proteins.
V. harveyi possesses a complicated, hybrid quorum-sensing regulation
system (1) that has characteristics of both Gram-negative and Gram-positive
QS systems. V. harveyi uses an acyl-HSL autoinducer (AI-1) similar to that
of other Gram-negative quorum sensing bacteria, but the signal
detection and relay apparatus consists of two-component proteins similar
to the quorum sensing systems of Gram-positive bacteria (2). AI-1 is an acyl-
HSL (3-hydroxyl-C4-HSL), but its synthesis is dependent on LuxLM,
which does not share any homology with the LuxI family of autoinducer
J
.
Z
H
U
A
N
D
J
.
J
.
M
E
K
A
L
A
N
O
S
104
synthases. V. harveyi also produces and responds to a second quorum-sensing
autoinducer (AI-2) (48), a furanosyl borate diester that is not closely related to
the homoserine lactones found in other bacteria (6, 43). Synthesis of AI-2 is
dependent on the LuxS protein (55).
Bassler and colleagues used the V. harveyi luciferase operon as a
heterologous reporter to examine quorum sensing in V. cholerae and
found that, like V. harveyi, V. cholerae has at least two quorum sensing
systems (38). System 2 (LuxSPQ) is similar to the V. harveyi system 2,
whereas system 1 (CqsAS) is novel (Figure 5.2). At low cell density, signal
concentration is low, and CqsS and LuxQ act as autophosphorylating
kinases. These phosphates are then transferred to the cytoplasmic
phosphotransferase LuxU, which in turn transfers the phosphates to
LuxO, a s
54
-dependent activator. Upon phosphorylation, LuxO is activated
and functions to repress hapR expression (see below). HapR belongs to
the TetR-family proteins and is a homolog of V. harveyi LuxR (although
unrelated to LuxR from V. fischeri). At high cell density, the CAI-1 and AI-2
signal molecules are produced at a high level and interact with their cognate
sensors. This interaction converts CqsS and LuxQ from kinases to
Figure 5.2. Current model for quorum-sensing regulation in Vibrio cholerae. At low cell
density, LuxO protein is phosphorylated and actively represses hapR expression through
Hfq and 4 sRNAs. Virulence genes are expressed. At high cell density, accumulation of
autoinducers leads to LuxO dephosphorylation; HapR is produced and represses virulence
gene expression and biofilm formation, and activates H/A protease production. A putative
signal system 3 may also be involved in this process. P: phosphate group.
105
B
I
O
F
I
L
M
G
R
O
W
T
H
A
N
D
V
I
R
U
L
E
N
C
E
O
F
V
.
C
H
O
L
E
R
A
E
phosphatases, resulting in the loss of phosphate from LuxU and LuxO.
Consequently, LuxO is inactivated and HapR is expressed. A gene called
cqsA is responsible for the production of CAI-1 molecules. As predicted by
domain conservation, cqsA likely encodes an aminotransferase, but the
structure and biosynthesis of the CAI-1 autoinducer are not similar to
those of previously identified autoinducer molecules.
The quorum sensing apparatus in V. cholerae is unusually complex.
Study of system1 and system2 double mutants revealed that a third sensory
circuit exists in V. cholerae (38). This system 3, which is hypothesized to
respond to an intracellular signal, does not seem to transmit its signal
through LuxU but rather directly through LuxO, the central regulator for
all three systems.
In a recent study, Lenz et al. (35) found that repression of hapR by
phosphorylated LuxO is indirect. At low cell density, phosphorylated LuxO
activates the expression of the small RNAbinding protein Hfq (47) and four
redundant small regulatory RNAs (sRNAs). The HfqsRNA repressor com-
plexes then act to destabilize V. cholerae hapRmRNAs. All four sRNAs must
be inactivated to eliminate Hfq-mediated quorum-sensing repression,
whereas overexpression of only one sRNA is sufficient for repression.
Control via sRNAs may permit an ultrasensitive response to the
concentration of active LuxO, as base pairing of a sRNA with its target
message is known to promote degradation of both the sRNA and the
mRNA. The use of sRNAs to accomplish an ultrasensitive response may
be particularly apt for processes such as quorumsensing in which an all-or-
nothing response is required.
QUORUM SENSING NEGATIVELY REGULATES VIRULENCE
GENE EXPRESSION
Unlike in V. harveyi, there is no luciferase operon in V. cholerae. In an
effort to determine the targets of quorum sensing in V. cholerae, mutations
in quorum-sensing regulators luxO and hapR were tested for their roles in
V. cholerae pathogenesis (60). The hapR mutant colonizes as well as the
wildtype, but the luxO mutant is profoundly defective in colonization in an
infant mouse model. V. cholerae colonization of the infant mouse
(46 d old) intestine is an animal model commonly used for the human
diarrheal disease cholera. This model has been extremely useful in the
identification and characterization of proven and putative virulence factors
involved in human cholera (28). In addition, the expression of the ToxR
regulon was significantly depressed in the luxOmutant, as determined by a
J
.
Z
H
U
A
N
D
J
.
J
.
M
E
K
A
L
A
N
O
S
106
whole-genome microarray analysis. Overexpression of TcpP or ToxT, but
not of ToxR, restores CT production in a luxOmutant, indicating that LuxO
controls the ToxR regulon by repressing TcpP. As predicted, because LuxO
represses hapR, HapR acts downstream of LuxO to repress tcpP expression,
leading to repression of the ToxR virulence regulon. A follow-up study (31)
suggests that, at high cell density, HapR decreases tcpPH transcription
indirectly by binding directly to the aphA promoter and repressing aphA
transcription. Owing to decreased intracellular levels of AphA, hapR
sensor 2
sensor 2
G
A
A
R
D
-
A
N
D
E
R
S
E
N
270
the formation of the spore-filled fruiting bodies is initiated in response to
starvation of cells at a high density on a solid surface (13). Fruiting-body
formation proceeds in a relatively stereotyped pattern of morphological
events, which are separated in time and space (Figures 11.1, 11.2).
The starting point is an initially unstructured lawn of randomly oriented
cells on a solid surface. The first explicit signs of fruiting-body formation
are evident after 46h with changes in cell behaviour (29) as the cells begin
to aggregate to form small aggregation centers (Figure 11.2). A character-
istic of the aggregation process is that cells move into the aggregation
centers organized as streams of cells, rather than entering the centers
as single cells from all directions (61) (Figure 11.2). As more cells enter
the aggregation centers, these centers increase in size and eventually
become symmetric mounds. By 24 h, the aggregation process is complete
and the nascent fruiting bodies each contain c. 10
5
densely packed cells
(Figures 11.1, 11.2). Inside the nascent fruiting bodies, the rod-shaped,
motile cells undergo morphological and physiological differentiation
into spherical, non-motile, dormant spores, resulting in mature fruiting
bodies (Figure 11.1). Although the aggregation process takes c. 24h to com-
plete, spore maturation is finished c. 72 h after the onset of starvation.
Although all cells exposed to starvation have the potential to develop into
spores (14, 52) only 1020% of cells differentiate into spores. These cells are
specifically those which have accumulated inside the mounds. Up to 30%
nutrients
+ nutrients
0 h 6 h 9 h
12 h 18 h 24 h
72 h
Figure 11.1. The life cycles of Myxococcus xanthus. In the panel to the left a vegetative,
spreading colony is shown. The diameter of the colony is c. 2 cm. In the scanning EM
pictures to the right, the different stages of fruiting body formation are shown. In the 72 h
panel, a fruiting body has been opened to visualize the spores. Scale bars in 24 and 72 h
panels: 5 and 10mm, respectively. The scanning EM pictures are adapted from Kuner and
Kaiser (43).
271
C
O
N
T
A
C
T
-
D
E
P
E
N
D
E
N
T
S
I
G
N
A
L
I
N
G
I
N
M
.
X
A
N
T
H
U
S
remain outside the fruiting bodies. These cells remain rod-shaped and
differentiate to a cell type called peripheral rods. Even after extended periods
of starvation, peripheral rods do not differentiate into spores (60). Finally,
the remaining cells undergo lysis (69).
Fruiting-body formation involves temporally coordinated changes in
gene expression in which genes are turned on at specific time points during
development (27, 41) (Figure 11.2). Moreover, developmental gene expression
is spatially controlled (Figure 11.2). Genes turned on after 6h are preferen-
tially expressed in aggregating and sporulating cells, whereas genes activated
prior to 6h are expressed in all cells including peripheral rods (30). Finally,
genetic and biochemical evidence suggests that fruiting-body formation
depends on the exchange of intercellular signals (71) (Figure 11.2).
Myxobacteria are the only bacteria that cope with starvation by forming
spore-filled fruiting bodies. This survival strategy is optimally suited to the
multicellular life-style of myxobacteria. Each fruiting body consists of c. 10
5
0
C
Cellular organization
Developmental gene
expression
Hours of development
Intercellular signals
6 12 18 24 72
A
0 h 6 h 15 h 24 h
Figure 11.2. Morphogenesis of fruiting bodies in Myxococcus xanthus. On the developmental
timeline, each triangle represents a gene, which is turned on during fruiting-body
formation. Black triangles represent genes that are expressed in all cells; grey triangles
represent genes that are expressed only in aggregating and sporulating cells. The times of
action of the A and C signals are indicated by the arrows below the timeline. Cellular
arrangements during the different stages of fruiting-body formation are shown above the
timeline. Cell arrangements are visualized by fluorescence microscopy of green fluorescent
protein (GFP)-labeled cells. GFP-labeled wild-type cells were co-developed with non-
fluorescent wild-type cells at a ratio of 1 : 40. Images were acquired at the time points
indicated. White circles and arrows in the 6h image indicate aggregation centers and
streams, respectively. White arrows in the 15 h image indicate streams of cells entering a
nascent fruiting body. Scale bar: 50mm. The pictures of the cellular arrangements during
the different stages of fruiting-body formation are adapted from (28).
L
.
S
G
A
A
R
D
-
A
N
D
E
R
S
E
N
272
spores and is essentially a spore-filled sac. Under the appropriate condi-
tions, the spores in fruiting bodies germinate to give rise to motile, meta-
bolically active vegetative cells. Germination immediately gives rise to a
new, spreading, cooperatively feeding colony. Thus, fruiting bodies are
optimally designed to ensure that a new vegetative cycle is initiated by a
community of cells rather than by a single cell.
GLIDING MOTILITY IN M. XANTHUS
The multicellular lifestyle of M. xanthus crucially depends on the
ability of cells to display active movement. M. xanthus cells move by gliding
motility, which is the movement of a rod-shaped cell in the direction of
the cells long axis on a surface in the absence of a flagellum (22). Gliding
and its regulation constitutes the basis for the formation of spreading
colonies and f ruiting-bo dy fo rma tio n. M. xanthus has two mech anisms
for gliding, adventurous (A)- and social (S)-motility (24). Mutations in both
systems (A
, S
m
m
i
n
1
)
Time (seconds)
0 s 60 s 120 s 180 s 240 s 300 s 360 s 420 s
480 s 540 s 600 s
120 240 360 480 720
660 s 720 s 780 s 840 s 900 s
2 4
1
3
2
1
0
2
1
3
3 5
Direction of gliding
S-engine
Type IV pili
Pulling
A-engine
Active nozzle-like structures
Pushing
(c)
600 840
Figure 11.3. Characteristics of Myxococcus xanthus gliding motility. (a) A sequence of
phase-contrast images of a single cell gliding on a solid surface. Images were recorded
every 15 s for 900s. Slime deposited by the cell is evident as a refractile trail; white
arrows indicate the direction of gliding. (b) The speed profile of the cell in (a). The
gliding speed was calculated for each 15 s interval between recordings and plotted as a
function of recording time. The dashed horizontal lines indicate the detection limit for
active movement (0.35 mmmin
1
). The dotted vertical lines indicate intervals where the
cell showed active movement (intervals 2, 3, and 4) and periods of no active movement
(intervals 1 and 5). A change in gliding speed froma negative to a positive value or vice versa
indicates a reversal. This cell reversed its direction of gliding at t 75, 345, 570 and 870s.
L
.
S
G
A
A
R
D
-
A
N
D
E
R
S
E
N
274
by retraction of Tfp and thus the forward movement of the Tfp
containing cell. Thus, retraction of Tfp essentially pulls cells forward. Tfp
are only observed at one pole at a time (32). Nevertheless, A
cells, which
move only by means of their S-engine, reverse direction at regular intervals
(82), suggesting that the pole at which the Tfp are located changes
regularly.
M. xanthus cells moving by means of A-motility leave behind a slime
trail. Currently, the secreted slime in these slime trails is thought to be
the key to an understanding of A-motility. Wolgemuth et al. (91) identified
(by electron microscopy) nozzle-like structures, which are clustered at
both poles of A- m otile cells in M. xanthus (Figure 11.3c ). These s tructures
are similar to the junctional pore complexes used in gliding cyanobacteria
to secrete the slime that generates gliding motility in these bacteria (25).
Accordingly, it was proposed that the nozzle-like structures in M. xanthus
are also involved in slime secretion and that slime extrusion generates
the force for movement. To account for how slime extrusion could
produce sufficient thrust to propel a bacterial cell, Wolgemuth et al. (91)
proposed that slime is introduced into the nozzle-like structures in a
dehydrated form. The subsequent hydration of the slime would cause
it to swell and be extruded from the nozzle. Adherence of the hydrated
slime to the substrate would provide the slime with a footing that would
allow it to push the cell forward. Slime extrusion thus essentially pushes
cells forward. Even though the nozzle-like structures are observed at
both poles, slime extrusion is only observed at one pole at a time, implying
that only one polar cluster of the nozzle-like structures is actively
se creting slime at a t ime ( Figure 11.3c ). Nevertheless, A
cells that
move as single cells, and hence only translocate by means of their A-engine,
reverse direction regularly (5). This, in turn, implies that the polarity of
the active nozzles also switches at regular intervals. The molecular compo-
sition of the nozzle-like structures in M. xanthus is so far unknown.
Figure 11.3. (cont.)
(c) Longitudinal cross-section of M. xanthus cells on a solid surface, showing the arrangement
and location of the two engines involved in gliding motility. The dashed and solid lines
indicate the outer and inner membrane, respectively. Type IV pili project from the left
pole. Black cylinders indicate proteins involved in biogenesis and retraction of type IV pili
spanning the cell envelope. White barrels indicate the slime-extruding nozzle-like structures
implicated in A-motility. These structures are present at both poles; however, only one
cluster at a time is actively secreting slime. In this cell, the cluster at the right pole secretes
slime as indicated in grey. Parts (a) and (b) were adapted from(28); (c) was adapted from(78).
275
C
O
N
T
A
C
T
-
D
E
P
E
N
D
E
N
T
S
I
G
N
A
L
I
N
G
I
N
M
.
X
A
N
T
H
U
S
Interestingly, homologs of the TolR, TolB, and TolQ proteins have been
shown to be important for A-motility (89, 93). In Gram-negative bacteria
these proteins, together with the TolA and Pal proteins, form a complex,
which is involved in transport processes across the inner and outer mem-
branes (53).
INTERCELLULAR SIGNALING DURING FRUITING-BODY
MORPHOGENESIS
Whereas gliding motility and its regulation constitutes the basis for the
formation of fruiting bodies, the role of the intercellular signals involved
in fruiting-body formation seems to be to coordinate and synchronize the
efforts of thousands of cells during the construction process. Genetic
evidence suggests that there may be at least five intercellular signals,
known as the A- to E-signals, which are involved in fruiting-body formation
(71). Initially, mutants deficient in the synthesis of an intercellular signal
required for fruiting-body formation were identified in a collection
of mutants that were unable to complete fruiting body formation and
sporulation (18). A specific characteristic of a group of these mutants
was that their development was rescued by co-development with wild-type
cells. This rescue is referred to as extracellular complementation (18)
to emphasize that it does not involve transfer of genetic material from
wild-type cells to mutant cells. In addition it was found that none of the
non-autonomous mutants were auxotrophs, suggesting that extracellular
complementation did not involve cross-feeding (18). Extracellular comple-
mentation experiments involving pairs of non-autonomous mutants lead
to the classification of the mutants into four classes referred to as the
asg (A-signal), bsg (B-signal), csg (C-signal) and dsg (D-signal) mutants,
respectively (18). In these co-development experiments, mutants from one
class were able to rescue development of a mutant from a different class, i.e.
an asg mutant could rescue sporulation of a bsg mutant and vice versa,
whereas mutants belonging to the same class did not result in rescue of
development when co-developed (18). Later, a fifth class of non-autonomous
mutants referred to as the esg (E-signal) mutant was identified (12).
Extracellular complementation was explained by suggesting that the inability
of a non-autonomous mutant to complete development was caused by the
inability to produce an intercellular signal required for development. In the
co-development experiments, this missing signal would be provided either
by wild-type cells or by a mutant from a different class of non-autonomous
mutants (18).
L
.
S
G
A
A
R
D
-
A
N
D
E
R
S
E
N
276
Despite intensive work, only two of the intercellular signals the A- and
C-signals have been characterized biochemically. Likewise, the A- and
C-signals are the only signals whose function has been clarified. The
A-signal becomes important for development after 2 h of starvation (44)
(Figure 11.2). The A-signal consists of a subset of amino acids, which are
produced by the action of extracellular proteases that are activated in
response to starvation (45, 65). The A-signal functions as part of a system
that measures the density of starving cells: each starving cell produces a
constant amount of A-signal and once a threshold concentration of A-signal
is reached development proceeds (46). The function of the A-signaling
system therefore seems to be to ascertain that fruiting-body morphogenesis
is not initiated unless a sufficiently high number of cells are starving. The
C-signal comes into action after 6h of starvation, coinciding with the first
signs of morphogenesis (40).
THE C-SIGNAL INDUCES THREE RESPONSES THAT ARE
SEPARATED IN TIME AND SPACE
Mutants that cannot synthesize the C-signal are unable to aggregate
and sporulate (73) and the expression of the genes that are normally turned
on from 6h is reduced or abolished (40). The C-signal is encoded by the
csgA gene (73). Consequently, in a csgA mutant the developmental program
is arrested after 6h. Development of csgA mutant cells can be restored in
either of two ways: by co-development with wild-type cells or with cells from
either the asg, bsg, dsg, or esg classes of non-autonomous mutants (18), or by
exogenous C-signal (36).
Formally, the developmental defects in a csgA mutant and the rescue
of these defects by extracellular complementation or by exogenous C-signal
only provide evidence that the C-signal is required for fruiting-body formation.
These experiments do not provide evidence that the C-signal is a true signal
that induces a specific response. To distinguish between these possibilities,
Kruse et al. (42) overproduced the C-signal early during starvation, the idea
being that if the C-signal was a true signal that induced a response(s), then
this/these response(s) would be induced earlier in the strain overproducing
the signal. In the strain overproducing the C-signal early during development
it was observed that aggregation, sporulation, and C-signal-dependent gene
expression were indeed induced earlier than in wild-type cells. Thus, this
experiment provided the crucial piece of evidence demonstrating that the
C-signal induces aggregation, sporulation, and full expressionof developmental
genes, which are turned on after 6h.
277
C
O
N
T
A
C
T
-
D
E
P
E
N
D
E
N
T
S
I
G
N
A
L
I
N
G
I
N
M
.
X
A
N
T
H
U
S
THE MOLECULAR NATURE OF THE C-SIGNAL
The molecular nature of the C-signal has been controversial. Kim and
Kaiser (36, 37) originally purified the C-signal by detergent extraction and
biochemical fractionation from starving M. xanthus cells on the basis of
its ability to rescue development of csgA cells. Kim and Kaiser identified the
C-signal as a protein with molecular mass c. 17 kDa, which is encoded by
the csgA gene. The understanding that this 17 kDa protein was the C-signal
was questioned by several observations that suggested that the CsgA
protein might act as an enzyme to produce the C-signal. Firstly, from the
sequence of the csgA gene, the size of the CsgA protein was predicted to be
25 kDa (47). Secondly, the CsgA protein is homologous to members of
the short-chain alcohol dehydrogenase (SCAD) family of intracellular
proteins (2, 47). SCAD enzymes contain two conserved sequence motifs,
both of which are present in the CsgA protein: an N-terminal motif corres-
ponding to the NAD(P)-coenzyme binding pocket and a more C-terminal
motif involved in the catalytic mechanism (63). Consistently, the CsgA
protein was observed to bind NAD
G
A
A
R
D
-
A
N
D
E
R
S
E
N
278
C-signal activity (54). Importantly, these recombinant p17 proteins lack the
NAD
in vitro (54).
Thus, p17 does not depend on SCAD activity to engage in C-signaling. Rather
these data strongly support the idea that p17 is the bona fide C-signal.
The precise N-terminus of p17 remains to be determined. Another
unsolved question regarding the exact biochemical nature of the C-signal
is how p25 and p17 are anchored in the outer membrane. A homology
model of p25 revealed that p25 is not an amphiphilic protein and does not
have the b-barrel structure typical of outer membrane proteins (54).
However, in Triton X-114 phase separation experiments, p17 and p25 both
partition to the detergent phase (54). As this partitioning pattern is a
characteristic of amphiphilic membrane proteins and lipoproteins, this
led to the speculation that p25 and p17 are post-translationally modified
with a hydrophobic molecule and that this hydrophobic moiety serves to
anchor the proteins in the outer membrane. Neither the chemical nature
of this modification nor the position in p17 and p25 that carries the
modification have been determined. It should be pointed out that secreted
lipoproteins are typically modified on an N-terminal Cys residue. However,
p25 does not contain a lipoprotein signal peptide.
SYNTHESIS OF THE C-SIGNAL
To understand a signaling pathway, it is essential to define the mechanisms
by which cells produce this signal. Shimkets and co-workers have provided
evidence that the csgA gene is transcribed from the same promoter during
vegetative growth and development (50) and that the translation start
codon for p25 synthesis is essential for synthesis of the C-signal (47). These
observations argued against the idea that p17 was synthesized from an
alternative start codon. A synthesis mechanism for p17 involving translational
frameshifts also appeared unlikely, as this mechanismwould involve at least two
frameshifts. Synthesis mechanism involving transcriptional or translational
mechanism having been ruled out by Shimkets and co-workers, Lobedanz
and Sgaard-Andersentested whether p17 synthesis involved proteolytic proces-
sing of p25 (54). This hypothesis was tested experimentally by using an in vitro
protease assay in which total cell extracts were prepared from starving
M. xanthus cells. When this extract was added to a recombinant p25 protein
purified fromE. coli, a protein with a molecular mass of c. 17 kDa was produced.
This protein was recognized by the antibodies against the C-terminus of p25,
whereas the antibodies against the N-terminus of p25 did not recognize it.
Control experiments provided evidence that the recombinant p25 protein
279
C
O
N
T
A
C
T
-
D
E
P
E
N
D
E
N
T
S
I
G
N
A
L
I
N
G
I
N
M
.
X
A
N
T
H
U
S
does not harbor the protease activity involved in the N-terminal proteolytic
processing of p25. By adding protease inhibitors specific for different types of
proteases to the cell extract, evidence was obtained that the protease involved in
p25 processing is a serine protease. Consistent with the observation that p17 is
only detected in developing cells (42), it was observed that the activity of the
protease is developmentally regulated. The protease and the corresponding
gene remain to be identified.
Several observations in addition to those already mentioned still need
to be explained before the molecular nature of the C-signal can be declared
solved. In particular, the inability of mutant p25 proteins, which carry sub-
stitutions in the coenzyme binding pocket or in the catalytic site, to rescue
development of csgAcells in the C-signal bioassay (47) is thought-provoking. It
has been speculated that the substitutions in the coenzyme binding pocket
may interfere with proteolytic processing of p25 and that the substitutions in
the catalytic site could interfere with recognition by the C-signal receptor (54).
An unresolved issue is the potential enzymatic activity of p25. Is p25
an enzymatic fossil, which no longer has SCAD activity and which only
functions as a precursor for p17? Or does p25 still have enzymatic activity?
Clearly, this potential enzymatic activity is not required for fruiting body
formation, as development of csgA cells is rescued by exogenous p17.
Irrespective of whether p25 has SCAD activity, it is interesting to speculate
about why p25 was, at some point in its evolution, adopted to become the
precursor for the 17 kDa C-signal protein. An enzyme is optimized to recognize
a substrate. This interaction could potentially be exploited to generate a
signalreceptor pair in which the signal molecule is the substrate-binding
part of the enzyme and the receptor is the original substrate or a protein that
carries the original substrate as a secondary modification. It will be interesting
to see whether this is the case for the C-signal receptor (cf. below).
C-SIGNAL TRANSMISSION RELIES ON A CONTACT-DEPENDENT
MECHANISM
Early on, Kaiser and co-workers observed a conspicuous relationship
between cell motility and C-signal transmission. First, it was found that
non-motile cells have an altered pattern of developmental gene expres-
sion (39). This altered pattern matches exactly the pattern observed in
csgA mutants. The similarity in the pattern of developmental expression
suggested that motility is required for C-signal transmission. Secondly,
it was found that both the donor cell of the C-signal as well as the
receiver cell of the C-signal need to be motile in order for C-signal
L
.
S
G
A
A
R
D
-
A
N
D
E
R
S
E
N
280
transmission to occur (34). The interpretation of these experiments was
that specific cellcell contacts are needed for C-signal transmission to
occur and that motility is required to establish these contacts.
This hypothesis was tested in a simple and elegant experimental setup
developed by Kim and Kaiser (33). Briefly, an agar plate containing
starvation medium was scored with a finely grained sandpaper to
create grooves, which were approximately 0.5 to 1 cell length in width.
Subsequently, non-motile cells were positioned in the grooves. In
the grooves, the rod-shaped cells generally aligned with extensive
side-to-side contacts and end-to-end contacts. Amazingly, this simple
manipulation of cell position restored C-signal-dependent gene expression
and sporulation in the non-motile mutants. Interestingly, cells outside the
grooves also aligned in a pattern that established extensive side-to-side
contacts. However, these cells neither expressed C-signal dependent genes
nor did they sporulate. The defining difference between cells in the grooves
and outside the grooves is the frequency of end-to-end contacts (33). Thus,
Kim and Kaiser suggested that C-signal transmission depends on direct
contacts between adjacent cells and that these contacts were end-to-end
contacts (33). Cell motility would be required to establish these contacts (33).
Later, the observation that wild-type cells and csgA cells need to be
in direct contact in order for extracellular complementation to occur has
offered further support to the contact-dependent C-signal transmission
mechanism (36). Finally, the findings that CsgA antibodies recognize
epitopes, located on the surface of developing wild-type cells (74) and
that the 17 kDa C-signal protein is localized to the outer membrane
showed that the C-signal is non-diffusible, and thus further supported
the idea that C-signal transmission would rely on a contact-dependent
mechanism (54). Definitive evidence that C-signal transmission depends
on specific end-to-end contacts is still lacking. However, analyses of cell
behaviour during rippling, which is a specialized type of organized
cell movement that is occasionally observed during the early stages
of aggregation, lend support to the notion that C-signal transmission
involves end-to-end contacts (70).
THE C-SIGNAL TRANSDUCTION PATHWAY
In order to understand how a single signal can induce three responses,
i.e. aggregation, sporulation, and developmental gene expression, which
are separated in time and space, it is essential to elucidate the structure of
the signal transduction pathway. Several of the components in the C-signal
281
C
O
N
T
A
C
T
-
D
E
P
E
N
D
E
N
T
S
I
G
N
A
L
I
N
G
I
N
M
.
X
A
N
T
H
U
S
transduction have been identified (Figure 11.4). Most of these components
have been identified by using genetic approaches in which developmental
mutants were specifically screened for those deficient in C-signal-
dependent responses (52, 80).
The receptor of the C-signal has yet to be identified. The first
recognized component in the C-signal transduction pathway is the DNA
binding response regulator protein FruA, which consists of an N-terminal
receiver domain and a C-terminal DNA binding domain (15). fruA mutants
are unable to aggregate and sporulate and are deficient in the expression of
C-signal-dependent genes (15, 26, 62, 78). FruA activity is regulated at the
level of transcription as well as at a post-translational level (Figure 11.4).
The regulatory mechanism acting at the level of fruA transcription ensures
the timely induction of fruA transcription after 36h of starvation. Several
pathways converge to stimulate fruA transcription: the early-acting A-signal
induces fruA transcription by an unknown mechanism (15, 62). The MrpC
protein, which is a homolog of the cyclic AMP receptor protein in E. coli
(84), binds to the fruA promoter and induces fruA transcription. Finally, the
DevT protein directly or indirectly stimulates transcription of fruA (7).
The regulatory mechanism acting at the post-translational level results in
the activation of FruA. Genetic evidence suggests that this activation
involves the phosphorylation of a conserved Asp residue in the N-terminal
receiver domain (15). In other response regulator proteins, the corresponding
Asp residue is phosphorylated by a cognate histidine protein kinase (64).
Moreover, genetic evidence suggests that FruA phosphorylation is induced
by the C-signal (15, 78). The cognate FruA histidine protein kinase has yet to
be identified.
Downstream from phosphorylated FruA the C-signal transduction
pathway branches (Figure 11.4). One branch leads to aggregation; the
proteins in the Frz chemosensory system act in this branch (78, 80).
The Frz proteins constitute a cytoplasmic signal transduction system that
controls several gliding-motility parameters including the frequency of
gliding reversals (5, 28). The Frz proteins are similar to proteins involved
in chemotaxis responses in other bacteria (88). In this branch, the C-signal
is an input signal to the Frz system and induces methylation of the FrzCD
protein (78), a methyl-accepting chemotaxis protein (57). C-signal-induced
methylation of FrzCD occurs via phosphorylation of FruA and depends on
the FrzF methyltransferase (15, 78) (Figure 11.5). Presumably C-signaling
alters the activity of the Frz system in such a way that aggregation is
induced. Genetic evidence suggests that C-signaling inhibits the activity
of the Frz system (77). This in turn, alleviates the Frz-dependent inhibition
L
.
S
G
A
A
R
D
-
A
N
D
E
R
S
E
N
282
S
t
a
r
v
a
t
i
o
n
1
F
r
u
A
f
r
ff
u
rr
A
uu
d
o
f
A
R
e
l
A
(
p
)
p
p
G
p
p
D
e
v
T
M
r
p
C
A
-
s
i
g
n
a
l
s
d
e
K
t
o
d
K
F
r
u
A
-
P
A
g
g
r
e
g
a
t
i
oo
n S
p
o
r
u
l
a
t
i
o
n
p
2
5
p
1
7
1
S
d
e
K
T
o
d
K
c
s
g
A
gg
a
c
t
A
tt
B
C
D
H
P
K
2
F
r
z
d
e
dd
v
T
R
S
7
5
3
6
c
s
g
A
gg
F
i
g
u
r
e
1
1
.
4
.
M
u
l
t
i
p
l
e
s
i
g
n
a
l
t
r
a
n
s
d
u
c
t
i
o
n
p
a
t
h
w
a
y
s
c
o
n
v
e
r
g
e
t
o
c
o
n
t
r
o
l
m
o
r
p
h
o
g
e
n
e
s
i
s
.
T
h
e
s
c
h
e
m
a
t
i
c
i
l
l
u
s
t
r
a
t
e
s
C
-
s
i
g
n
a
l
t
r
a
n
s
m
i
s
s
i
o
n
b
e
t
w
e
e
n
t
w
o
c
e
l
l
s
.
T
h
e
d
a
s
h
e
d
a
n
d
c
o
n
t
i
n
u
o
u
s
l
i
n
e
s
i
n
d
i
c
a
t
e
t
h
e
o
u
t
e
r
a
n
d
i
n
n
e
r
m
e
m
b
r
a
n
e
,
r
e
s
p
e
c
t
i
v
e
l
y
.
F
o
r
s
i
m
p
l
i
c
i
t
y
,
t
h
e
c
o
m
p
o
n
e
n
t
s
i
n
t
h
e
p
a
t
h
w
a
y
a
r
e
o
n
l
y
s
h
o
w
n
i
n
t
h
e
c
e
l
l
t
o
t
h
e
r
i
g
h
t
.
T
h
e
s
e
c
o
m
p
o
n
e
n
t
s
a
r
e
a
l
s
o
p
r
e
s
e
n
t
i
n
t
h
e
c
e
l
l
t
o
t
h
e
l
e
f
t
.
I
n
t
h
i
s
c
e
l
l
,
o
n
l
y
c
s
g
A
i
s
s
h
o
w
n
t
o
i
l
l
u
s
t
r
a
t
e
t
h
e
s
i
g
n
a
l
a
m
p
l
i
f
i
c
a
t
i
o
n
l
o
o
p
l
a
b
e
l
l
e
d
.
T
h
e
s
e
c
o
n
d
s
i
g
n
a
l
a
m
p
l
i
f
i
c
a
t
i
o
n
l
o
o
p
i
s
l
a
b
e
l
l
e
d
.
T
h
e
s
y
m
b
o
l
i
n
d
i
c
a
t
e
s
t
h
e
h
y
p
o
t
h
e
t
i
c
a
l
C
-
s
i
g
n
a
l
r
e
c
e
p
t
o
r
;
H
P
K
i
n
d
i
c
a
t
e
s
t
h
e
h
y
p
o
t
h
e
t
i
c
a
l
F
r
u
A
h
i
s
t
i
d
i
n
e
p
r
o
t
e
i
n
k
i
n
a
s
e
;
a
n
d
7
5
3
6
s
y
m
b
o
l
i
z
e
s
t
h
e
s
p
o
r
u
l
a
t
i
o
n
g
e
n
e
m
o
n
i
t
o
r
e
d
b
y
t
h
e
T
n
5
l
a
c
7
5
3
6
i
n
s
e
r
t
i
o
n
.
T
h
e
p
o
s
s
i
b
l
e
c
o
n
v
e
r
g
e
n
c
e
p
o
i
n
t
o
f
t
h
e
s
i
g
n
a
l
t
r
a
n
s
d
u
c
t
i
o
n
p
a
t
h
w
a
y
s
d
e
f
i
n
e
d
b
y
t
h
e
S
d
e
K
a
n
d
T
o
d
K
k
i
n
a
s
e
s
w
i
t
h
t
h
e
C
-
s
i
g
n
a
l
t
r
a
n
s
d
u
c
t
i
o
n
p
a
t
h
w
a
y
i
s
i
n
d
i
c
a
t
e
d
b
y
t
h
e
s
h
a
d
e
d
b
o
x
.
S
e
e
t
h
e
t
e
x
t
f
o
r
a
d
e
t
a
i
l
e
d
e
x
p
l
a
n
a
t
i
o
n
o
f
t
h
e
p
a
t
h
w
a
y
s
.
of the MglA protein, a member of the RasRabRho superfamily of small
eukaryotic GTPases (21), which controls polarity switching of the A- and
S-engines (83). Consequently, MglA inhibits polarity switching of Tfp and
the active nozzle-like structures (Figure 11.5). The connection between the
C-signal and the Frz system, its interaction with the gliding machinery, and
the connection to cell behavior is discussed further below.
The second branch downstream from phosphorylated FruA leads to
C-signal-dependent gene expression and sporulation (15, 26) (Figure 11.4).
The C-signal and FruA jointly regulate the expression of at least 50
genes (26) including the devTRS operon (15). The DevTRS proteins, in
turn, are required for the expression of the sporulation gene tagged by
the Tn5lac 7536 insertion (52). Moreover, DevT is required for full expres-
sion of the fruA gene (7). In addition to regulating the expression of
C-signal-dependent genes, FruA regulates the expression of at least eight
genes, including the dofA gene, in a C-signal independent manner (26)
(Figure 11.4). Presumably these genes are induced by unphosphorylated
FruA.
A third branch in the C-signal transduction pathway is located
upstream from FruA and leads to increased transcription of the csgA gene
(35) (Figure 11.4). csgA is transcribed in vegetative cells and transcription
increases approximately four-fold during development (50). This increase
in csgA transcription is paralleled in the accumulation of p25, which also
FrzCD
FrzE
MglA
FrzF
FrzG
C-signal
Direction of gliding
FrzCD-CH
3
FruA FruA-P
Figure 11.5. The C-signal inhibits polarity switching of the gliding engines in Myxococcus
xanthus. Longitudinal cross-section of a M. xanthus cell on a solid surface, showing the
arrangement and location of the two engines involved in gliding motility. The interactions
that result in C-signal-dependent inhibition of polarity switching of the two gliding engines
during fruiting-body formation are indicated in black. C-signaling results in increased
methylation of the FrzCDprotein. Genetic evidence suggests that this leads to an inhibition
of the FrzE histidine protein kinase. This in turn results in an alleviation of the Frz-
dependent inhibition of the MglA protein. Consequently, MglA inhibits polarity switching
of the two gliding engines. The figure was adapted from (78).
L
.
S
G
A
A
R
D
-
A
N
D
E
R
S
E
N
284
increases approximately four-fold in response to starvation (42). The
increase in csgA transcription in response to starvation involves RelA and
the stringent response (9) and the four proteins encoded by the act operon
(17). Specifically, ActA and ActB, both of which are response regulators, are
required for full transcription of csgA during development whereas ActC
and ActD are important for the correct timing of csgA transcription. It
has been suggested that the Act proteins are specifically involved in
the C-signal-dependent increase in csgA transcription (17). However, an
interaction between C-signal transmission and act transcription or the
Act protein has yet to be reported. Following csgA transcription, p25 accu-
mulates, is exported, and is then processed to produce the 17 kDa C-signal
protein. The p17 protein is exposed on the cell surface and may interact with
a C-signal receptor on a different cell.
The C-signal transduction pathway is only active during starvation.
Starvation sets the pathway in motion by inducing the stringent response
(75). The stringent response, in turn, induces csgA transcription (9) and
A-signal accumulation (20) (Figure 11.4).
The C-signal transduction pathway contains two signal-amplification
loops, which ensure that cells engaged in C-signaling are exposed
to increased levels of C-signaling during development. In the first loop,
C-signaling induces aggregation and thus the accumulation of cells at a
higher cell density. As C-signal transmission involves a contact-dependent
mechanism, the prediction is that during the aggregation process the
level of C-signaling to which an aggregating cell is exposed increases
(Figure 11.4, loop 1). In the second amplification loop, C-signaling results
in increased csgA transcription; this in turn, results in p25 accumulation,
which is subsequently processed to p17, whichmay thenengage inC-signaling
with a neighboring cell (Figure 11.4, loop 2).
HOW DOES A SINGLE SIGNAL INDUCE THREE RESPONSES
SEPARATED IN TIME AND SPACE?
A hallmark in fruiting-body formation is the temporal and spatial
coordination of aggregation and sporulation: aggregation precedes sporu-
lation and cells do not initiate sporulation until the aggregation process is
complete and cells have accumulated at a high cell density inside the fruiting
bodies. With the C-signal inducing aggregation as well as sporulation, the
question becomes: how is the C-signal transduction pathway structured
to ensure the spatial and temporal coordination of aggregation and
sporulation?
285
C
O
N
T
A
C
T
-
D
E
P
E
N
D
E
N
T
S
I
G
N
A
L
I
N
G
I
N
M
.
X
A
N
T
H
U
S
Three independent lines of evidence converge to suggest that
the three C-signal-dependent responses are induced at different thresholds
of C-signaling. Kim and Kaiser added different amounts of exogenous
C-signal to starving csgA cells and observed that aggregation and early
C-signal-dependent gene expression were induced at an intermediate
level of C-signaling whereas sporulation and late C-signal-dependent
gene expression were induced at a higher level (35). By manipulating
expression of the csgA gene in vivo, Li et al. (50) made similar observations.
Finally, by systematically varying the accumulation of the C-signal in vivo,
Kruse et al. (42) observed that increased synthesis of the C-signal early
during development resulted in early aggregation, sporulation and C-signal-
dependent gene expression. Vice versa, decreased accumulation of the C-signal
resulted in delayed aggregation and sporulation. Importantly, it was
also observed that overexpression of the C-signal results in uncoupling of
aggregation and sporulation, with spores being formed outside fruiting
bodies. Thus, the regulated increase in C-signaling levels is a key parameter
in the temporal and spatial coordination of aggregation and sporulation.
The current view of how the C-signal ensures the temporal coordination
of aggregation and sporulation is as follows (79). The C-signal thresholds in
combination with the ordered increase in the level of C-signaling ensure that
the C-signal first induces aggregation and early gene expression and then late
gene expression and sporulation. According to this model, the C-signal is a
timer of developmental events. Moreover, the C-signal is a non-diffusible
morphogen as it induces distinct morphogenetic events at distinct
thresholds.
The spatial coordination of aggregation, sporulation and gene expression
is likely to be a direct consequence of the contact-dependent C-signal transmis-
sion mechanism (79). This signal transmission mechanism ensures that the
level of C-signaling to which a cell is exposed reflects cell density and thus the
position of a cell. The high level of C-signaling that induces late gene expres-
sion and sporulation is only obtained in cells that are closely packed inside the
nascent fruiting bodies. Consequently, only cells that have accumulated inside
the nascent fruiting bodies express late genes and undergo sporulation. The
observation that overexpression of csgA results in uncoupling of aggregation
and sporulation suggests that in wild-type cells the balance between the two
C-signal amplificationloops is carefully regulated to ensure that the sporulation
threshold is explicitly obtained by cells inside the nascent fruiting bodies.
Thus, the mechanism of the C-signal essentially allows cells to decode their
position with respect to that of other cells and in that way match gene expres-
sion, and ultimately sporulation, to their position.
L
.
S
G
A
A
R
D
-
A
N
D
E
R
S
E
N
286
This model also provides an explanation for the spatial control of
C-signal-dependent gene expression. C-signal-dependent genes are prefer-
entially expressed in aggregating and sporulating cells whereas they are not
expressed in the peripheral rods (30). Peripheral rods are present at a lowcell
density outside the nascent fruiting bodies. Consequently, they will only
infrequently engage in direct contacts with other cells with C-signal trans-
mission. Therefore, they experience a low level of C-signaling that allows
neither C-signal-dependent gene expression nor sporulation.
MULTIPLE SIGNAL TRANSDUCTION PATHWAYS CONTROL
MORPHOGENESIS
Two additional signal transduction pathways converge with the C-signal
transduction pathway to regulate aggregation, sporulation, and gene
expression after 6h (Figure 11.4). Each of the pathways is defined by
a specific histidine protein kinase. The SdeK histidine protein kinase is
synthesized in a RelA-dependent manner immediately after the initiation
of starvation; the SdeK pathway converges with the C-signal transduction
pathway to stimulate aggregation, sporulation, and gene expression (16, 66).
The pathway defined by the TodK histidine protein kinase inhibits aggrega-
tion, sporulation, and gene expression (67). Synthesis of TodKis inhibited by
starvation in a RelA-independent manner (67). Genetic evidence suggests
that the TodK-dependent inhibition of aggregation, sporulation and gene
expression is alleviated after 69h of starvation (67). Interestingly, SdeK and
TodK are both predicted to be located in the cytoplasm and they both contain
PAS domains in their sensor part. PAS domains have been implicated in
sensing changes in redox potential, oxygen, light, small ligands, and overall
energy level of a cell and also mediate proteinprotein interactions (86).
Therefore, it has been proposed that the kinase activities of TodK and SdeK
are controlled by intracellular signals, which are informative about the
metabolic state of individual cells and which are indicative of continued
starvation (67). According to this model, continued starvation of cells results
in the accumulation of these signals. This would subsequently trigger an
alteration in the activity of the TodK and SdeK kinases, resulting in the
alleviation of the inhibitory effect of TodK and stimulating the activating
effect of SdeK on the C-signal transduction pathway. In this model, the
C-signal transduction pathway is anintegrationpoint at whichthe intercellular
signals needed to coordinate the efforts of thousands of cells during fruiting-
body formation and intracellular signals reflecting the energy status of
individual cells are integrated. The advantage of this kind of integration
287
C
O
N
T
A
C
T
-
D
E
P
E
N
D
E
N
T
S
I
G
N
A
L
I
N
G
I
N
M
.
X
A
N
T
H
U
S
would be that productive C-signaling, and thus morphogenesis, is strictly
coordinated with the energy status of individual cells and only occurs when
the energy status of individual cells is appropriate. The SdeK and TodK
pathways may also help to make sure that, if nutrients become available
during fruiting body formation, then fruiting-body formation is arrested and
vegetative growth resumes.
THE C-SIGNAL-DEPENDENT MOTILITY RESPONSE
As fruiting-body formation depends on changes in cell behavior from
spreading to aggregation, a complete understanding of the morphogenetic
properties of the C-signal entails a description of how this signal molecule
alters cell behavior. Using fluorescent time-lapse video microscopy, Jelsbak
and Sgaard-Andersen (29) found that, during the aggregation stage of
fruiting body formation, the C-signal induces a motility response that
includes increases in the gliding speed and in the duration of gliding
intervals and decreases in the stop and reversal frequencies. The combined
effect of these changes is a switch in the motility behaviour of individual
cells from an oscillatory to a unidirectional type of behaviour (Figure 11.6).
In order for M. xanthus cells to display directional movement such
as that seen during aggregation, they need to be able to regulate their
frequency of direction changing. A priori, a stop as well as a reversal
could result in a change in the direction of movement. However, as
M. xanthus cells adhere to each other and to the substratum, they are
not buffeted by Brownian motion. Consequently, among the motility
parameters that characterize gliding in M. xanthus, only a reversal results
in a change in the direction of movement. Therefore, among the motility
parameters regulated by the C-signal, the key parameter is the reversal
frequency (29). The remaining motility parameters regulated by the C-signal
may contribute to aggregation by increasing the net distance travelled by a
cell per minute (29).
The C-signal dependent decrease in the reversal frequency fits with the
genetic and biochemical evidence demonstrating that the C-signal is an
input signal to the Frz chemosensory system (78) (Figures 11.5, 11.6).
Consistent with the observation that the C-signal induces a decrease in
the reversal frequency, methylation of FrzCD correlates with a low reversal
frequency (56).
The C-signal-dependent decrease in the reversal frequency suggests
that the C-signal inhibits polarity switching of the Tfp and nozzle-like
structures involved in S- and A-motility, respectively (77). The net
L
.
S
G
A
A
R
D
-
A
N
D
E
R
S
E
N
288
result of this inhibition is that the two motility engines are locked at
their respective poles, and consequently C-signaling cells are locked in a
unidirectional mode of behavior.
C-SIGNAL-INDUCED AGGREGATION: A MODEL
The ability of C-signaling cells to move a long distance is clearly
beneficial during the aggregation stage of fruiting-body formation.
However, in order for cells to aggregate they need to move with a sense
of direction. The identification of the motility parameters controlled by the
C-signal in combination with the contact-dependent C-signal transmission
mechanism has allowed the generation of a model for C-signal-induced
aggregation (Figure 11.7). The model is composed of three discrete events.
The basic event is an end-to-end contact between two cells with C-signal
transmission. Cells engaged in end-to-end contact with C-signal transmis-
sion gain the ability to travel over longer net distances for as long as they
0 10 20 30 40 50
0
0 10 20 30 40 50
10
20
30
40
50
wild type
wild type
csgA
csgA
0
10
20
30
40
50
wild type
wild type
csgA
csgA
wild type
csgA
y
p
o
s
i
t
i
o
n
(
m
)
y
p
o
s
i
t
i
o
n
(
m
)
3 h 15 h
x position (m)
x position (m)
Figure 11.6. Effect of the C-signal on the motility behaviour of M. xanthus cells. By means of
fluorescent time-lapse video-microscopy the x, y positions of wild-type cells, which express
GFP and which were co-developed with wild-type cells that do not express GFP, and of csgA
cells, which express GFP and which were co-developed with csgA cells that do not express
GFP, were recorded every 15 s for a period of 900s. The trajectories in the left panel show
the behaviour of two wild-type cells and of two csgA cells starved for 3 h (i.e. 3 h prior to the
initiation of C-signaling); the trajectories in the right panel show the behavior of three wild-
type cells and of three csgA cells starved for 15 h (i.e. 9h after the initiation of C-signaling).
Before the initiation of C-signaling, wild-type and csgA cells behave similarly. After the
initiation of C-signaling in wild-type cells, these cells display a unidirectional type of
behavior. The figure was adapted from (30).
289
C
O
N
T
A
C
T
-
D
E
P
E
N
D
E
N
T
S
I
G
N
A
L
I
N
G
I
N
M
.
X
A
N
T
H
U
S
End-to-end contact
Chain formation
Stream formation
Change in behaviour
induced by C-signal
transmission
Figure 11.7. Amodel for C-signal-induced aggregation.The model consists of three elements.
The basic element is an end-to-end contact between two cells with C-signal transmission
followed by a change in cell behavior. The second element is chain formation, which is
predicted to be a consequence of repeated end-to-end contacts with C-signal transmission
L
.
S
G
A
A
R
D
-
A
N
D
E
R
S
E
N
290
maintain the end-to-end contact. In a population of starving cells, this basic
event is predicted to result in the second discrete event, chain formation
(Figure 11.7). End-to-end contacts will occur frequently at the high cell
density required for normal development. This will sequentially result in
the recruitment of cells to pairs of cells that are C-signaling and, thus, in the
formation of chains of cells. Cells in a chain are moving at the same speed
and in the same direction, which is determined by the direction of move-
ment of the cell at the leading end of the chain. The information about
which direction to move in is relayed from the leading cell in a chain to the
following cell by the direct cellcell contacts. A reversal of direction of a cell
positioned inside a chain would break the chain. However, cell reversals in
chains are unlikely based on two observations. First, the cohesiveness of
the cells increases during development (72). Second, cells are exposed to
increasing levels of C-signaling during aggregation (see above).
The arrangement and movement of cells in chains is predicted to result
in the third discrete event, streamformation (Figure 11.7). Movement of cell
in a chain may create alignment of neighboring cells. This will result in the
formation of secondary chains that are associated with the initiating chain
by lateral interactions. This could lead to the formation of the streams of
cells that have been observed experimentally (Figure 11.2). Aggregation
Figure 11.7. (cont.)
between cells in a field. Consider cell A in scenario 1, which for simplicity is located at the
edge of an aggregate and moving towards the aggregate. This cell is moving at a high speed
in long gliding intervals and with low stop and reversal frequencies, as it is engaged in
C-signaling with cells inside the aggregate. The bold, single-headed arrow indicates this
type of behavior. Cells not engaged in C-signaling move at low speeds and with high stop
and reversal frequencies, as marked by the double-headed arrows. If cell B establishes an
end-to-end contact with cell A (scenario 2), then the two cells will transmit the C-signal to
each other. As a consequence, cell B is induced to move with a high speed and low stop and
reversal frequencies as long as it maintains the end-to-end contact. As cell A is moving
towards the aggregation center, cell B can only move with a high speed and low stop and
reversal frequencies if it also moves towards the aggregation center. This sequence of
events could be repeated sequentially, adding cell C, etc., thus creating a chain in which cells
are moving in the direction determined by the leading cell A (scenarios 34). The third
element in the model is stream formation. Cell movement in chains is predicted to create
alignment of neighboring cells. This will result in the formation of secondary chains of cells
(marked by dark gray colour). The cells in these secondary chains are associated with the
initiating chain by lateral cellcell contacts and with other cells in the secondary chain by
end-to-end contacts. Together, an initiating chain and its associated secondary chains will
make up a stream. The figure was adapted from (28).
291
C
O
N
T
A
C
T
-
D
E
P
E
N
D
E
N
T
S
I
G
N
A
L
I
N
G
I
N
M
.
X
A
N
T
H
U
S
centers could form by collisions of streams or by a single stream turning on
itself in a spiral movement. Once the leading cell of a stream is trapped
inside an aggregation center, the remaining cells in the stream will follow
into that center, as the direction of movement of a cell in a stream is deter-
mined by the leading cell. In this model C-signal transmission is a local event
between two cell ends, which occurs without reference to the global pattern,
and the result is a global organization of cells. Therefore, according to this
model C-signal-induced aggregation is a self-organizing process.
SIGNAL INTEGRATION DURING FRUITING-BODY
MORPHOGENESIS
Formation of the spore-filled fruiting bodies is clearly an effective survival
strategy in response to starvation. However, it is also costly, as only 10%20%
of cells differentiate into spores. The starvation-induced stringent response and
the intercellular A-signal systemconstitute two checkpoints, which ensure that
cells only embark on fruiting-body formation when starvation is severe and
gives the impression of being long-lasting. The C-signal comes into action
when the cells have passed the tests of the stringent response and the A-signal.
The primary functions of the C-signal are to induce and coordinate aggregation,
sporulation and full gene expression after 6h. Thus, the C-signaling system
cannot be regarded as a system whose primary function is to monitor starva-
tion. Rather the C-signal is the temporal and spatial coordinator of the different
morphogenetic events involved in fruiting-body formation. Regarded in this
way, the stringent response and the A- and C-signaling systems essentially act
to stimulate fruiting-body formation. Predictably, it is becoming evident that
fruiting-body formation is also subject to intensive negative control.
The negative regulators of fruiting-body formation include two cyto-
plasmic histidine protein kinases (EspA and TodK) (8, 67), a member of
the NtrC family of two-component transcriptional regulators (SpdR) (19),
the Che3 chemosensory system (38), two serine/threonine protein kinases
(Pkn1 and Pkn2) (59, 87), a protein that is homologous to flavin-containing
monooxygenases (BcsA) (11), and a protein of unknown biochemical function
that modulates the stringent response (SocE) (10). Although the presence of a
PAS domain in the sensor part of the TodK kinase hints that it could be
involved inmonitoring the metabolic state of cells (67), the specific parameters
monitored by these systems are still unknown. However, the multitude of
negative regulators of fruiting-body formation indicate that cells are continu-
ously monitoring the conditions to evaluate whether or not fruiting-body
formation should continue.
L
.
S
G
A
A
R
D
-
A
N
D
E
R
S
E
N
292
From a design point of view, a regulatory circuit that includes the
integration of positively as well as negatively acting pathways is highly
robust. It endows the system with the capacity to tailor the final decision,
i.e. to continue or not to continue fruiting-body formation, to the specific
conditions to which the cells are exposed.
CONCLUDING REMARKS
The C-signal is a remarkably versatile signal and we nowhave a general
framework for understanding how a single signal induces three responses
that are separated in time and space. However, many questions are still
unanswered. So far, the identification of components important for devel-
opment has to a large extent depended on the often painstaking identifica-
tion of relevant genes and proteins on a step-by-step basis using genetic
approaches. Recently, the M. xanthus genome sequence was finished
(W. C. Niermann, personal communication). This together with proteome
analysis (26) and the construction of an M. xanthus DNA microarray
(H. Kaplan and D. Kaiser, personal communication) promise to pave the
way for the systematic identification of additional important players in the
regulatory pathways that drive and coordinate fruiting-body formation.
ACKNOWLEDGEMENTS
I thank Jimmy Jakobsen for carefully reading the manuscript, and Martin
Overgaard, Anders Aa. Rasmussen, Sune Lobedanz, Eva Ellehauge and Lars
Jelsbak for many helpful discussions.
REFERENCES
1 Arnold, J. W. and L. J. Shimkets 1988. Cell surface properties correlated with
cohesion in Myxococcus xanthus. J. Bacteriol. 170: 57717.
2 Baker, M. E. 1994. Myxococcus xanthus C-factor, a morphogenetic paracrine
signal, is similar to Escherichia coli 3-oxoacyl-[acyl-carrier-protein] reductase and
human 17 beta-hydroxysteroid dehydrogenase. Biochem. J. 301: 31112.
3 Behmlander, R. M. and M. Dworkin 1994. Biochemical and structural analyses of
the extracellular matrix fibrils of Myxococcus xanthus. J. Bacteriol. 176: 6295303.
4 Behmlander, R. M. and M. Dworkin 1991. Extracellular fibrils and contact-
mediated cell interactions in Myxococcus xanthus. J. Bacteriol. 173: 781021.
5 Blackhart, B. D. and D. R. Zusman 1985. Frizzy genes of Myxococcus xanthus are
involved in control of frequency of reversal of gliding motility Proc. Natn. Acad.
Sci. USA 82: 87714.
293
C
O
N
T
A
C
T
-
D
E
P
E
N
D
E
N
T
S
I
G
N
A
L
I
N
G
I
N
M
.
X
A
N
T
H
U
S
6 Bowden, M. G. and H. B. Kaplan 1998. The Myxococcus xanthus lipopolysac-
charide O-antigen is required for social motility and multicellular development.
Molec. Microbiol. 30: 27584.
7 Boysen, A., E. Ellehauge, B. Julien and L. Sgaard-Andersen 2002. The DevT
protein stimulates synthesis of FruA, a signal transduction protein required
for fruiting body morphogenesis in Myxococcus xanthus. J. Bacteriol. 184:
15406.
8 Cho, K. and D. R. Zusman 1999. Sporulation timing in Myxococcus xanthus is
controlled by the espAB locus. Molec. Microbiol. 34: 71425.
9 Crawford, E. W. and L. J. Shimkets 2000. The Myxococcus xanthus socE and csgA
genes are regulated by the stringent response. Molec. Microbiol. 37: 78899.
10 Crawford, E. W. and L. J. Shimkets 2000. The stringent response in Myxococcus
xanthus is regulated by SocE and the CgsA C-signaling protein. Genes Dev.
14: 48392.
11 Cusick, J. K., E. Hager and R. E. Gill 2002. Characterization of bcsA mutations
that bypass two distinct signaling requirements for Myxococcus xanthus develop-
ment. J. Bacteriol. 184: 514150.
12 Downard, J., S. V. Ramaswamy and K. S. Kil 1993. Identification of esg, a genetic
locus involved in cell-cell signaling during Myxococcus xanthus development.
J. Bacteriol. 175: 776270.
13 Dworkin, M. 1996. Recent advances in the social and developmental biology of
the Myxobacteria. Microbiol. Rev. 60: 70102.
14 Dworkin, M. and S. M. Gibson 1964. A system for studying microbial
morphogenesis: rapid formation of microcysts in Myxococcus xanthus.
Science 146: 2434.
15 Ellehauge, E., M. Nrregaard-Madsen and L. Sgaard-Andersen 1998. The FruA
signal transduction protein provides a checkpoint for the temporal co-ordination
of intercellular signals in M. xanthus development. Molec. Microbiol. 30: 80717.
16 Garza, A. G., J. S. Pollack, B. Z. Harris et al. 1998. SdeK is required for early
fruiting body development in Myxococcus xanthus. J. Bacteriol. 180: 462837.
17 Gronewold, T. M. A. and D. Kaiser 2001. The act operon controls the level and
time of C-signal production for Myxococcus xanthus development. Molec.
Microbiol. 40: 74456.
18 Hagen, D. C., A. P. Bretscher and D. Kaiser 1978. Synergism between morpho-
genetic mutants of Myxococcus xanthus. Dev. Biol. 64: 28496.
19 Hager, E., H. Tse and R. E. Gill 2001. Identification and characterization of spdR
mutations that bypass the BsgA protease-dependent regulation of developmental
gene expression in Myxococcus xanthus. Molec. Microbiol. 39: 76580.
20 Harris, B. Z., D. Kaiser and M. Singer 1998. The guanosine nucleotide (p)ppGpp
initiates development and A-factor production in Myxococcus xanthus. Genes Dev.
12: 102235.
21 Hartzell, P. L. 1997. Complementation of sporulation and motility defects in a
prokaryote by a eukaryotic GTPase. Proc. Natn. Acad. Sci. USA 94: 98816.
L
.
S
G
A
A
R
D
-
A
N
D
E
R
S
E
N
294
22 Henrichsen, J. 1972. Bacterial surface translocation: a survey and a classification.
Bacteriol. Rev. 36: 478503.
23 Hodgkin, J. and D. Kaiser 1979. Genetics of gliding motility in Myxococcus
xanthus (Myxobacterales): genes controlling movement of single cells. Molec.
Gen. Genet. 171: 16776.
24 Hodgkin, J. and D. Kaiser 1979. Genetics of gliding motility in Myxococcus
xanthus (Myxobacteriales): two gene systems control movement. Molec. Gen.
Genet. 171: 17791.
25 Hoiczyk, E. and W. Baumeister 1998. The junctional pore complex, a prokaryotic
secretion organelle, is the molecular motor underlying gliding motility in
cyanobacteria. Curr. Biol. 8: 11618.
26 Horiuchi, T., M. Taoka, T. Isobe, T. Komano and S. Inouye 2002. Role of
fruA and csgA genes in gene expression during development of Myxococcus
xanthus. Analysis by two-dimensional gel electrophoresis. J. Biol. Chem. 277:
2675360.
27 Inouye, M., S. Inouye and D. R. Zusman 1979. Gene expression during develop-
ment of Myxococcus xanthus: pattern of protein synthesis. Dev. Biol. 68: 57991.
28 Jelsbak, L. and L. Sgaard-Andersen 1999. The cell surface-associated intercel-
lular C-signal induces behavioral changes in individual Myxococcus xanthus cells
during fruiting body morphogenesis. Proc. Natn. Acad. Sci. USA 96: 50316.
29 Jelsbak, L. and L. Sgaard-Andersen 2002. Pattern formation by a cell surface-
associated morphogen in Myxococcus xanthus. Proc. Natn. Acad. Sci. USA
99: 20327.
30 Julien, B., A. D. Kaiser and A. Garza 2000. Spatial control of cell differentiation in
Myxococcus xanthus. Proc. Natn. Acad. Sci. USA 97: 9098103.
31 Kaiser, D. 2003. Coupling cell movement to multicellular development in myxo-
bacteria. Nature Rev. Microbiol. 1: 4554.
32 Kaiser, D. 1979. Social gliding is correlated with the presence of pili in
Myxococcus xanthus. Proc. Natn. Acad. Sci. USA 76: 59526.
33 Kim, S. K. and D. Kaiser 1990. Cell alignment required in differentiation of
Myxococcus xanthus. Science 249: 9268.
34 Kim, S. K. and D. Kaiser 1990. Cell motility is required for the transmission of
C-factor, an intercellular signal that coordinates fruiting body morphogenesis of
Myxococcus xanthus. Genes Dev. 4: 896904.
35 Kim, S. K. and D. Kaiser 1991. C-factor has distinct aggregation and sporulation
thresholds during Myxococcus development. J. Bacteriol. 173: 17228.
36 Kim, S. K. and D. Kaiser 1990. C-factor: a cell-cell signaling protein required for
fruiting body morphogenesis of M. xanthus. Cell 61: 1926.
37 Kim, S. K. and D. Kaiser 1990. Purification and properties of Myxococcus xanthus
C-factor, an intercellular signaling protein. Proc. Natn. Acad. Sci. USA87: 36359.
38 Kirby, J. R. and D. R. Zusman 2003. Chemosensory regulation of developmental
gene expression in Myxococcus xanthus. Proc. Natn. Acad. Sci. USA 100:
200813.
295
C
O
N
T
A
C
T
-
D
E
P
E
N
D
E
N
T
S
I
G
N
A
L
I
N
G
I
N
M
.
X
A
N
T
H
U
S
39 Kroos, L., P. Hartzell, K. Stephens and D. Kaiser 1988. A link between cell
movement and gene expression argues that motility is required for cell-cell
signaling during fruiting body development. Genes Dev. 2: 167785.
40 Kroos, L. and D. Kaiser 1987. Expression of many developmentally regulated genes
in Myxococcus depends on a sequence of cell interactions. Genes Dev. 1: 84054.
41 Kroos, L., A. Kuspa and D. Kaiser 1986. A global analysis of developmentally
regulated genes in Myxococcus xanthus. Dev. Biol. 117: 25266.
42 Kruse, T., S. Lobedanz, N. M. S. Berthelsen and L. Sgaard-Andersen 2001.
C-signal: A cell surface-associated morphogen that induces and coordinates
multicellular fruiting body morphogenesis and sporulation in M. xanthus.
Molec. Microbiol. 40: 15668.
43 Kuner, J. M. and D. Kaiser 1982. Fruiting body morphogenesis in submerged
cultures of Myxococcus xanthus. J. Bacteriol. 151: 45861.
44 Kuspa, A., L. Kroos and D. Kaiser 1986. Intercellular signaling is required for
developmental gene expression in Myxococcus xanthus. Dev. Biol. 117: 26776.
45 Kuspa, A., L. Plamann and D. Kaiser 1992. Identification of heat-stable A-factor
from Myxococcus xanthus. J. Bacteriol. 174: 331926.
46 Kuspa, A., L. Plamann and D. Kaiser 1992. A-signaling and the cell density
requirement for Myxococcus xanthus development. J. Bacteriol. 174: 73609.
47 Lee, B.-U., K. Lee, J. Mendez and L. J. Shimkets 1995. A tactile sensory system of
Myxococcus xanthus involves an extracellular NAD(P)
G
A
A
R
D
-
A
N
D
E
R
S
E
N
296
56 McBride, M. J., T. Kohler and D. R. Zusman 1992. Methylation of FrzCD, a
methyl-accepting taxis protein of Myxococcus xanthus, is correlated with factors
affecting cell behaviour. J. Bacteriol. 174: 424657.
57 McBride, M. J., R. A. Weinberg and D. R. Zusman 1989. Frizzy aggregation
genes of the gliding bacterium Myxococcus xanthus show sequence similarities
to the chemotaxis genes of enteric bacteria. Proc. Natn. Acad. Sci. USA
86: 4248.
58 Merz, A. J., M. So and M. P. Sheetz 2000. Pilus retraction powers bacterial
twitching motility. Nature 407: 98102.
59 Munoz, D. J., S. Inouye and M. Inouye 1991. A gene encoding a protein serine/
threonine kinase is required for normal development of M. xanthus, a gram-
negative bacterium. Cell 67: 9951006.
60 OConnor, K. A. and D. R. Zusman 1991. Development in Myxococcus xanthus
involves differentiation into two cell types, peripheral rods and spores. J. Bacteriol.
173: 331833.
61 OConnor, K. A. and D. R. Zusman 1989. Patterns of cellular interactions during
fruiting-body formation in Myxococcus xanthus. J. Bacteriol. 171: 601324.
62 Ogawa, M., S. Fujitani, X. Mao, S. Inouye and T. Komano 1996. FruA, a putative
transcription factor essential for the development of Myxococcus xanthus. Molec.
Microbiol. 22: 75767.
63 Oppermann, U., C. Filling, M. Hult et al. 2003. Short-chain dehydrogenases/
reductases (SDR): the 2002 update. Chem. Biol. Interact. 1434: 24753.
64 Parkinson, J. S. 1993. Signal transduction schemes of bacteria. Cell 73: 85771.
65 Plamann, L., A. Kuspa and D. Kaiser 1992. Proteins that rescue A-signal-defective
mutants of Myxococcus xanthus. J. Bacteriol. 174: 331118.
66 Pollack, J. S. and M. Singer 2001. SdeK, a histidine kinase required for
Myxococcus xanthus development. J. Bacteriol. 183: 358996.
67 Rasmussen, A. A. and L. Sgaard-Andersen 2003. TodK, a putative histidine
protein kinase, regulates timing of fruiting body morphogenesis in Myxococcus
xanthus. J. Bacteriol. 185: 545264.
68 Reichenbach, H. 1999. The ecology of the myxobacteria. Environ. Microbiol. 1: 1521.
69 Rosenbluh, A., R. Nir, E. Sahar and E. Rosenberg 1989. Cell-density-dependent lysis
and sporulation of Myxococcus xanthus in agarose beads. J. Bacteriol. 171: 49239.
70 Sager, B. and D. Kaiser 1994. Intercellular C-signaling and the traveling waves of
Myxococcus. Genes Dev. 8: 2793804.
71 Shimkets, L. J. 1999. Intercellular signaling during fruiting-body development of
Myxococcus xanthus. Au. Rev. Microbiol. 53: 52549.
72 Shimkets, L. J. 1986. Role of cell cohesion in Myxococcus xanthus fruiting body
formation. J. Bacteriol. 166: 84288.
73 Shimkets, L. J., R. E. Gill and D. Kaiser 1983. Developmental cell interactions in
Myxococcus xanthus and the spoC locus. Proc. Natn. Acad. Sci. USA 80: 140610.
74 Shimkets, L. J. and H. Rafiee 1990. CsgA, an extracellular protein essential for
Myxococcus xanthus development. J. Bacteriol. 172: 5299306.
297
C
O
N
T
A
C
T
-
D
E
P
E
N
D
E
N
T
S
I
G
N
A
L
I
N
G
I
N
M
.
X
A
N
T
H
U
S
75 Singer, M. and D. Kaiser 1995. Ectopic production of guanosine penta- and
tetraphosphate can initiate early developmental gene expression in Myxococcus
xanthus. Genes Dev. 9: 163344.
76 Skerker, J. M. and H. C. Berg 2001. Direct observation of extension and retraction
of type IV pili. Proc. Natn. Acad. Sci. USA 98: 69014.
77 Sgaard-Andersen, L. 2004. Cell polarity, intercellular signaling and mor-
phogenetic cell movements in Myxococcus xanthus. Curr. Opin. Microbiol.
7: 58793.
78 Sgaard-Andersen, L. and D. Kaiser 1996. C factor, a cell-surface-associated
intercellular signaling protein, stimulates the cytoplasmic Frz signal trans-
duction system in Myxococcus xanthus. Proc. Natn. Acad. Sci. USA 93:
26759.
79 Sgaard-Andersen, L., M. Overgaard, S. Lobedanz et al. 2003. Coupling gene
expression and multicellular morphogenesis during fruiting body formation in
Myxococcus xanthus. Molec. Microbiol. 48: 18.
80 Sgaard-Andersen, L., F. J. Slack, H. Kimsey and D. Kaiser 1996. Intercellular
C-signaling in Myxococcus xanthus involves a branched signal transduction
pathway. Genes Dev. 10: 74054.
81 Spormann, A. M. 1999. Gliding motility in bacteria: insights from studies of
Myxococcus xanthus. Microbiol. Molec. Biol. Rev. 63: 62141.
82 Spormann, A. M. and A. D. Kaiser 1995. Gliding movements in Myxococcus
xanthus. J. Bacteriol. 177: 584652.
83 Spormann, A. M. and D. Kaiser 1999. Gliding mutants of Myxococcus xanthus
with high reversal frequencies and small displacements. J. Bacteriol. 181:
2593601.
84 Sun, H. and W. Shi 2001. Analyses of mrp genes during Myxococcus xanthus
development. J. Bacteriol. 183: 67339.
85 Sun, H., D. R. Zusman and W. Shi 2000. Type IV pilus of Myxococcus xanthus is
a motility apparatus controlled by the frz chemosensory system. Curr. Biol. 10:
11436.
86 Taylor, B. L. and I. B. Zhulin 1999. PAS domains: internal sensors of oxygen,
redox potential, and light. Microbiol. Molec. Biol. Rev. 63: 479506.
87 Udo, H., M. Inouye and S. Inouye 1996. Effects of overexpression of Pkn2, a
transmembrane protein serine/threonine kinase, on development of Myxococcus
xanthus. J. Bacteriol. 178: 66479.
88 Ward, M. J. and D. R. Zusman 1999. Motility in Myxococcus xanthus and its role
in developmental aggregation. Curr. Opin. Microbiol. 2: 6249.
89 White, D. J. and P. L. Hartzell 2000. AglU, a protein required for gliding motility
and spore maturation of Myxococcus xanthus, is related to WD-repeat proteins.
Molec. Microbiol. 36: 66278.
90 Winans, S. C. and B. L. Bassler 2002. Mob psychology. J. Bacteriol. 184: 87383.
91 Wolgemuth, C., E. Hoiczyk, D. Kaiser and G. Oster 2002. How myxobacteria
glide. Curr. Biol. 12: 36977.
L
.
S
G
A
A
R
D
-
A
N
D
E
R
S
E
N
298
92 Wu, S. S. and D. Kaiser 1995. Genetic and functional evidence that Type IV pili
are required for social gliding motility in Myxococcus xanthus. Molec. Microbiol. 18:
54758.
93 Youderian, P., N. Burke, D. White and P. L. Hartzell 2003. Identification of genes
required for adventurous gliding motility in Myxococcus xanthus with the trans-
posable element mariner. Molec. Microbiol. 49: 55570.
299
C
O
N
T
A
C
T
-
D
E
P
E
N
D
E
N
T
S
I
G
N
A
L
I
N
G
I
N
M
.
X
A
N
T
H
U
S
Index
Note: page numbers in italics refer to figures and tables.
A to E signals 276
ABC transporters 238
Lsr 154
QsrAB 248
Streptococcus gordonii 252
accessory gene regulator see Agr
ActA response regulator 2845
ActB response regulator 2845
Actinobacillus actinomycetemcomitans
AI-2 183
iron acquisition regulation 184
Lsr transport system 189
receptor 18890
response 189
sensor kinase 1901
signal structure 190
signal transduction 1878
signal transduction cascade 188
Hfq protein 187
Lux S 182
luxS 131
inactivation 1367
Porphyromonas gingivalis recognition of
signal 192 3
RbsB 1889
response to AI-2 188
RTX leukotoxin 186
Actinomyces, lactate production in dental
biofilm 177
N-acylhomoserine lactones (AHLs) 104
absence from oral bacteria 181
bacterial crosstalk 135
cognate signals 74
LuxR interaction 11718
QS 135
biofilm growth 180
system dependency 67
virulence 180
receptors 43, 523
recycling 49
signals 72, 768
reception blockade 736
sulfonamide derivatives 75
synthetic analogs 736
categories 745 see also AHL synthase
S-adenosylhomocysteine (SAH) 1213, 1268
S-adenosylmethionine (SAM) 44, 121,
1523, 155
adhesins, surface-associated 2067
Aeromonas hydrophila, biofilmformation 70
Affymetrix Pseudomonas aeruginosa
GeneChip
1
824
aggregation 2857
aggregation centers 271, 2912
Agr
correspondence with disease types 210
evolution in Staphylococcus aureus 2224
group II AIP 224
model 201
polymorphism 21011
QS system 199203
specificity groups 20911, 2234
staphylococcal biofilms 21617, 21819
staphylococcal virulence factors 2067
Staphylococcus epidermidis 207
Staphylococcus saprophyticus 209
variants 2204
generation in Staphylococcus 223
negative 222, 224
virulence factor activation 207
virulence gene regulation 199
in vivo 21416
301
Agr (cont.)
virulence regulation 21112, 213
agr gene
expression 213, 219 20
locus 200
mutations 220, 221, 2224
AgrA 201
agrBCD nucleotides 20910
AgrC 201
agrD 20910
agrobacteria, pathogenic 40
Agrobacterium tumefaciens 3940
QS 42
reporter 76
Ti plasmids 403
conjugation 41 3
Agr-regulated genes 2037
AHL synthase 43
AI-1 11921
knockout of luxS effects on synthesis 155
Vibrio harveyi 1345
AI-2 1523
Actinobacillus actinomycetemcomitans 183
iron acquisition regulation 184
Lsr transport system 189
sensor kinase 1901
signal structure 190
signal transduction 1878
signal transduction cascade 188
bacteria with ambiguous roles 132 4
Campylobacter jejuni 133
Clostridium perfringens 131
crosstalk 1924
dental plaque 1357
Escherichia coli 130, 153
Helicobacter pylori 1323
induction by LuxS 119
LuxS role 126 8
metabolic pathway of production 1213
microbial intestinal flora production 155
mixed-species signaling in cystic
fibrosis 1378
Photorhabdus luminescens 133
Porphyromonas gingivalis 183
signal transduction 1924
virulence 186
production 127, 139
Pseudomonas aeruginosa 138
QS
interspecies signal 1345
oral bacteria 1825
signal 12832 , 134 5
Vibrio 188
QS-mediated virulence repression 107
receptor in A. actinomycetemcomitans
18890
reporter of metabolic status 13841
Salmonella 153
Serratia marcescens 1301
signal specificity 192 4
signal transduction
in Actinobacillus
actinomycetemcomitans 1878
cascade 188
in Porphyromonas gingivalis 1878
signaling 1535
pathway 1289
Streptococcus gordonii secretion 187
structural forms 190
structures 123 6, 125 , 153
Vibrio harveyi 134 5
AI-3 130
bacterialhost communication 157, 158
knockout of luxS effects on synthesis
155
microbial intestinal flora production 155
QS signaling cascade 165
QseBC quorum sensing through 163
receptor recognition 164
signaling 1535
AI-3-dependent quorum sensing signaling
cascade 164
AiiA enzyme 74
AinS in Vibrio fischeri 129
AIP signal 2001
Allium sativum (garlic) 81
A-motility 273 6, 2889
anthranilate 28, 34
antibiotics
QS inhibitor combinations 8990
QS inhibitor synergy 90
resistance 65, 8990
antigen-presenting cells 204 5
antimicrobials
myxobacterial secretion 270
P. aeruginosa tolerance 84
Arabidopsis thaliana 910
arc operon 45
ArcB 131
arcB inactivation 191
ArcB sensor kinase 1901
ArlRS 213
asg mutants 276
A-signal 276, 277
attaching and effacing (AE) lesions 152,
157, 158
attKLM operon 489
attM gene 48
autoinducers 23, 139
antibodies 1415
immunomodulatory effects 1112
synthesis 8
Vibrio cholerae 112
Vibrio fischeri 117 see also AI-2
I
N
D
E
X
302
autoinducing peptide see AIP signal
autoinduction 43
Bacillus subtilis oligopeptide signaling 118
bacterial colonization inhibition 723
bacterialhost communication,
AI-3 157, 158
bacteriocins 238
BcsA 292
bfrAB genes 177
biofilms 65 6
antimicrobial tolerance 845
architecture 69
bacterial gene expression 70
CSP signaling 257
detachment 218
development 176
QSI effects 845
EPEC 167
eukaryotic defense strategy 713
filamentous 70
formation limitation 90
genetic competence 2558
growth
conditions 6970
mode 856
hydrogen peroxide treatment 85
infections 656, 89
maturation 176
microcolony formation 167
mixed 178
models 846
Myxococcus xanthus 270
natural blockers 713
QS
in formation 70
formation inhibition 107 11
QS-controlled genes 71
QSI drug effects 846
sloughing 84 5
staphylococcal 21617
Agr 21819
agr gene mutants 220
antibiotic exposure 220
behavior 21617
detachment 21820
development 21617, 219 20
Staphylococcus aureus 219
Staphylococcus epidermidis 216
maturation 217 18
Streptococcus 1312
Vibrio cholerae 1078 , 110
formation regulation 108
host infection 109 see also dental
biofilm; Pseudomonas aeruginosa,
biofilms
biofouling, eukaryotic defense strategy 713
bioluminescence expression 76
Blp quorum-sensing system 2478
BlpABCSRH regulon 2478
BlpC 248
BlpR 248
cross-communication 248
BlpS 248
Borrelia burgdorferi, luxS system 1334
bsg mutants 276
B-signal 276
bundle-forming pili (BFP) 166 7
Burkholderia cepacia
biofilm formation 70
cystic fibrosis 137
N-butyryl homoserine lactone see C
4
-HSL
butyryl lactone 119
C
4
-HSL 23, 5, 89, 234
cystic fibrosis sputa 13
mammalian cell transcription regulator
activation 12
pqsABCDE induction inhibition 30
C
4
-HSL synthase 25
C-30
drug specificity 82
Pseudomonas aeruginosa QS
suppression 88
QS inhibitor pulmonary infection
treatment model 889
QS system inhibition 14, 845
C-56 845
Caenorhabditis elegans 910
CAI-1
QS-mediated virulence repression 107
signal pathways 112
signaling 108
Campylobacter jejuni 133
capsular polysaccharide 2056
cell density, quorum sensing 140
cell lysis, competence-induced 2445
cell-to-cell adherence, interbacterial in
dental biofilm 179
cell-to-cell signaling 117
bacterial host 156, 1579
co-ordinated behavior 141
dental biofilm 17594
EHEC 1557
LuxS-dependent 1934
Pseudomonas aeruginosa 24
Vibrio fischeri 1401 see also quorum
sensing
Che3 chemosensory system 292
CheY 191
cholera 102
pathogenesis 102
cholera toxin (CT) 102, 109
Chromobacterium violaceum 76
303
I
N
D
E
X
ciaR gene mutations 2467
CiaRH 2467
Clostridium perfringens, AI-2 131
ClpP 213
ClpX 213
coagulase 2067
pro duction by Stap hylococcus aureus 20 6 7
colony expansion 67
com regulon, Streptococcus pneumoniae
2545
ComA 238, 251
comAB gene 255
comAB locus 238
comAB operon 251
ComAB transporter 251
ComB 238, 251
com-box 255
comC gene 2378, 255
ComCDE competence regulon
Streptococcus pneumoniae 23642
signal 2467
comCDE operon 249
comCDE region 2545
ComD 2401
CSP interaction 255
receptor 2401
Streptococcus pneumoniae 241
comD genes 240
comDE gene 255
ComDE signal transduction system 244
ComE
binding site 2412
cross-communication 248
response regulator 241 2
ComE phosphorylation (ComEP) 2412 ,
251 2, 255
ComE-specific phosphatase (CEP) 2456
ComI 245
competence factors (CF) 2501
competence-stimulating peptide (CSP) 235 ,
2368, 2435
cell lysis 2445
ComD interaction 255
QS regulation 239
receptor 2401, 257
signaling in biofilm formation 257
Streptococcus intermedius biofilm
growth 2578
competence-stimulating peptide (CSP)
precursor 2368, 2545
amino acid sequences 237
competence-induced cell lysis 2445
competitive inhibitors 74
ComX 2424, 245
comX gene 255
comY operon 252
conjugation factor (CF) 41 3
CqsAS system 1046
crown gall tumors 40, 41
csg mutants 276
csgA gene 2845
aggregation 286
extracellular complementation 281
mutants 277
sporulation 286
transcription 2845
CsgA protein 278
CshA 252
C-signal molecule in Myxococcus xanthus
269, 276, 277
aggregation induction 2857 , 28992,
291
cell motility relationship 2801
contact-dependent mechanisms 2801
end-to-end contacts 281
molecular nature 2789
motility
behavior 289
gliding engines 284
response 2889
responses 277
sporulation induction 2857
synthesis 27980
transduction pathway 2815, 283
morphogenesis control 2878
transmission 269 70, 2801, 283
mechanism 286
CTX genetic element 102
CVO26 76
cystic fibrosis 23
AI-2 in mixed-species signaling 1378
antibiotic-resistant bacteria 8990
autoinducers in sputa 13
chronic endobronchiolitis 89
Pseudomonas aeruginosa
infections 68
mucoid variants 89
RNAIII 210, 215
sputum samples 13, 334
CytR protein 108
Delisea pulchra (red macroalga) 73
furanones 713, 756
delta-toxin, see d -toxin
dental biofilm
bacterial community 1756
bacterial interactions 1779
cell-to-cell signaling 17594
contact-dependent bacterial signaling
17680
dental plaque 135
interbacterial cell-to-cell-adherence 179
iron acquisition regulation 1845
lactate production by bacteria 177
I
N
D
E
X
304
LuxS 1823
LuxS-dependent virulence regulation
1858
mixed 178
oral bacteria growth 181
populational shifts 176
QS-dependent communication 1801
quorum sensing 17594
dental caries 1756
Streptococcus mutans 254
dental plaque 1357
cell-to-cell signaling 1357
Streptococcus 136
DevT protein 282
Dictyostelium discoideum 910
4,5-dihydroxy 2,3-pentanedione (DPD)
1213, 1523
derivatives 1256
DNA
bacterial acquisition 234
transforming factor 234
DNA microarray transcriptomics 812
Drosophila melanogaster 910
dsg mutants 276
D-signal 276
EAF plasmid 166
elastase 89, 1112
endobronchiolitis, chronic 89
endocarditis 216
enterobactin-like siderophores 185
Enterococcus faecalis, oligopeptide
signaling 118
enterotoxins 2045
EnvZ 191
epinephrine 1589
receptor recognition 164
Escherichia coli
AI-2 130, 153, 183
activity 1201
communication 188
as QS signal 12930
diffusely adherent (DAEC) 151
enteroaggregative (EAEC) 151
enterohemorrhagic (EHEC) 1512
AI-3 QS signaling cascade 165
attaching and effacing lesions 152
cell-to-cell signaling 1557, 160
flagellar expression 163
flagellar regulon expression
activation 164
LEE genes 157, 158
LuxS-dependent autoinducer 1535
luxS mutant 156, 1579
luxS QS system 1523
motility expression 163
QS regulation 1667
QS signaling cascade 15965
virulence 157, 158, 160
enteroinvasive (EIEC) 151
enteropathogenic (EPEC) 151
adherence factor plasmid 166
biofilm development 167
pathogenesis 166
QS regulation 1667
quorum sensing 1667
enterotoxigenic (ETEC) 151
pSB401-containing 76
QS 139
SdiA 1645
virulence and LuxS-dependent regulation
15168
esg mutants 276
E-signal 276
EspA histidine protein kinase 292
exoenzymes 204
exopolymeric substances (EPS) 69
exotoxins
expression 21112
staphylococci 204
extracellular complementation 276
csgA gene 281
fatty-acid modifying enzyme (FAME) 205
fibrinogen 21516
fibronectin 206
fibronectin-binding proteins 2067, 221
fimA transcription 17980
flagellar regulon 1623, 166
expression 163, 1667
transcription 1623
FlgM 1623
FlhDC flagellar regulon 1623
flhDC gene
transcription 157, 158
transcriptional start sites 163
fnbA 2067, 221
fnbB 2067
FruA 282, 284
fruiting-body morphogenesis
intracellular signaling 2767
Myxococcus xanthus 26993, 272
aggregation and sporulation
coordination 2857
negative regulators 292
signal integration 2923
spore-filled 2712
Frz proteins 2824, 288
fungal extracts 801
furanones 845
bacterial colonization inhibition 723
Delisea pulchra 713
drug specificity 82
efficacy 867
305
I
N
D
E
X
furanones (cont.)
food content 80
halogenated 713
Pseudomonas aeruginosa QS
suppression 88
QS inhibitor pulmonary infection
treatment model 889
Serratia liquefaciens inhibition 723
furanosyl-borate-diester 153
Fusobacterium nucleatum
AI-2 quorum sensing 182
Lux S 182
gacA gene 89
GadX 1667
Galleria melonella 910
garlic 81, 845
gene transfer, horizontal 234, 250
GeneChips 812
genetic competence
biofilms 2558
cell-density-dependent development 2356
development 2434
genetic regulation 2545
genetics 2501
induction 2356
oral bacteria 24859
phases 235
regulation
in Streptococcus gordonii 251
in Streptococcus pneumoniae 23648,
251
shut-off 2456
streptococci 2345
Streptococcus gordonii 253
Streptococcus mutans 256
genetic exchange 234
GISA 2212
GlyGly leader peptides 238
gppX 192
green fluorescent protein 3, 768, 77, 86
growth, sessile mode 656
Haemophilus influenzae, cystic fibrosis 137
HapR 112
hapR mutations 1067, 108, 109
hcnABC operon 33
Helicobacter pylori 1323
hemolysins 204
2-heptyl-3-hydroxy-4-quinolone 234
2-heptyl-4-hydroxyquinolone oxide 32
Hfq protein 187
histidine kinase (HK) 236, 248, 2545
histidine protein kinase 2878
hk11 gene 258
hla gene 2013
transcription 202, 21112
hla RNA leader 202
homocysteine 1213
homoserine lactone ring 75
HPK10 subfamily 2401
Hpp permease 252
hydrogen peroxide 85
b-hydroxybutyryl homoserine lactone 119
immunocompromised patients 1
infections, biofilm 656, 89
infective endocarditis 250
interleukin-8 (IL-8) 1112
iron acquisition regulation 1845
lactate production by dental biofilm
bacteria 177
lactonases 1415, 74
las boxes 23, 6
las system 19, 23, 31, 68
Pseudomonas aeruginosa 1, 4
PQS relationship 245
lasA gene transcripts 1213
LasB elastase 234, 33
lasB gene 234
transcripts 1213
lasI mutant 1011, 69
lasIrhll mutant 1012
LasR 2, 3, 234, 77
lasR gene
mutant 1011, 234
transcripts 1213
LasRLasI system 68
lecA expression 32
LEE (locus of enterocyte effacement) 152
EHEC virulence 157, 158
EPEC 1667
expression regulation 164
LEE1 152
leukotoxins 186
ligand binding 4950
lipB transporter 67
localized adherence (LA) 166
Lsr transporter system 153, 154, 189
LsrB structure 124
luxCDABE 101
LuxI protein 11718
Vibrio fischeri 129
LuxI-family proteins 104
LuxIR pathway 129
LuxLM proteins 11718
LuxO 1056, 112, 192
luxO mutations 1067
LuxP 124, 153
LuxQ 191, 192
LuxR 3, 55, 77
activation antagonism 75
AHL interaction 11718
I
N
D
E
X
306
OHHL displacement 73
overexpression 768
receptor 745
LuxR-type proteins 104
LuxS 11742
AI-2 production 119
cell-to-cell signaling in bacteria 1525
characterization 123
Escherichia coli virulence regulation
15168
identification 11921
oral bacteria 1823
Porphyromonas gingivalis 183
phylogenetic tree 122
role 1268
signal molecule role 138
Vibrio fischeri 129
Vibrio harveyi 187
Vibrio vulnificus 129
virulence regulation 1858
luxS gene 1201, 182
Actinobacillus actinomycetemcomitans 131
expression by S. gordonii 187
Helicobacter pylori 1323
inactivation 1312, 1367, 191
knockout 155
location 128
mutant 129, 1301, 157, 158, 1667
A-12 signaling 1535
Porphyromonas gingivalis 1845, 187
Shigella flexneri 131
Streptococcus pneumoniae 140
operon 128
Streptococcus mutans 13940
luxS system, Borrelia burgdorferi 1334
LuxS/AI-2, Escherichia coli 12930
luxS/AI-2, Neisseria meningitidis 134
LuxS-dependent signaling 1845
cell-to-cell communication 1934
Porphyromonas gingivalis 1867
LuxSPQ system 1046
LuxU 191
LytA (autolytic amidase) 244
LytC (autolytic lysozyme) 244
mannopine 48
medical devices, implanted 216
methionine 127
recycling 1334
(2R,4S)-2-methyl-2,3,3,4-
tetrahydroxytetrahydrofuran
(R-THMF) 124
metK 134
microbial activity 656
modulins, Staphylococcus epidermidis 208
mot operon 157, 158
MrcpC protein 282
multicellularity, survival strategy 2703
mvaT gene 89
myxobacteria
antimicrobial secretion 270
social lifestyle 270
spore-filled fruiting bodies 2723
starvation 2723
Myxococcus xanthus
aggregation 288
signal 26970
aggregation centers 271, 2912
A-signal 119
biofilms 270
colonies 270
C-signal 119, 269, 277, 2789
aggregation induction 2857,
28992, 291
contact-dependent mechanism 2801
end-to-end contacts between cells
281, 28991
molecular nature 2789
motility behavior 289
motility response 2889
sporulation induction 2857
synthesis 27980
transmission 26970, 2801, 283
transmission mechanism 286
C-signal transduction pathway 2815, 283
branches 2824
morphogenesis control 2878
signal amplification loops 285
fruiting-body morphogenesis 26993, 272
aggregation and sporulation
coordination 2857
negative regulators 292
signal integration 2923
gliding motility 26970, 2736, 275
adventurous 2736
social 2736
intracellular signaling 2767
life cycles 271
motility 26970, 2736, 275, 2889
C-signal 289
C-signal dependent response 2889
C-signal transmission 2801
directional 288
gliding engines 284
stream formation 2912
nozzle-like structures 2756, 2889
peripheral rods 287
reorientation 26970
slime trail 2756
spore development 2712
spore-filled fruiting bodies 2712, 292
starvation 2712, 292
stringent response 2712, 292
Tfp 2735
307
I
N
D
E
X
natural blockers, biofilm 713
Neisseria meningitidis, luxS/AI-2 134
NFkB induction 12
norepinephrine 1589
receptor recognition 164
siderophore activity 185
NtrC transcriptional regulators 292
3-O-C
12
-HSL 2 3, 5, 89
cystic fibrosis sputa 13
immunomodulatory effects 11 12
mammalian cell transcription regulator
activation 12
prostaglandin E
2
link 12
OccR 45
OdDHL 68, 74
OHHL 42
analogs 745
bioluminescence studies 768
displacement from LuxR 73
furanone efficacy studies 867
OOHL 42, 434
degradation 56
structure 2, 51
TraR
binding 50
maturation 4950
polar interactions 523
protection against proteolysis 567
opines 41, 43, 44 5
oral bacteria
genetic competence 248 59
specializations 248
Streptococcus mutans 2589
oropharyngeal flora 137
osteomyelitis 216
3-oxo-C6-homoserine lactone see OHHL
3-oxo-C8-homoserine lactone see OOHL
3-oxo-C
12
-HSL 234 , 30
N-(3-oxododecanoyl) homoserine lactone
see 3O-C
12
-HSL
N-[3-oxo-dodecanoyl]-L-homoserine lactone
see OdDHL
p17 protein 27880, 2845
p25 protein 27880, 2845
mutant 280
pathogenicity of Pseudomonas aeruginosa 8
pATK84b 45
patulin 84 5
pea exudates 79
Penicillium, QSI activity 81
periodontal disease 1756
Pfs 1213
phenol-soluble modulins 208
phnAB genes 29, 30
expression 32
Photorhabdus luminescens 133
pili, type IV 2735
Pisum sativum (pea) exudates 79
Pkn1 292
Pkn2 292
plant extracts 80 1
plant-associated bacteria 3940
polymorphonuclear leucocytes (PMNs),
biofilm mode of growth 856
polyphosphate kinase (PPK) 89
polysaccharide intercellular adhesion
(PIA) 21617
Porphyromonas gingivalis 136
Actinobacillus actinomycetemcomitans
signal recognition 1923
adherence to viridans streptococci 1867
AI-2 183
iron acquisition regulation 184
quorum sensing 182
signal transduction 1878 , 1924
virulence modulation 186
hemin acquisition 184 5
LuxS 182, 183
luxS
inactivation 1367
mutant 1845, 187
LuxS-dependent signaling 1867
mixed biofilms 178
proteases 192
Streptococcus cristatus adherence
17980
Streptococcus gordonii adherence
179, 1867
Treponema denticola association 177
virulence 136 7, 1845
PQS see Pseudomonas quinolone
signal (PQS)
pqsABCD 2930
pqsABCDE operon 31
pqsH gene 258
pqsR mutant 33
PqsR regulation 30
Prevotella intermedia, AI-2 quorum
sensing 182
prostaglandin E
2
12
Protein A 2067, 213
proteins, intrinsically unstructured 4950
Pseudomonas aeruginosa 12
AI-2 138
biofilms 8, 33
QS role in development 6971
cell-to-cell signals 24
furanone effects 824
mucoid variants 89
PAO1 genome sequencing 56
pathogenicity 8, 910, 1378
pyoveridine 184, 185
I
N
D
E
X
308
QS 68
activity in vivo 1213
behavior regulation 14
biofilm development 6971
circuitry 245
genes 4, 83
influence on virulence 912, 11
las 1, 4
rhl 1, 4
suppression 88
as therapeutic target 1315
QS factors 19
QS inhibitors 824
in garlic 81
target genes 4, 83
QS regulon 5
activation 89
QS-regulated genes 7
expression 7, 8, 78
4-quinolones 35
tobramycin treatment 84
virulence 912
PQS 334
virulence factors 1, 8, 234, 68
control by PQS 33
QS inhibitors 824
virulence genes 910, 11
Pseudomonas putida, biofilm formation 70
Pseudomonas quinolone signal (PQS)
35, 2335
cystic fibrosis sputa 13, 334
discovery 234
drug target potential 34
genes for production 289
Pseudomonas aeruginosa
QS circuitry relationship 245
virulence 334
production
regulation 31
timing 312
synthesis 27
genetics 259
regulation 2930
pTiBo542 45
pulmonary doseresponse models 5,
868, 87
pulmonary infection, QS inhibitor
treatment model 889
pyocyanin 28
pyoveridine 184, 185
qscR system 3
QseA 15961
qseA mutation 1667
QseB 1612
QseBC 162
flagellar regulon transcription 1623
quorum sensing 163
through AI-3 163
QseC 1612
qseD 164
qseE 164
qseF 164
QsrAB 248
4-quinolones 35
quorum sensing (QS)
Agr in Staphylococcus aureus 199200
Agrobacterium tumefaciens 42
AHL-dependent 86, 135, 180
AI-2 as signal 12832
interspecies 1345
oral bacteria 1825
Vibrio 188
AI-3-dependent signaling cascade 164
ArlRS 213
biofilms 70
formation inhibition 10711
gene control 71
cell density 140
cell-density-dependent 257
circuitry 245
colony expansion 67
CSP-dependent 239
deficiency 845
definition 138, 140
dental biofilm 17594
bacteria communication 1801
Escherichia coli 139
EHEC signaling cascade 15965
EPEC 1667
luxS in EHEC 1523
gene regulation in Pseudomonas
aeruginosa 7, 8, 78
green fluorescent monitors 3, 77
green fluorescent sensors 768
homoserine lactone systems 11718
intracellular signals 66
las system 31
luxS in EHEC 1523
oligopeptide pathways 11819
oral streptococci 249
Pseudomonas aeruginosa 68
activity in vivo 1213
behavior regulation 14
biofilm development 6971
circuitry and PQS 245
las system 1, 4
rhl system 1, 4
therapeutic target 1315
virulence influence 912, 11
QseBC system through AI-3 163
regulation
in EPEC/EHEC 1667
in Vibrio 101
309
I
N
D
E
X
quorum sensing (QS) (cont.)
regulatory mutants 845
rhl system 31
Staphylococcus epidermidis 207 8
sae locus 212
SrrAB 212
staphylococcal 199 226
therapeutic tool 2246
streptococcal 2356
surface-associated behavior 67
systems
function 67 8
inhibition by C-30 14
through QseBC 163
TraR/TraI systems 47
Vibrio cholerae 101, 110
apparatus 106
infectious cycle 109
negative regulation of virulence genes
1067 , 111
QS-mediated virulence repression 107
regulation 104 6, 105
sensing systems 1046
targets 106 7
Vibrio harveyi 120
pathways 185
quorum sensing factors 19
quorum sensing inhibitor selectors 79,
80, 81
quorum sensing inhibitors (QSI) 66 8, 72,
75 6
antibiotic combination 8990
antibiotic synergism 90
anti-pathogenic therapy 678
biofilm effects 846
novel natural 7981
Pseudomonas aeruginosa QS suppression
88
pulmonary dose-response model 5 , 87
screens 768
novel 789
treatment model 889
quorum sensing regulon 7, 71
Pseudomonas aeruginosa 5, 89, 10
RbsB 1889, 190
rbsDACBK 189
RbsK 1889
red fluorescent protein 78
relA gene 8 9
Streptococcus mutans 13940
repABC operon 53
response regulator (RR) 236, 2545
BlpR 248
rhamnolipid 89
Rhizobiaceae 3940
rhizosphere 39
rhl system 1 9, 23 4, 31, 68
Pseudomonas aeruginosa 1 , 4
PQS relationship 245
Rhl1RRh1I system 68
rhlI gene 25
mutant 1011
S-ribosyl homocysteine (SRH) 1213
RIP/RAP QS system 224 6
RNAII 214
RNAIII 201 3, 204
cystic fibrosis 210, 215
fibrinogen depletion 21516
sarA mutants 214
Staphylococcus epidermidis 207
Staphylococcus saprophyticus 209
RopA 259
Rot virulence regulator 214
rpoN gene 89
rpoS gene 8 9
rr11 gene 258
rsmA gene 89
sae locus 212
salivary pellicle, colonizing bacteria 176
Salmonella
AI-2 153
PhoB/PhoR 162
SdiA 1645
Salmonella typhimurium
ABC transporter 153
AI-2 183
activity 1201
binding protein structure 124
signal transduction cascade 188
Lsr transporter 153
PmrB 161
SarA family 214
SdeK histidine protein kinase 2878
SdiA 1645
sed gene expression 2023
Serratia liquefaciens 70
inhibition by furanones 723
Serratia marcescens, luxS mutants 1301
Shiga toxin (Stx) 152
Shigella flexneri, luxS mutation 131
short-chain alcohol dehydrogenase (SCAD)
278
siderophores 185
enterobactin-like 185
sigma factor s
B
213
sigma X see ComX
skin infections 216
slime trail 2756
SLUSHpeptides, Staphylococcus lugdunensis
208
SmcR system 129
S-motility 2736, 2889
I
N
D
E
X
310
SocE 292
spa gene
expression 213
transcription inhibition 202
SpdR 292
sporulation 2857
SrrAB 212
sspAB genes 1767
staphylococcal enterotoxin A (SEA) 205
staphylococci 199226
agr homologs 20910
Agr specificity groups 20911
Agr variants
generation 223
in pathogenesis 2204
Agr-regulated genes 2037
AIP signal 2001
attachment 217
biofilms 21617
Agr 21819
agr gene mutants 220
antibiotic exposure 220
behavior 21617
detachment 21820
development 21617, 21920
maturation 21718
ClpP 213
ClpX 213
diseases 199
enterotoxins 2045
exoenzymes 204
exotoxins 204
expression 21112
fibrinogen 21516
hemolytic variants 222
with intermediate resistance to
glycopeptide antibiotics (GISA)
2212
QS 199226
therapeutic tool 2246
RIP/RAP QS system 2246
RNAII 214
RNAIII 2013, 204, 214
cystic fibrosis 215
SarA family 214
sigma factor s
B
213
surface adhesion 217
virulence 203, 2067
regulation by Agr 21112
Staphylococcus aureus
Agr evolution 2224
Agr QS system 199200
biofilm 216
capsular polysaccharide 2056
cystic fibrosis 137
gene array 207
oligopeptide signaling 118
Staphylococcus epidermidis
agr mutants in biofilm formation 220
biofilms 216
infections 2078, 211
QS 2078
Staphylococcus lugdunensis 208
SLUSH peptides 208
Staphylococcus saprophyticus 209
starvation
myxobacteria 2723
Myxococcus xanthus 2712, 292
streptococci
biofilms 1312
cell density-dependent competence
development 2356
regulation 23360
ComE response regulator 2412
ComX 242
dental plaque 136
genetic competence 2345
genetic transformation 2345
lactate production in dental biofilm 177
luxS/AI-2 QS systems 1312
oral 234, 24859
Porphyromonas gingivalis adherence
1867
quorum sensing 2356
Streptococcus cristatus, Porphyromonas
gingivalis adherence 17980
Streptococcus gordonii 1367
AI-2 secretion 187
cell density-dependent QS 257
ComD 240
genetic competence 253
infective endocarditis 250
interaction with saliva 1767
mixed biofilms 178
Porphyromonas gingivalis adherence
179, 1867
transformation 2504
Treponema denticola genetic exchange
257
Streptococcus intermedius biofilm 2578
Streptococcus mutans 136
dental caries 254
genetic competence 256
luxS 13940
oral cavity 2589
pathogenicity 258
relA 13940
RopA 259
survival 258
transformation 2549
virulence factors 254
Streptococcus pneumoniae
avirulent strain 2334
CiaRH TCSTS 2467
311
I
N
D
E
X
Streptococcus pneumoniae (cont.)
com AB locus 238
com regulon 2545
ComCDE competence regulon 23642
ComD sequence analysis 241
CSP-dependent QS 239
genetic competence
regulation 23648
shut off 2456
luxS mutant 140
oligopeptide signaling 118
R strain 2334
S strain 2334
Streptomyces, butyryl lactone signals 119
survival, multicellularity 2703
swarming 67
swr system 67
T cells 2045
tatC gene 11
TCP pathogenicity island 102, 109
TcpPH 103
TCSTS (two-component signal
transduction system) 236, 2467, 258
T-DNA transfer 401
Tfp 2735, 2889
Ti plasmids 46
tobramycin 845
TodK histidine protein kinase 2878, 292
TolB 276
TolQ 276
TolR 276
TonB 1845
Tox R regulon 103
toxA transcripts 1213
toxic shock 2045
d-toxin 2013, 204
cell detachment from biofilms 218
S. epidermidis 207
toxin-coregulated pilus (TCP) 102
ToxR regulon 102, 1067
ToxRS 103
ToxT 103
Tr1R 48, 56
tra box 50, 535
structure 2, 51
TraR-dependent promoters 54
tra genes 41
traI gene 434
TraM 468, 556
transcriptional autoregulation 162
transcriptomics 814
DNA microarray 81
transformation
groups 240
principle 2334
process 243
Streptococcus gordonii 2504
Streptococcus mutans 2549
transforming factor 2334
TRAP 2246
TraR
class I and II promoters 535
C-terminal DNA binding domain 52
cytoplasmic membrane binding 49
dimerization interface 502
function 503
inactivation 556
maturation 4950
models 54
N-terminal pheromone binding domain
52
OOHL polar interactions 523
post-transcriptional regulation of
activity 469
protection against proteolysis 567
structure 2, 503, 51
transcription activator 535
traR gene 434
expression regulation 445
regulation 46
TraR-dependent promoters 54
transcription start sites 535
TraR-TraI quorum-sensing system 42
trb genes 41
Treponema denticola
Porphyromonas gingivalis association 177
Streptococcus gordonii genetic
exchange 257
twin-arginine-translocation (TAT)
pathway 11
Veillonella, lactate production in dental
biofilm 177
vfr gene 89
Vibrio
AI-2 cell signaling 1289
AI-2 quorum sensing signal 188
Vibrio cholerae 10112
AI-2 signaling pathway 1289
autoinducers 112
biofilms 1078, 110
formation regulation 108
host infection 109
environmental fitness 111
environmental phase of life cycle 110
flagellar torque monitoring 108
infections 104
infectious cycle 1014
LuxQ 191
LuxU 191
pathogenicity 1014
QS 101, 110
apparatus 106
I
N
D
E
X
312
infectious cycle 109
negative regulation of virulence genes
1067, 111
regulation 1046, 105
sensing systems 1046
targets 1067
QS-deficient hapR mutants 108
QS-mediated virulence repression 107
toxigenic strains 111
virulence genes 102, 103
expression 1023, 111
QS negative regulation 1067, 111
Vibrio fischeri 43, 101
autoinducer 117
cell-to-cell signaling 1401
signaling pathways 129
Vibrio harveyi 101, 1046
AI-1 1345
AI-2 1345
luciferase operon 1046
LuxLM proteins 11718
LuxS protein 187
luxS/AI-2 pathway 11921
QS pathways 120, 185
reporter strain generation 11920
Vibrio polysaccharide synthesis (vps)
genes 108
Vibrio vulnificus 129
vicK gene 2589
vicR gene 2589
VicRK TCSTS 247
violacein 76
virulence
AHL-dependent QS 180
Escherichia coli
enterohemorrhagic (EHEC) 157,
158, 160
LuxS-dependent regulation 15168
LuxS-dependent regulation 1858
Pseudomonas aeruginosa 912
PQS 334
Porphyromonas gingivalis 1367, 1845
modulation by AI-2 186
regulation by Agr 21112
staphylococci 203, 2067
regulation by Agr 21112
virulence factors
Agr regulation 21112
Pseudomonas aeruginosa 1, 8, 234, 68
control by PQS 33
QS inhibitors 824
Streptococcus mutans 254
virulence genes
Agr regulation 204
Pseudomonas aeruginosa 910, 11
QS negative regulation 1067
regulation by Agr 21416
Vibrio cholerae 102, 103
expression 1023, 111
QS negative regulation 1067, 111
virulence regulator, Rot 214
vitronectin 206
vitronectin-binding protein 2067
VpsR response regulator 108
VpsT response regulator 108
vqsR gene 8
313
I
N
D
E
X
rhl l rhl R
RhlI RhlR
RhlR
RhlR
Target genes:
rhlAB rhlI lasB
Lasl
las l las R
LasR
LasR
LasR
Target genes:
lasB,A lasI toxA
xcpR,P apr rhlR
C
4
-HSL
C
4
-HSL
C
4
-HSL
C
4
-HSL
3-oxo-C
12
-HSL
3-oxo-C
12
-HSL
3-oxo-C
12
-HSL
3-oxo-C
12
-HSL
Figure 1.1. The las and rhl QS systems in P. aeruginosa. Both the las and rhl systems are
composed of a transcriptional regulator protein (LasR, RhlR) and an autoinducer synthase
(LasI, RhlI). The LasI synthase produces 3-oxo-C
12
-HSL, and the RhlI synthase produces
C
4
-HSL. The autoinducer then binds to its respective cognate protein. The LasR:3-oxo-
C
12
-HSL complex activates transcription of genes involved in the production of several
virulence factors, including lasB, aprA, and toxA, as well as upregulating transcription of lasI
and of rhlR. The RhlR:C
4
-HSL complex activates transcription of several genes involved in
virulence, including rhlAB.
(a)
(b)
(c)
G5
T4
210
9
9
N
C
C
N
206
1
3
1
3
Figure 3.3. Ternary structure of TraR, OOHL, and tra box DNA. (a) Just the N-terminal
domains of a dimer. The dimerization interface is highlighted, and is along the length of
-helix 9 of each monomer. The OOHL and water molecule bound in each N-terminal
domain are shown in space-fill and can be seen most clearly in the right-most monomer.
The linker between the N-terminal domains and the C-terminal domains is marked with a
C. (b) Just the C-terminal domains of the TraR dimer bound to DNA. Hydrogen bonds
between the side-chains of arginine 206 and 210 of the recognition helix and bases T4 and
G5 of the binding site are shown. The dimerization interface is also highlighted, along
-helix 13 of each monomer, and the linker between the NTD and CTD of each monomer is
marked with an N. (c) A view of a full dimer down the long axis of the DNA, showing the
asymmetry of the crystallized protein due to the flexible linkers. Coordinates for these
models are from references 81 and 92.
Green fluorescent cells Dark cells
(a)
(b)
No
signal
or
signal
block
+
signal
R
e
s
p
o
n
s
e
t
i
m
e
s
:
1
0
1
5
m
i
n
4
5
h
r
s
lasR
P
lasB
Gfp(ASV)
luxR
P
luxl
Gfp(ASV) luxR
P
luxl
Gfp(ASV)
lasR
P
lasB
Gfp(ASV)
Active receptor Blocked receptor AHL signal QSI
R
R
R
R
R
R
R*
R*
R*
R
Figure 4.2. (a) Molecular details of two green fluorescent QS monitors. The LuxR-based
monitor responds to a variety of AHL signals except for BHL, whereas the LasR-based
monitor primarily responds to OdDHL. (b) Microscopic inspection of Escherichia coli cells
carrying the LuxR-based monitor (right panels show fluorescent microscopy). The cells
respond to the addition of 10 nM OHHL by producing detectable amounts of the unstable
GFP protein. If the OHHL is removed by washing, or if a QSI compound is added which
blocks GFP synthesis, growing cells lose the GFP signal in 45 hours.
Figure 4.4. Gene expression atlas of QS-controlled genes and QSI target genes in
Pseudomonas aeruginosa PAO1. Upregulated genes are shown in green; downregulated
genes are red. QS-controlled gene expression is shown in the outer half of the atlas;
furanone C-30 target genes are indicated in the inner half. QS-controlled genes were
identified by growing a P. aeruginosa PAO1 lasIrhlI mutant with or without exogenous
AHL signals (2 mM OdDHL and 5 mM BHL) and retrieving samples for microarray analysis at
several culture densities. C-30 target genes were identified by growing P. aeruginosa PAO1
with or without 10 mM furanone C-30. P. aeruginosa PAO1 ORFs are shown in red (sense
strand) and blue (antisense strand) in the innermost circle. The outermost scale gives the
gene localization (in base pairs) in the genome. The color scale bar gives the correlation
between color coding and fold-change in gene expression.
R
R
OdDHL QSI
Time 0
(e)
Active receptor Blocked receptor
Figure 4.5. The pulmonary doseresponse model. (a) Mice are challenged intratracheally
with alginate beads containing P. aeruginosa. (b) Photomicrographs of mouse lung tissue
infected with P. aeruginosa. The arrow points at an alginate bead surrounded by numerous
PMNs. Adapted from reference (126). (c) QSI drugs can be injected intravenously in the tail
vein. (d, e) Mouse lung tissue infected with P. aeruginosa carrying the LasR-based monitor
PlasBgfp for detection of cell-to-cell signaling (green fluorescence) and a tag for simple
identification in tissue samples (red fluorescence) examined by SCLM. (d) Mice were
administered C-30 via intravenous injection at time zero. (e) Infected animals were
sacrificed in groups of three at the time point indicated and the lung tissue samples were
examined by SCLM according to Hentzer et al. (43). Parts (d) and (e) are adapted from (43).
Figure 9.3. Three-dimensional reconstruction of a Staphylococcus aureus biofilm. Cells
expressing a quorum-controlled green fluorescent protein reporter are green; the
remaining biofilm is red from staining with propidium iodide. Each side of the grid
represents about 600mm.